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  The exosome is a 3’ to 5’ exoribonuclease complex that consists of ten essential 
subunits. In the cytoplasm, the exosome degrades mRNA in a general mRNA turnover pathway 
and in several mRNA surveillance pathways. In the nucleus, the exosome processes RNA 
precursors to form small, stable, mature RNA species, including rRNA, snRNA, and snoRNA. In 
addition to processing these RNAs, the nuclear exosome is also involved in degrading aberrantly 
processed forms of these RNAs, and others, including mRNA.  
The 3’ to 5’ exoribonuclease activity of the exosome is contributed by the RNB domain 
of the only catalytically active subunit, Rrp44p, a member of the RNase II family of enzymes. In 
addition to the RNB domain, Rrp44p consists of three putative RNA binding domains and has an 
uncharacterized N-terminus, which includes a CR3 region and PIN domain. In an effort to 
characterize the cellular functions of the domains of Rrp44p,  this study identified a second 
nuclease active site in the PIN domain. Specifically, the PIN domain exhibits endoribonuclease 
activity in vitro and is essential for exosome function. Further analysis of the nuclease activities 
of Rrp44p indicate a role for the exoribonuclease activity of Rrp44p in the cytoplasmic and 
nuclear exosome.  
This work has also characterized the CR3 region of Rrp44p, a region that has not yet 
been characterized in any other protein. This region is needed for the majority, if not all, of the 
cytoplasmic exosome functions as well as for interaction with the exosome. The CR3 region, 
along with a histidine residue in the N-terminus of Rrp44p, may coordinate a zinc atom. 
Preliminary evidence supports a role for this coordination in exosome function. Further 
investigation, however, is needed to determine the molecular dependence of the exosome on the 
CR3 region of Rrp44p.  
Despite its initial discovery thirteen years ago, the essential function of Rrp44p, and the 
exosome, is not yet known. The studies presented here, however, indicate that the essential 
function of Rrp44p and the exosome is in the nucleus and depends on the nuclease activities of 
Rrp44p.  
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Chapter 1: Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
INTRODUCTION AND BACKGROUND 
Eukaryotic RNA metabolism and surveillance 
 RNA metabolism and function in eukaryotes requires a transition of RNAs between 
different cellular compartments and protein complexes. For example, mRNA metabolism 
involves transcription, nuclear processing, nuclear-cytoplasmic transport, translation, and 
ultimately cytoplasmic degradation. During these processes, mRNA associates with a variety of 
complexes that are needed for mRNA biogenesis, function, and degradation. In addition, these 
complexes promote the association and disassociation of cofactors that regulate these steps of 
mRNA metabolism and, thus, dictate the function and half-life of an mRNA (Dreyfuss et al., 
2002; Moore, 2005). 
 Similarly, the small, stable RNAs of the nucleus, including small nuclear (sn)RNA, 
small nucleolar (sno)RNA, rRNA, and tRNA, are subject to the same mechanisms of 
metabolism. In the nucleus, however, the biogenesis of these RNAs, as well as the protein 
complexes they encounter, differ from that of mRNAs. These nuclear complexes are not only 
responsible for the synthesis of nuclear RNAs, but they also serve as a checkpoint to ensure 
RNAs are functional prior to their export into the cytoplasm (Nazar, 2004; Wolin and Matera, 
1999).  
Aberrant RNAs arise through mistakes in gene expression, and not surprisingly, there 
are many ways in which gene expression can be faulty. For example, aberrant mRNAs can arise 
from mutations in the gene, which can lead to transcripts that lack termination codons or contain 
premature termination codons. Typically these transcripts produce truncated proteins and/or 
proteins that have a dominant-negative effect. Aberrant RNAs can also arise due to a defect in 
ribonucleoprotein (RNP) assembly or nuclear pre-RNA processing, from the inherent error rate 
of transcription, or through transcription of intergenic regions. To prevent the harmful effects of 
these aberrant RNAs, the cell has adopted specialized RNA degradation pathways, termed RNA 
surveillance. Interestingly, the same cellular machinery can degrade normal and aberrant RNAs. 
Therefore, it is important to understand the regulation of RNA turnover, how normal and 
aberrant RNAs are differentiated, and what factors are involved.  
 One protein complex that is involved in both cytoplasmic and nuclear RNA metabolism 
is the eukaryotic exosome. This complex of proteins associates with a variety of cofactors to 
promote the processing and degradation of RNAs, and also acts as a quality control mechanism 
to rapidly degrade aberrant RNAs. 
 
 
2 
The eukaryotic exosome 
The eukaryotic exosome consists of 10 essential subunits. These subunits were initially 
identified genetically in the budding yeast Saccharomyces cerevisiae in independent screens for 
mutants that were defective in rRNA maturation (Mitchell et al., 1996) and cytoplasmic mRNA 
transport, mutants that accumulated poly(A) RNA in the nucleus (Kadowaki et al., 1994), and for 
mutants that expressed viral toxins (Ridley et al., 1984). Although these studies identified the 
exosome subunits for their unique mutant phenotypes, further genetic and biochemical analysis 
was required to show that these subunits are a part of a large complex that was subsequently 
named the exosome (Mitchell et al., 1997). Further analysis indicated that the exosome is highly 
conserved in eukaryotes. Additionally, the 10 subunit exosome was found to be present in both 
the cytoplasm and the nucleus (Allmang et al., 1999b).  
 
The composition and structure of the eukaryotic exosome  
 Sequence analysis of several exosome subunits revealed similarities to bacterial RNase 
PH, PNPase, RNase II, and RNase R. Specifically, six of the subunits (Rrp41p, Rrp42p, Rrp43p, 
Rrp45p, Rrp46p, and Mtr3p; Table 1.1) assemble into three distinct heterodimers to form a ring, 
or channel structure (Figure 1.1), that structurally resembles the PH ring in bacterial PNPase and 
the archaeal exosome (Buttner et al., 2005; Liu et al., 2006; Lorentzen and Conti, 2005). The 
subunits that constitute the PH ring were named for their homology to RNase PH (Zuo and 
Deutscher, 2001). RNase PH is a phosphorolytic 3’ to 5’ exoribonuclease, in that it uses an 
inorganic phosphate to cleave RNA from the 3’-end. Specifically, RNase PH processes, or trims, 
bacterial tRNA precursors to form mature tRNA species (Wen et al., 2005).  Although these 
subunits are catalytically active in PNPase and the archaeal exosome (Buttner et al., 2005; 
Lorentzen and Conti, 2005; Navarro et al., 2008; Symmons et al., 2000), the six PH subunits of 
the yeast and human exosome are catalytically inactive due to mutations the RNase PH-like 
active sites (Dziembowski et al., 2007; Liu et al., 2006). This suggests that the ring of the 
exosome is not the catalytic center of the exosome, but rather acts as a protein scaffold that may 
be needed for the recruitment of exosome cofactors. This, however, is not the case in all 
eukaryotes. Interestingly, Arabidopsis thaliana Rrp41p has retained the phosphorolytic 3’ to 5’ 
exonuclease activity of RNase PH (Chekanova et al., 2000). It is not yet known how the 
enzymatic activity of this subunit contributes to the overall activity of the exosome in plants. 
 The PH ring of the eukaryotic exosome is not stable on its own in vitro. Specifically, 
formation of the ring requires three additional proteins (Rrp4p, Rrp40p, and Csl4p; Table 1.1) 
that bind to one side of the PH ring, forming a cap (Figure 1.1; Liu et al., 2006). These subunits 
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Figure 1.1: Schematic representation of the eukaryotic exosome and domain 
organization of Rrp44p. 
A. 
B. 
C. 
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Figure 1.1: Schematic representation of the eukaryotic exosome and domain organization 
of Rrp44p. A, A top view, looking down through the exosome. B, A side view of the exosome. 
The exosome contains a PH ring of six proteins that have RNase PH domains. Assembly and/or 
stability of the PH ring require three additional proteins that form a cap on top of the ring. 
Between the cap proteins, there are five putative RNA binding domains. The exoribonuclease 
activity of the exosome is provided by a tenth subunit, Rrp44p, that associates with the bottom of 
the PH ring. RNA substrates are thought to associate with the cap proteins, pass through the 
central channel, and are degraded by Rrp44p after they emerge from the bottom of the ring. C, 
Rrp44p consists of six putative regions/domains. In the N-terminus, is a CR3 region, which 
consists of at least three conserved cysteine residues, and a PIN domain, which is a putative 
nuclease domain. Rrp44p has homology to two bacterial proteins, RNase II and RNase R. In the 
RNase II/R homology region, are three putative RNA binding domains, including two 
consecutive Cold Shock Domains (CSD1 and CSD2) and an S1 domain. Separating the putative 
RNA binding domains is the 3’ to 5’ exoribonucleolytic RNB domain. This domain is solely 
responsible for the 3’ to 5’ exoribonuclease activity of the exosome. 
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are not homologous to any known nucleases, and instead contain RNA binding domains of either 
the KH (K-homology domain; Grishin, 2001) or S1 (ribosomal protein S1) type (Suryanarayana 
and Subramanian, 1984). Therefore, in addition to stabilizing the exosome, these cap proteins are 
thought to bind the RNA substrates of the exosome.  
 
The catalytic subunit of the eukaryotic exosome, Rrp44p 
The tenth subunit of the exosome, Rrp44p, is the only catalytically active subunit of the 
yeast (Dziembowski et al., 2007; Liu et al., 2006) and Drosophila exosome (Mamolen and 
Andrulis, 2009) with its 3’ to 5’ exoribonuclease activity contributed by the RNB domain 
(Dziembowski et al., 2007). This is also likely the case in humans, where the other nine exosome 
subunits are catalytically inactive (Liu et al., 2006). The RNB domain is also found in two 
bacterial enzymes that are homologous to Rrp44p, RNase II and RNase R (Table 1.1). These 
enzymes are hydrolytic 3’ to 5’ exoribonucleases, in that they use a water molecule to degrade 
mRNA from the 3’-end (Cannistraro and Kennell, 1994; Cheng and Deutscher, 2002). In 
addition to sharing the RNB domain, these proteins also share three putative RNA binding 
domains, two consecutive cold shock domains (CSDs) and a C-terminal S1 domain (Figure 1.1).  
In all three proteins, these domains are positioned on one side of the RNB domain, with ssRNA 
threaded through the putative RNA binding domains such that the 3’-end of the RNA rests in the 
catalytic site of the RNB domain (Bonneau et al., 2009; Frazao et al., 2006; Lorentzen et al., 
2008; Zuo et al., 2006). Biochemically, Rrp44p is more similar to RNase R. Unlike RNase II, 
RNase R and Rrp44p are able to degrade structured RNAs and double stranded RNAs that 
contain a single stranded 3’ overhang (Dziembowski et al., 2007; Vincent and Deutscher, 2006).  
 While the RNase II/R homologous region of Rrp44p constitutes the middle- and C-
terminal portion of the protein, the N-terminus of Rrp44p is not well characterized. This is due, 
in part, to a lack of functional and structural data on this region. Despite the large number of 
recent studies on the catalytic subunit of the exosome, these reports have focused only on the 
nuclease activities of the Rrp44p (Dziembowski et al., 2007; Lorentzen et al., 2008; Mamolen 
and Andrulis, 2009; Schneider et al., 2007) or on the structure of the exosome (Bonneau et al., 
2009; Liu et al., 2006; Lorentzen et al., 2008; Wang et al., 2007). Recently, crystal structures of 
Rrp44p were published (Bonneau et al., 2009; Lorentzen et al., 2008), however, both structures 
lack the first 33 residues (Bonneau et al., 2009). Sequence analysis shows that the far N-terminus 
of Rrp44p, which includes residues 1-46, contains a linker region of a conserved stretch of 
residues, residues 34-46. This region is then followed by a CR3 region, which consists of three 
conserved cysteine residues (C47, C52, and C55; Figure 1.1). Currently, no information exists on 
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the CR3 region in Rrp44p or in any other protein, and because the crystal structure of Rrp44p 
lacks the first 33 residues, it is not yet known whether the CR3 region consists of more than the 
three cysteine residues or if this region has a unique fold. 
Sequence analysis of the N-terminus of Rrp44p also revealed the presence of a PIN 
domain (Figure 1.1). PIN domains, named for their homology to a bacterial pilus biosynthetic 
protein, are found in all three kingdoms of life. These domains are approximately 100 residues in 
length and are characterized by a motif of four conserved acidic residues (Clissold and Ponting, 
2000; Makarova et al., 1999). Similar acidic residue conservation occurs in enzymes that ligate 
divalent cations, including nucleases. In support of this, several PIN domain-containing proteins 
exhibit nuclease activity in vitro and in vivo (Arcus et al., 2004; Bleichert et al., 2006; Daines et 
al., 2007; Fatica et al., 2004; Glavan et al., 2006; Levin et al., 2004). Because the PIN domain of 
Rrp44p has these four conserved acidic residues, this domain may also have nuclease activity. 
Despite the little information that is available on the N-terminus of Rrp44p, sequence analysis 
shows a possible link between the CR3 region and the PIN domain, as CR3 regions are present 
in most eukaryotic homologs of Rrp44p that have a PIN domain.  
 The association of Rrp44p with the exosome is controversial and seems to depend on the 
organism. For example, in yeast and Drosophila, Rrp44p only loosely associates with the 
exosome (Allmang et al., 1999b; Graham et al., 2009). In contrast, although homologs of Rrp44p 
are present in humans, Arabidopsis, and trypanosomes, Rrp44p does not associate with the 
exosome in these organisms (Allmang et al., 1999b; Chekanova et al., 2002; Estevez et al., 
2001). This lack of interaction, however, could be an artifact of the biochemical assays used to 
detect exosome interaction. Regardless of its interaction with the exosome, Rrp44p is clearly 
important for the exosome in a variety of eukaryotes (Mamolen and Andrulis, 2009; Shiomi et 
al., 1998).  
 
Eukaryotic exosome cofactors 
The cellular localization of the exosome dictates its association with exosome cofactors. 
These cofactors play a dual role in regulating exosome activity. First, because the intrinsic 
exonucleolytic activity of the exosome is low, exosome cofactors are required to stimulate the 
catalytic activity of the exosome. Additionally, exosome cofactors are needed to direct the 
exosome to specific RNA substrates.  
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Cytoplasmic exosome cofactors 
In the cytoplasm, the exosome is solely involved in mRNA degradation (see below). 
Here the exosome associates with, and is activated, by the Ski complex and Ski7p (Table 1.1). 
The Ski complex consists of Ski2p, Ski3p, and Ski8p. Ski2p is a putative DEVH-box RNA 
helicase (Widner and Wickner, 1993) that may function to remove mRNA-bound proteins or 
secondary structures from mRNAs. Ski7p is a small GTPase that is homologous to eEF1A and 
eRF3 (Benard et al., 1999) and interacts with both the Ski complex and the exosome (Araki et 
al., 2001). Because Ski7p can interact with both complexes, it may bridge the interactions 
between the Ski complex and the exosome. Additionally, Ski7p is thought to aid in the 
recognition of specific RNA substrates, causing recruitment of the exosome, and ultimately 
leading to the 3’ to 5’ decay of these mRNAs (Frischmeyer et al., 2002; Mitchell and Tollervey, 
2003; van Hoof et al., 2002). Thus far, it is not yet known how the Ski complex and Ski7 
activate the exosome. 
 
Nuclear exosome cofactors 
In contrast to the cytoplasmic exosome, the nuclear exosome is involved in RNA 
processing and RNA degradation. In RNA processing, an RNA precursor is trimmed to form a 
mature RNA, however, in RNA degradation, an RNA substrate is completely degraded to 
nucleotide monophosphates. The nuclear exosome processes and degrades “normal” RNAs, 
however, the major role of the nuclear exosome is its degradation of aberrantly processed RNAs 
(see below). The association of nuclear exosome cofactors determines whether the nuclear 
exosome processes or degrades a specific RNA substrate. 
The nuclear exosome associates with at least three proteins, Rrp6p, Rrp47p, and Mpp6, 
and at least one protein complex called TRAMP (Table 1.1). Rrp6p is the only other catalytically 
active nuclease subunit that associates with the exosome. Specifically, Rrp6p is a hydrolytic 3’ to 
5’ exoribonuclease that is needed for most, if not all, of the nuclear exosome functions (Allmang 
et al., 1999a; Briggs et al., 1998; Butler, 2002; Fatica et al., 2000; van Hoof et al., 2000a). 
Rrp47p also associates with the nuclear exosome and is required for nuclear RNA processing, 
but not for nuclear RNA surveillance (Mitchell et al., 2003). Mpp6p is an RNA binding protein 
that, like Rrp47p, is only needed for specific nuclear exosome functions. Specifically, Mpp6p is 
needed for the recognition of specific RNA elements in nuclear RNA surveillance (Milligan et 
al., 2008; Schilders et al., 2005). Lastly, the nuclear exosome associates with, and is activated 
by, a complex of proteins called TRAMP (for Trf4/5-Air1/2-Mtr4). This complex constitutes a 
non-canonical poly(A) polymerase (Trf4p or Trf5), a zinc knuckle protein (Air1p or Air2p), and 
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a DEVH-box RNA helicase (Mtr4p). The TRAMP complex is solely involved in nuclear RNA 
surveillance, whereby Air1/2 is thought to bind an RNA substrate, which is then polyadenylated 
by Trf4/5, and subsequently degraded by the nuclear exosome (Davis and Ares, 2006; Egecioglu 
et al., 2006; Houseley and Tollervey, 2006; LaCava et al., 2005; Vanacova et al., 2005; Wyers et 
al., 2005). Mtr4p is thought to unwind any secondary structures and also directly associates with 
the exosome (Milligan et al., 2008; Peng et al., 2003; Schilders et al., 2007), providing a link 
between the TRAMP complex and the exosome.  
One similarity between the cytoplasmic and nuclear exosome is that both associate with 
a helicase. This association may facilitate the degradation of structured RNA substrates or 
protein-bound RNAs. Not surprisingly, a similar association is seen in the RNA degradation 
machine in E. coli, termed the degradosome. Here, the RhlB helicase is a key component of the 
at least four-member complex (Py et al., 1996). Therefore, the association of additional 
enzymatic activities with RNA degradation systems seems to be a common theme in nature.  
Not surprisingly, exosome cofactors also impart differences between the cytoplasmic 
and nuclear exosome. Specifically, the cofactors influence how polyadenylation ultimately 
affects the fate of an RNA. In the cytoplasm, polyadenylation stabilizes transcripts, making them 
resistant to nucleolytic cleavage, and more amenable to translation. In contrast, polyadenylation 
in the nucleus is similar to that in bacteria, where polyadenylation triggers rapid degradation 
(Carpousis, 2007; Dreyfus and Regnier, 2002). This difference is one of many between the 
cytoplasmic and nuclear exosome. In fact, the cofactors exist in the cytoplasm and nucleus to 
direct the exosome to different RNA substrates and help tailor the catalytic activity of the 
exosome to these distinct RNAs. 
 
Functions of the cytoplasmic exosome 
General 3’ to 5’ mRNA degradation 
 Two general pathways of eukaryotic mRNA degradation have been identified using S. 
cerevisiae as a model system (Figure 1.2; Decker and Parker, 1993; Muhlrad and Parker, 1994). 
The initiating and rate-limiting step in both of the degradation pathways is the shortening of the 
poly(A) tail, in a process termed deadenylation. In yeast, the initial shortening of the poly(A) tail 
is catalyzed by the Pan2p/Pan3p complex, whereas the majority of deadenylation is performed 
by the Ccr4p/NOT complex (Muhlrad and Parker, 1992; Tucker et al., 2001). Removal of the 
poly(A) tail triggers cytoplasmic 5’ to 3’ decay in yeast. In this pathway, the 5’ cap is removed 
by the decapping complex, which consists of Dcp1p and Dcp2p. This exposes the 5’-end of an 
mRNA to the 5’ to 3’ exoribonuclease, Xrn1p, which is responsible for degrading an mRNA 
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Figure 1.2: Schematic representation of the two cytoplasmic mRNA degradation 
pathways in eukaryotes. 
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Figure 1.2: Schematic representation of the two cytoplasmic mRNA degradation pathways 
in eukaryotes. Two general pathways exist in the cytoplasm to degrade eukaryotic transcripts. 
Both pathways require removal of the poly(A) tail (deadenylation) as the first step. In one 
pathway, deadenylation is followed by removal of the 5’ cap (decapping) and degradation of the 
body of the mRNA by the 5’ to 3’ exoribonuclease, Xrn1p. In the second pathway, the body of 
the mRNA is degraded by the 3’ to 5’ exoribonucleolytic complex, the exosome.  
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from its 5’-end (Decker and Parker, 1993; Hsu and Stevens, 1993; Muhlrad et al., 1994). 
Deadenylation can also trigger the degradation of an mRNA from its 3’-end, a process catalyzed 
by the cytoplasmic exosome and the cytoplasmic exosome cofactors, Ski7p and the Ski complex 
(Anderson and Parker, 1998; Mukherjee et al., 2002; Rodgers et al., 2002). Following decay of 
the body of the transcript, the scavenger decapping complex, which consists of Dcs1p and 
Dcs2p, removes the 5’ cap from the remaining oligonucleotide (Wang and Kiledjian, 2001). The 
enzymes involved in these decay pathways are conserved in other eukaryotes and inactivation of 
both mRNA decay pathways results in loss of viability (Anderson and Parker, 1998; Johnson and 
Kolodner, 1995). This conservation and the requirement for cellular mRNA decay underscore 
the importance of eukaryotic mRNA turnover. 
 
Cytoplasmic degradation of aberrant transcripts 
  The cytoplasmic exosome is also involved in mRNA surveillance pathways, whereby 
exosome cofactors and adaptor proteins distinguish aberrant mRNAs from normal mRNAs, and 
ultimately direct the aberrant transcripts to the exosome for rapid degradation. Specifically, the 
cytoplasmic exosome degrades transcripts that lack termination codons (Frischmeyer et al., 
2002; van Hoof et al., 2002) or poly(A) tails (Meaux and van Hoof, 2006), and transcripts that 
have premature termination codons (Mitchell and Tollervey, 2003; Takahashi et al., 2003) or 
cause stalls in translation elongation (Doma and Parker, 2006). Not surprisingly, the rate-limiting 
step of deadenylation is bypassed in these mRNA surveillance pathways to rapidly rid the cell of 
these potentially harmful transcripts.   
Transcripts that lack termination codons, termed nonstop transcripts, can arise from 
mistakes in gene expression, including genetic mutations, defects in transcription, or premature 
polyadenylation, due to inaccurate 3’-end formation or through the use of a cryptic 
polyadenylation site (Bucheli et al., 2007). These transcripts are degraded in a process termed 
the nonstop mRNA degradation pathway (Figure 1.3; Frischmeyer et al., 2002; van Hoof et al., 
2002). In the current model of nonstop decay, the translating ribosome reads through the poly(A) 
tail and stalls at the 3’-end. The cytoplasmic exosome cofactor, Ski7p, is then believed to 
recognize the ribosome with an empty A-site, and along with the Ski complex, recruits the 
exosome to rapidly degrade the transcript from the 3’-end (van Hoof et al., 2002).  
Transcripts that cause stalls in translation elongation, perhaps due to secondary structure, 
are also degraded by the cytoplasmic exosome in a process termed no-go decay (Doma and 
Parker, 2006). In the current model of no-go decay, a ribosome stalls during translation 
elongation. Hbs1p and Dom34p, paralogs of eRF3 and eRF1, respectively, then recognize the 
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Figure 1.3: Schematic representation of the cytoplasmic nonstop mRNA degradation 
pathway in eukaryotes. 
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Figure 1.3: Schematic representation of the cytoplasmic nonstop mRNA degradation 
pathway in eukaryotes. In the current model of nonstop mRNA decay, a translating ribosome 
stalls at the 3’-end of an mRNA that lacks in-frame termination codons, termed a nonstop 
transcript. The stalled ribosome is then thought to be recognized by the cytoplasmic exosome 
cofactors, Ski7p and the Ski complex. Ski7p then recruits the exosome, which rapidly degrades 
the nonstop transcript from its 3’-end. This mRNA surveillance pathway differs from general 3’ 
to 5’ mRNA degradation in that prior removal of the poly(A) tail is not required. 
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stalled ribosome. The ribosome is then released by endonucleolytic cleavage, which generates a 
5’- and 3’-degradation intermediate. The 5’-degradation fragment is degraded by the exosome, 
with help from the cytoplasmic exosome cofactors, Ski7p and the Ski complex. The 3’-
degradation fragment is degraded by the 5’ to 3’ exoribonuclease, Xrn1p (Figure 1.4; Doma and 
Parker, 2006). The endoribonuclease responsible for the initial cleavage of the transcript has not 
yet been identified. Additionally, it is not yet known how Hbs1p and Dom34p recognize the 
stalled ribosome or recruit the endonuclease. 
Several of the aberrant transcripts targeted by the cytoplasmic exosome have harmful 
and deleterious effects on the cell, and can even lead to disease (Ameri et al., 2007; Bulman et 
al., 1991; Chatr-Aryamontri et al., 2004; Kerem et al., 1990; Yasuda et al., 2003). The 
participation of the exosome in the cytoplasmic mRNA surveillance pathways used to degrade 
these aberrant mRNAs ensures that these transcripts are rapidly degraded and are, thus, unable to 
exert their negative effects on the cell.  
 
Antiviral activity of the cytoplasmic exosome 
 Many yeast strains contain the L-A virus and the M satellite RNA. The L-A virus 
encodes an RNA-dependent RNA polymerase. The M satellite RNA encodes a protein toxin that 
is secreted from infected cells that ultimately kills uninfected cells. In a screen for “superkiller” 
mutants, or mutants that were able to kill uninfected cells more efficiently, several SKI genes 
were identified (Toh and Wickner, 1980). Many of these SKI genes encode exosome subunits 
and cytoplasmic exosome cofactors, including Ski7p and components of the Ski complex (Ski2p, 
Ski3, and Ski8p). The molecular mechanism of the exosome/Ski complex antiviral function is 
not completely understood, however, it seems that the cytoplasmic exosome limits killer toxin 
secretion by degrading unadenylated viral RNA (Brown et al., 2000; Meaux and van Hoof, 
2006). Future studies are needed to determine whether the exoribonuclease activity of the 
exosome is needed for this degradation and, thus, for the antiviral function of the cytoplasmic 
exosome. 
 
Functions of the nuclear exosome 
General nuclear RNA processing and degradation 
 The nuclear exosome processes and degrades RNA. Specifically, the nuclear exosome 
processes RNA precursors, including snRNA, snoRNA and rRNA to form small, stable, mature 
RNA species. In yeast, ribosomal RNA processing begins with the 35S rRNA precursor, which 
contains the sequences for the mature 18S, 5.8S, and 25S rRNAs, which are separated by two 
16 
Figure 1.4: Schematic representation of the cytoplasmic no-go decay pathway in 
eukaryotes. 
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Figure 1.4: Schematic representation of the cytoplasmic no-go decay pathway in 
eukaryotes. In the current model of no-go decay, a translating ribosome stalls during translation 
elongation, possibly due to secondary structure in the transcript. The stalled ribosome is then 
thought to be recognized by the eRF3 and eRF1 paralogs, Hbs1p and Dom34p, respectively. An 
unidentified endoribonuclease then cleaves the transcript, releasing the stalled ribosome, and 
generating a 5’- and 3’-degradation fragment. The 5’- and 3’-degradation fragments are 
degraded by the cytoplasmic exosome and the 5’ to 3’ exoribonuclease, Xrn1p, respectively.  
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internal transcribed spacers, the ITS1 and the ITS2. On either ends of the 35S rRNA precursor, 
are two external transcribed spacers, the 5’ ETS and the 3’ ETS. Processing of 35S rRNA 
precursor liberates the mature rRNAs, which are subsequently packaged into the small and large 
ribosomal subunits. The nuclear exosome and the nuclear exosome cofactor, Rrp6p, are involved 
in two steps of 35S rRNA processing (Figure 1.5). In the first cleavage event, the 35S rRNA 
precursor is cleaved at site A0, liberating the 5’ ETS. The nuclear exosome and Rrp6p then 
degrade the 5’ ETS to completion (de la Cruz et al., 1998).  
The nuclear exosome and Rrp6p are also involved in processing the 7S rRNA precursor 
to form the mature 5.8S rRNA (Figure 1.5). Cleavage at the B1L and B1S sites generates the long 
and short forms of the 7S rRNA precursor (7SL and 7SS). The nuclear exosome then converts the 
7SL/S pre-rRNAs to 5.8SL/S+30 [5.8S pre-rRNA species that are 3’-extended by approximately 30 
nucleotides] (Allmang et al., 1999a). Rrp6p then processes the 5.8SL/S+30 pre-rRNAs to 6SL/S 
[5.8S pre-rRNA species that are 3’-extended by approximately five to eight nucleotides] (Briggs 
et al., 1998). The 6SL/S pre-rRNAs are then exported to the cytoplasm where the final maturation 
step is completed to form the mature 5.8SL/S rRNA (Thomson and Tollervey, 2010). 
 
Nuclear RNA surveillance 
Aberrant nuclear RNAs are typically generated due to defects in nuclear pre-RNA 
processing. There are three nuclear quality control systems to prevent the function of these 
defective RNAs, including export to the cytoplasm for cytoplasmic RNA decay, nuclear 
retention, and nuclear RNA degradation. The majority of transcripts that are targeted to the latter 
quality control system are degraded by the nuclear exosome, with the help of the nuclear 
exosome cofactors, Rrp6p and the TRAMP complex (Table 1.1). Specifically, the nuclear 
exosome degrades mRNAs that have defects in 3’-end processing (Libri et al., 2002; Torchet et 
al., 2002) or splicing (Bousquet-Antonelli et al., 2000). The nuclear exosome also degrades 
improperly modified tRNAs, including the hypomodified initiator tRNAiMet (Kadaba et al., 2004; 
Kadaba et al., 2006), as well as improperly processed rRNA, snRNA and snoRNA precursors 
(Egecioglu et al., 2006; LaCava et al., 2005). In addition to degrading RNAs that are improperly 
processed or modified, the nuclear exosome also degrades cryptic unstable transcripts (CUTs), 
which result from the transcription of intergenic regions. These transcripts ultimately result in 
small noncoding RNAs that are highly unstable in wild-type cells (Davis and Ares, 2006; Wyers 
et al., 2005).  
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Figure 1.5: Nuclear 35S pre-rRNA processing in S. cerevisiae 
A. 
B. 
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Figure 1.5: Nuclear 35S pre-rRNA processing in S. cerevisiae. A, The 35S rRNA precursor 
contains the sequences for the mature 18S, 5.8S, and 25S rRNAs. These rRNA sequences are 
separated by two internal transcribed spacers, ITS1 and ITS2, and are flanked by two external 
transcribed spacers, the 5’ ETS and the 3’ ETS. There are 11 processing sites in the 35S rRNA 
precursor, which are used to generate the mature rRNAs. B, The 35S pre-rRNA is cleaved at 
sites A0 and A1, generating the 5’ ETS fragment and the 32S pre-rRNA. This RNA is 
subsequently processed at sites A2, D, A3, B2, and B1L/S, resulting in the production of the long 
and short forms of the 27SB rRNA precursor (27SBL and 27SBS). The 27SBL/S pre-rRNAs are 
cleaved at site C2, generating the 7S L/S pre-rRNAs. The nuclear exosome then processes these 
rRNA precursors to form the 5.8SL/S+30 (5.8S pre-rRNA species that are 3’ extended by 
approximately 30 nucleotides). The nuclear exosome cofactor, Rrp6p, then further processes the 
5.8SL/S+30 pre-rRNA to 6SL/S (5.8S pre-rRNA species that are 3’ extended by approximately five 
to eight nucleotides). The 6SL/S pre-rRNAs are then exported to the cytoplasm where they 
undergo the final step of maturation, which generates the mature 5.8S rRNA. 
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The nuclear retention and degradation of these aberrant RNAs is an important 
checkpoint because cytoplasmic export of these defective RNAs could lead to deleterious effects 
on the cell if these RNAs escape the cytoplasmic RNA degradation machinery.  
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SIGNIFICANCE OF THE STUDY 
 Eukaryotic RNA metabolism is important in the post-transcriptional regulation of gene 
expression and is required to maintain the fidelity of gene expression. Not surprisingly, the key 
components involved in RNA metabolism are conserved in other eukaryotes and are required for 
optimal cell growth or viability. One key component of eukaryotic RNA metabolism is the 
exosome, a complex of ten essential proteins that is present in the nucleus and the cytoplasm. 
 When this study started, little was known about the catalytic subunit of the exosome, 
Rrp44p, and its involvement in regulating RNA metabolism. Specifically, it was not known 
which regions of the protein were needed for viability, exosome association, or exosome 
function. The data presented in these studies have uncovered new regions and activities of 
Rrp44p that influence the function of not only Rrp44p, but of the exosome. 
Thirteen years after the discovery of the exosome, this study has demonstrated the 
presence of an additional nuclease active site in Rrp44p. Specifically, Chapter 3 describes the 
endoribonuclease active site of Rrp44p, the physiological importance of this nuclease activity, 
and how the endoribonucleolytic PIN domain interacts with the well-characterized 
exoribonucleolytic RNB domain of Rrp44p. This breakthrough finding will force the RNA 
metabolism field to re-evaluate how eukaryotic RNAs are recognized and degraded by the 
exosome.  
Prior to this study, it was not known why Rrp44p was required for viability. Here, 
several Chapters describe the regions of Rrp44p that are needed for optimal cell growth and 
viability. Specifically, the N-terminus of Rrp44p, as well as the nuclease activities of the protein, 
are needed for cell survival. Most importantly, data in Chapter 6 suggest that the essential 
function of Rrp44p is likely nuclear.  
Before this study was started, Rrp44p was known to loosely associate with the yeast 
exosome, however, it was not known which regions of the protein mediated this interaction. The 
data presented here show that not just one region of Rrp44p is needed for exosome interaction. 
Specifically, Chapters 5 and 6 show that two separate regions in the N-terminus of Rrp44p are 
needed for exosome association. These results, combined with several other biochemical and 
genetic analyses, demonstrate that multiple regions of Rrp44p are involved in exosome 
interaction, suggesting that these regions may be redundant for exosome association. 
Lastly, this study uncovered a novel region of Rrp44p, the CR3 region, which has not 
yet been described in any other protein. The data in Chapter 5 suggest that CR3 region is needed 
for a large number of exosome functions, including the essential function. Additionally, recent 
structural data, coupled with in vitro biochemical analysis, suggest that this region is needed to 
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coordinate a zinc ion. The implications of this coordination may help to explain why mutating 
the CR3 region results in numerous exosome defects. 
Taken together, the results of these studies show that the catalytic subunit of the 
eukaryotic RNA degrading exosome, Rrp44p, has novel nuclease activity and has a region that is 
important for the function of Rrp44p and the exosome. The studies presented in this dissertation 
contribute to a better understanding of eukaryotic RNA metabolism, both its role as a post-
transcriptional regulator of gene expression and as a quality control mechanism to maintain the 
fidelity of gene expression. These studies also provide a foundation for further studies on the 
CR3 region, and nuclease activities, of Rrp44p and how they are involved in exosome function. 
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Strains and Plasmids 
The yeast strains used in these studies are described in Table 2.1. All of the S. cerevisiae 
strains were grown on rich yeast extract-peptone dextrose (YPD) [1% yeast extract, 2% peptone, 
2% dextrose (or galactose, as indicated)] or synthetic complete (SC) media lacking the 
appropriate nutrient for plasmid selection (Sunrise Science Products). SC media was also 
supplemented with 5-fluoroorotic acid (5-FOA; 5.74 mM) during complementation growth 
assays. Unless otherwise noted, yeast strains were grown at 30°C. The heterozygous diploid 
RRP44/ rrp44 deletion has been previously described and was obtained from Open Biosystems 
(Giaever et al., 2002). This strain was transformed with a URA3 plasmid that encoded wild-type 
RRP44.  
The temperature-sensitive mRNA decapping mutant, dcp1-2, has been previously 
described (Anderson and Parker, 1998). To create a dcp1-2, rrp44 deletion strain, the dcp1-2 
parent strain was crossed with an rrp44 deletion strain that contained a URA3 plasmid that 
encoded wild-type RRP44.  
To create a ski7, rrp44 deletion strain, a ski7 deletion parent strain was crossed with an 
rrp44 deletion strain that contained a URA3 plasmid that encoded wild-type RRP44.  
All diploid strains were sporulated, and haploid progeny spores were obtained by the 
hydrophobic spore isolation method as described (Rockmill et al., 1991). Isolated spores were 
germinated to generate a strain containing a genomic rrp44 deletion, complemented with the 
RRP44, URA3 plasmid, and where indicated, a second mutation.  
The GAL::rrp44 strains have been previously described and were obtained from Phil 
Mitchell and David Tollervey (Allmang et al., 1999b; Mitchell et al., 1997). 
Rrp43p was C-terminally Myc-tagged using the one-step PCR system with pFA6a-
13myc-His3MX6 as a template essentially as described (Longtine et al., 1998). 
The plasmids used in these studies, and their creation, are described in Table 2.2. All 
plasmids were built using standard PCR and restriction enzyme cloning techniques, or were built 
using homologous recombination of PCR products or restriction digestion fragments of 
plasmids. All plasmids contained a yeast centromere, the endogenous promoter and 3’ flanking 
region to control expression of Rrp44p and were verified by sequencing the insert.  
For plasmids constructed using PCR and restriction enzyme cloning, the sites used are 
listed in Table 2.2 and the oligonucleotides used are listed in Table 2.3. To generate Rrp44p C-
terminal truncations, 180 base pairs of the 3’ flanking region was PCR amplified and cloned into 
pRS415 (Sikorski and Hieter, 1989), which contains a LEU2 marker. 500 base pairs of the 
promoter and desired part of the coding region was PCR amplified and cloned into the plasmid 
26 
27 
St
ra
in
 N
am
e
G
en
ot
yp
e
Re
fe
re
nc
e
BY
47
41
M
AT
a;
 h
is3
!1
; l
eu
2!
0;
 m
et1
5!
0;
 u
ra
3!
G
ia
ev
er
 et
 al
., 
20
02
yA
V
86
2
M
AT
a;
 h
is3
!2
00
; l
eu
2!
1;
 tr
p1
; u
ra
3-
52
; g
al
2;
 g
al
!1
08
; G
AL
10
::R
RP
44
M
itc
he
ll 
et
 al
., 
19
97
yA
V
11
15
M
AT
a;
 h
is3
!1
; l
eu
2!
0;
 u
ra
3!
0;
 rr
p4
4!
::N
EO
 [R
RP
44
, U
RA
3]
Th
is 
stu
dy
yA
V
11
44
M
AT
a;
 h
is3
!1
; l
eu
2!
0;
 m
et1
5,
 u
ra
3!
; r
rp
6!
::N
EO
Th
is 
stu
dy
yA
V
11
37
M
AT
a;
 h
is3
!1
; l
eu
2!
0;
 u
ra
3!
; r
rp
6!
::N
EO
; r
rp
44
!:
:H
YG
 [R
RP
44
, U
RA
3]
Th
is 
stu
dy
yA
V
31
3
M
AT
!;
 le
u2
-3
,11
2;
 ly
s2
-2
01
; t
rp
1;
 u
ra
3-
52
; c
up
1:
:L
EU
2/
PG
K1
pG
/M
FA
2p
G;
 d
cp
1-
2:
:T
RP
1;
 sk
i7
!:
:N
EO
va
n 
H
oo
f e
t a
l.,
 2
00
0
yA
V
11
43
M
AT
!;
 le
u2
!0
; t
rp
1;
 u
ra
3!
0;
 d
cp
1-
2:
:T
RP
1;
 rr
p4
4!
::N
EO
 [R
RP
44
, U
RA
3]
Th
is 
stu
dy
yA
V
85
6
M
AT
a;
 h
is3
!1
; l
eu
2!
0;
 m
et1
5!
0;
 u
ra
3!
0;
 sk
i7
!:
:N
EO
Th
is 
stu
dy
yA
V
11
66
M
AT
!;
 le
u2
!0
; l
ys
2!
0;
 u
ra
3!
0;
 sk
i7
!:
:H
YG
; r
rp
44
!:
:N
EO
 [R
RP
44
, U
RA
3]
Th
is 
stu
dy
yA
V
11
79
M
AT
!;
 le
u2
!0
; l
ys
2!
0;
 u
ra
3!
0;
 sk
i7
!:
:H
YG
; r
rp
44
!:
:N
EO
 [R
RP
44
, L
EU
2]
Th
is 
stu
dy
yA
V
11
83
M
AT
!;
 le
u2
!0
; l
ys
2!
0;
 u
ra
3!
0;
 sk
i7
!:
:H
YG
; r
rp
44
!:
:N
EO
 [R
RP
44
 (D
17
1A
), 
LE
U2
]
Th
is 
stu
dy
yA
V
11
93
M
AT
!;
 le
u2
!0
; u
ra
3!
0;
 xr
n1
!:
:N
EO
; r
rp
44
!:
:H
YG
 [R
RP
44
, L
EU
2]
Th
is 
stu
dy
yA
V
11
94
M
AT
!;
 le
u2
!0
; u
ra
3!
0;
 xr
n1
!:
:N
EO
; r
rp
44
!:
:H
YG
 [R
RP
44
 (D
17
1A
), 
LE
U2
]
Th
is 
stu
dy
yA
V
11
17
M
AT
a;
 h
is3
!1
; l
eu
2!
0;
 m
et1
5!
0;
 u
ra
3!
0;
 R
RP
43
my
c:
:H
IS
3
Th
is 
stu
dy
Ta
bl
e 2
.1
: Y
ea
st 
str
ai
ns
 u
se
d
28 
N
am
e
D
es
cr
ip
ti
on
M
ar
ke
r
In
se
rt
/ O
ri
gi
n 
of
 p
la
sm
id
 
P
ar
en
t 
pl
as
m
id
pA
V
31
7
R
R
P
44
 p
ro
m
ot
er
U
R
A
3
oA
V
18
5 
an
d 
oA
V
18
8 
PC
R
pR
S4
16
pA
V
58
7
R
R
P
44
 p
ro
m
ot
er
LE
U
2
oA
V
18
5 
an
d 
oA
V
18
8 
PC
R
pR
S4
15
pA
V
31
8
R
R
P4
4 
3'
 f
la
nk
in
g 
re
gi
on
U
R
A
3
oA
V
18
9 
an
d 
oA
V
18
6 
PC
R
pR
S4
15
pA
V
47
3
R
R
P
44
 p
ro
m
ot
er
, R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
D
ig
es
t p
A
V
31
8
pA
V
31
7
pA
V
34
4
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
, R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
18
5 
an
d 
oA
V
18
6 
PC
R
pR
S4
15
pA
V
36
1
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
, R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
D
ig
es
t p
A
V
34
4
pR
S4
16
pA
V
36
3
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
79
2-
90
9,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
oA
V
35
4 
an
d 
oA
V
45
2 
PC
R
pA
V
31
8
pA
V
37
0
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
90
9,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
36
3
pA
V
34
4
pA
V
33
1
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
44
0,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
oA
V
18
5 
an
d 
oA
V
19
0 
PC
R
pA
V
31
8
pA
V
34
3
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
44
0,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
33
1
pR
S4
15
pA
V
36
4
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
47
4,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
18
5 
an
d 
oA
V
35
6 
PC
R
pA
V
34
3
pA
V
40
5
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
40
0,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
oA
V
18
5 
an
d 
oA
V
47
2 
PC
R
pA
V
31
8
pA
V
42
3
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
40
0,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
40
5
pR
S4
15
pA
V
32
9
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
36
0,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
oA
V
18
5 
an
d 
oA
V
28
2 
PC
R
pA
V
31
8
pA
V
34
2
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
36
0,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
32
9
pR
S4
15
pA
V
40
4
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
32
4,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
oA
V
18
5 
an
d 
oA
V
47
0 
PC
R
pA
V
31
8
pA
V
42
2
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
32
4,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
40
4
pR
S4
15
pA
V
41
4
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
23
5,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
oA
V
18
5 
an
d 
oA
V
46
8 
PC
R
pA
V
31
8
pA
V
45
4
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
23
5,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
41
4
pR
S4
15
pA
V
36
2
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
20
3,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
27
1 
an
d 
oA
V
45
1
pA
V
34
2
pA
V
57
7
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
13
-1
00
1,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
18
6 
an
d 
oA
V
66
3 
PC
R
pA
V
54
9
pA
V
58
6
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
34
-1
00
1,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
18
6 
an
d 
oA
V
67
8 
PC
R
pA
V
54
9
pA
V
57
8
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
47
-1
00
1,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
18
6 
an
d 
oA
V
66
4 
PC
R
pA
V
54
9
PA
V
54
9
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
84
-1
00
1,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
54
1 
an
d 
oA
V
18
6 
PC
R
pA
V
34
1
pA
V
32
8
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
36
0-
10
01
, R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
oA
V
18
6 
an
d 
oA
V
18
7 
PC
R
pA
V
31
7
PA
V
34
1
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
36
0-
10
01
, R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
32
8
pR
S4
15
pA
V
65
8
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
13
-2
35
LE
U
2
oA
V
72
0 
an
d 
oA
V
72
1 
PC
R
pA
V
58
7
pA
V
65
9
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
13
-2
35
, R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
18
6 
an
d 
oA
V
72
2 
PC
R
pA
V
65
8
pA
V
49
8
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 T
A
P,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
oA
V
54
2 
an
d 
oA
V
54
5 
(c
od
in
g 
re
gi
on
) 
oA
V
54
6 
an
d 
oA
V
54
9 
(T
A
P)
pA
V
47
3
pA
V
62
2
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
C
47
S,
 C
52
S,
 C
55
S)
  T
A
P,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
D
ig
es
t p
A
V
51
5
pA
V
49
8
pA
V
49
9
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
23
5 
TA
P,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
oA
V
54
2 
an
d 
oA
V
54
7 
(c
od
in
g 
re
gi
on
) 
oA
V
54
8 
an
d 
oA
V
54
9 
(T
A
P)
pA
V
47
3
pA
V
50
0
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
20
3 
TA
P,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
oA
V
54
2 
an
d 
oA
V
54
3 
(c
od
in
g 
re
gi
on
) 
oA
V
54
4 
an
d 
oA
V
54
9 
(T
A
P)
pA
V
47
3
pA
V
66
0
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
34
-1
00
1 
TA
P,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
D
ig
es
t p
A
V
58
6
pA
V
49
8
pA
V
66
1
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
47
-1
00
1 
TA
P,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
D
ig
es
t p
A
V
57
8
pA
V
49
8
pA
V
71
3
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
13
-2
35
 T
A
P,
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
oA
V
54
2 
an
d 
oA
V
75
7 
(c
od
in
g 
re
gi
on
) 
oA
V
54
9 
an
d 
oA
V
75
8 
(T
A
P)
pA
V
47
3
pA
V
48
3
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
, R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
-
oA
V
18
5 
an
d 
oA
V
18
6 
PC
R
pB
lu
es
cr
ip
t S
K
-
pA
V
58
8
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
E
38
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
-
oA
V
67
9 
an
d 
oA
V
68
0 
m
ut
ag
en
es
is
pA
V
48
3
pA
V
58
9
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
Y
40
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
-
oA
V
68
1 
an
d 
oA
V
68
2 
m
ut
ag
en
es
is
pA
V
48
3
pA
V
59
0
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
L
41
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
-
oA
V
68
3 
an
d 
oA
V
68
4 
m
ut
ag
en
es
is
pA
V
48
3
pA
V
59
1
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
R
42
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
-
oA
V
68
5 
an
d 
oA
V
68
6 
m
ut
ag
en
es
is
pA
V
48
3
pA
V
59
2
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
D
44
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
-
oA
V
68
7 
an
d 
oA
V
68
8 
m
ut
ag
en
es
is
pA
V
48
3
pA
V
59
3
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
I4
5A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
-
oA
V
68
9 
an
d 
oA
V
69
0 
m
ut
ag
en
es
is
pA
V
48
3
pA
V
59
4
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
C
47
S)
, R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
-
oA
V
69
1 
an
d 
oA
V
69
2 
m
ut
ag
en
es
is
pA
V
48
3
pA
V
59
5
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
C
52
S)
, R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
-
oA
V
69
3 
an
d 
oA
V
69
4 
m
ut
ag
en
es
is
pA
V
48
3
pA
V
59
6
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
C
55
S)
, R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
-
oA
V
69
5 
an
d 
oA
V
69
6 
m
ut
ag
en
es
is
pA
V
48
3
pA
V
50
6
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
C
47
S,
 C
52
S,
 C
55
S)
, R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
-
oA
V
48
2 
an
d 
oA
V
56
9 
m
ut
ag
en
es
is
pA
V
48
3
pA
V
48
4
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
D
91
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
-
oA
V
57
0 
an
d 
oA
V
57
1 
m
ut
ag
en
es
is
pA
V
48
3
pA
V
50
5
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
E
12
0A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
-
oA
V
48
4 
an
d 
oA
V
57
8 
m
ut
ag
en
es
is
pA
V
48
3
pA
V
48
5
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
D
17
1A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
-
oA
V
57
2 
an
d 
oA
V
57
3 
m
ut
ag
en
es
is
pA
V
48
3
pA
V
48
6
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
D
19
8A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
-
oA
V
57
4 
an
d 
oA
V
57
5 
m
ut
ag
en
es
is
pA
V
48
3
pA
V
48
2
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
36
0-
10
01
 (
D
55
1N
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
-
oA
V
56
5 
an
d 
oA
V
56
6 
m
ut
ag
en
es
is
pA
V
32
8
pA
V
62
9
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
C
47
S,
 C
52
S,
 C
55
S,
 D
17
1A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
-
oA
V
48
2 
an
d 
oA
V
56
9 
m
ut
ag
en
es
is
pA
V
48
5
pA
V
59
7
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
E
38
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
58
8
pR
S4
15
pA
V
59
8
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
Y
40
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
58
9
pR
S4
15
pA
V
59
9
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
L
41
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
59
0
pR
S4
15
pA
V
60
0
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
R
42
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
59
1
pR
S4
15
pA
V
60
1
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
D
44
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
59
2
pR
S4
15
Ta
bl
e 
2.
2:
 P
la
sm
id
s 
us
ed
N
am
e
D
es
cr
ip
ti
on
M
ar
ke
r
In
se
rt
/ O
ri
gi
n 
of
 p
la
sm
id
P
ar
en
t p
la
sm
id
pA
V
60
2
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
I4
5A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
59
3
pR
S4
15
pA
V
60
3
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
C
47
S)
, R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
59
4
pR
S4
15
pA
V
60
4
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
C
52
S)
, R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
59
5
pR
S4
15
pA
V
60
5
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
C
55
S)
, R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
59
6
pR
S4
15
pA
V
51
5
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
C
47
S,
 C
52
S,
 C
55
S)
, R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
50
6
pR
S4
15
pA
V
50
2
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
D
91
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
48
4
pR
S4
15
pA
V
51
4
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
E
12
0A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
50
5
pR
S4
15
pA
V
50
3
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
D
17
1A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
48
5
pR
S4
15
pA
V
65
6
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
D
17
1A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
D
ig
es
t p
A
V
50
3
pR
S4
16
pA
V
50
4
R
R
P4
4 
pr
om
ot
er
, r
es
id
ue
s 
1-
10
01
 (
D
19
8A
),
 R
R
P4
4 
3'
 f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
48
6
pR
S4
15
pA
V
50
1
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
D
55
1N
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
48
2
pA
V
34
4
pA
V
65
7
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
D
55
1N
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
D
ig
es
t p
A
V
50
1
pA
V
36
1
pA
V
70
9
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
Y
40
A
, D
55
1N
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
59
8
pA
V
50
1
pA
V
71
0
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
L
41
A
, D
55
1N
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
59
9
pA
V
50
1
pA
V
71
1
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
R
42
A
, D
55
1N
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
60
0
pA
V
50
1
pA
V
63
3
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
C
47
S,
 C
52
S,
 C
55
S,
 D
17
1A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
62
9
pR
S4
15
pA
V
53
6
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
C
47
S,
 C
52
S,
 C
55
S,
 D
55
1N
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
51
5
pA
V
50
1
pA
V
53
7
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
D
91
A
, D
55
1N
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
50
2
pA
V
50
1
pA
V
53
8
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
E
12
0A
, D
55
1N
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
51
4
pA
V
50
1
pA
V
53
9
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
D
17
1A
, D
55
1N
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
50
3
pA
V
50
1
pA
V
74
0
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
D
17
1A
, D
55
1N
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
D
ig
es
t p
A
V
53
9
pR
S4
16
pA
V
54
0
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
10
01
 (
D
19
8A
, D
55
1N
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
50
4
pA
V
50
1
pA
V
52
8
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
32
4 
(D
91
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
18
5 
an
d 
oA
V
47
0 
PC
R
pR
S4
15
pA
V
52
9
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
32
4 
(E
12
0A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
18
5 
an
d 
oA
V
47
0 
PC
R
pR
S4
15
pA
V
53
0
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
32
4 
(D
17
1A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
18
5 
an
d 
oA
V
47
0 
PC
R
pR
S4
15
pA
V
53
1
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
32
4 
(D
19
8A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
18
5 
an
d 
oA
V
47
0 
PC
R
pR
S4
15
pA
V
60
6
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
23
5 
(E
38
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
18
5 
an
d 
oA
V
46
8 
PC
R
pA
V
45
4
pA
V
60
7
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
23
5 
(Y
40
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
18
5 
an
d 
oA
V
46
8 
PC
R
pA
V
45
4
pA
V
60
8
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
23
5 
(L
41
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
18
5 
an
d 
oA
V
46
8 
PC
R
pA
V
45
4
pA
V
60
9
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
23
5 
(R
42
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
18
5 
an
d 
oA
V
46
8 
PC
R
pA
V
45
4
pA
V
61
0
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
23
5 
(D
44
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
18
5 
an
d 
oA
V
46
8 
PC
R
pA
V
45
4
pA
V
61
1
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
23
5 
(I
45
A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
18
5 
an
d 
oA
V
46
8 
PC
R
pA
V
45
4
pA
V
51
3
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
23
5 
(C
47
S,
 C
52
S,
 C
55
S)
, R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
oA
V
18
5 
an
d 
oA
V
46
8 
PC
R
pA
V
31
8
pA
V
61
5
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
23
5 
(C
47
S,
 C
52
S,
 C
55
S)
, R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
51
3
pR
S4
15
pA
V
71
4
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
34
-1
00
1 
(D
17
1A
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
oA
V
18
6 
an
d 
oA
V
67
8 
PC
R
pA
V
58
6
pA
V
71
5
R
R
P
44
 p
ro
m
ot
er
, r
es
id
ue
s 
34
-1
00
1 
(D
55
1N
),
 R
R
P
44
 3
' f
la
nk
in
g 
re
gi
on
LE
U
2
D
ig
es
t p
A
V
50
1
pA
V
58
6
pG
E
X
-4
54
G
ST
-R
R
P4
4 
re
si
du
es
 1
-2
35
-
Sc
ha
ef
fe
r 
et
 a
l.,
 2
00
9
-
pA
V
57
5
G
ST
-R
R
P4
4 
re
si
du
es
 1
-2
35
 (
C
47
S,
 C
52
S,
 C
55
S)
-
oA
V
64
7 
an
d 
oA
V
64
8 
PC
R
pG
E
X
4T
1
pA
V
57
6
G
ST
-R
R
P4
4 
re
si
du
es
 8
4-
23
5
-
oA
V
66
2 
an
d 
oA
V
64
8 
PC
R
pG
E
X
4T
1
pA
V
70
0
hi
s3
-n
on
st
op
LY
S2
D
ig
es
t p
A
V
18
8
pR
S3
17
pA
V
18
8
hi
s3
-n
on
st
op
U
R
A
3
va
n 
H
oo
f 
et
 a
l.,
 2
00
2
-
pA
V
17
5
G
A
L:
:p
gk
1-
no
ns
to
p
U
R
A
3
Fr
is
ch
m
ey
er
 e
t a
l.,
 2
00
2
-
pA
V
70
1
G
A
L:
:p
gk
1 
 
U
R
A
3
D
om
a 
an
d 
Pa
rk
er
, 2
00
6
-
pA
V
70
2
G
A
L:
:p
gk
1-
SL
U
R
A
3
D
om
a 
an
d 
Pa
rk
er
, 2
00
6
-
pA
V
47
6
TA
P
LE
U
2
oA
V
55
6 
an
d 
oA
V
55
7 
PC
R
pR
S4
15
pA
V
13
9
SK
I7
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
74
8,
 S
K
I7
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
B
en
ar
d 
et
 a
l.,
 1
99
9
-
pA
V
17
9
SK
I7
 p
ro
m
ot
er
, r
es
id
ue
s 
1-
74
8 
(P
26
5*
),
 S
K
I7
 3
' f
la
nk
in
g 
re
gi
on
U
R
A
3
oR
P1
05
5 
m
ut
ag
en
es
is
 
pA
V
15
2
pA
V
40
2
G
PD
 p
ro
m
ot
er
, A
. t
ha
lia
na
 R
R
P
41
 r
es
id
ue
s 
1-
24
1
H
IS
3
oA
V
46
4 
an
d 
oA
V
46
5 
PC
R
p4
23
G
PD
pA
V
34
9
E
. c
ol
i R
N
as
e 
II
 r
es
id
ue
s 
1-
64
4
-
G
if
t f
ro
m
 D
rs
. A
na
 B
ar
ba
s 
an
d 
C
ec
ili
a 
A
rr
ai
an
o
pE
T
15
b
pA
V
37
5
G
PD
 p
ro
m
ot
er
, E
. c
ol
i R
N
as
e 
II
 r
es
id
ue
s 
1-
64
4
H
IS
3
D
ig
es
t p
A
V
34
9
p4
23
G
PD
pA
V
35
0
E
. c
ol
i R
N
as
e 
R
 r
es
id
ue
s 
1-
81
3
-
G
if
t f
ro
m
 D
rs
. A
na
 B
ar
ba
s 
an
d 
C
ec
ili
a 
A
rr
ai
an
o
pE
T
15
b
pA
V
37
6
G
PD
 p
ro
m
ot
er
, E
. c
ol
i R
N
as
e 
R
 r
es
id
ue
s 
1-
81
3
H
IS
3
D
ig
es
t p
A
V
35
0
p4
23
G
PD
pA
V
47
4
G
PD
 p
ro
m
ot
er
, R
R
P
6 
re
si
du
es
 1
-7
34
H
IS
3
oA
V
45
9 
an
d 
oA
V
46
0 
PC
R
p4
23
G
PD
O
th
er
 p
la
sm
id
s
R
ep
or
te
r 
P
la
sm
id
s
Ta
bl
e 
2.
2:
 P
la
sm
id
s 
us
ed
 (c
on
ti
nu
ed
)
29 
PCR oligos Sequence
oAV185 5' ATATAGAGCTCAAAAACTGCCTACGTACCATTTAAC
oAV186 5' ATATACTCGAGCACCACCAAAATGTCAATTTTTTTG
oAV187 5' ATATAACTAGTAACAACATGTCCAATACCACCGTGATTTC
oAV188 5' ATATAACTAGTTTTGGCCTGTATGATGCAAG
oAV189 5' ATATAACTAGTTAGATGGAAGATGCTTCAGTATC
oAV190 5' ATATAACTAGTTTAACGCCTTGTTCTGATTCTGAC
oAV271 5' ATATAACTAGTTTATTCTCTATTCAAACGATCGTTGGTAAC
oAV282 5' ATATAACTAGTTTAGGAAGAGGACTCATTATTGTC
oAV354 5' ATATAACTAGTTTAATTCCTCATTACTTGCCCGAC
oAV356 5' ATATAACTAGTTTAAATTGTACCGAGGTCTCTCACAAAG
oAV451 5' GTGTGTGCTACTGCAGTACTTCTTAGAG
oAV452 5' CGAGCGGCCGCGGTGTGTGGATCCCGAAGATCC
oAV459 5' ATATAACTAGTTGCGTTATGACTTCTGAAAATCCGGATG
oAV460 5' ATATACTCGAGTCACCTTTTAAATGACAGATTCTT
oAV464 5' ATATAACTAGTCCATGGAGTACGTAAACCCTGAAGGTC
oAV465 5' ATATACTCGAGTTATGCAGCTCGGCGATACTCTAGC
oAV468 5' ATATAACTAGTTTAAATAGAGTCTCTGATGTCGTCTGCA
oAV470 5' ATATAACTAGTTTATGATTGAGGTAGCAGTTCCACGATAAC
oAV472 5' ATATAACTAGTTTACCAGGATCTTCTTTGTATATATACAA
oAV482 5' GATCGGACATCCCAAGTCTTTCTAGAAGTAGTACCAAGAGTCCGCAAATTGTCG
oAV484 5' TTGTCCCCCAGATTGTTCTAGATGCAGTGAGAAACAAGTC
oAV541 5' ATATAACTAGTATGGGTAAGCATTACGTCG
oAV542 5' GATCAAACGAGTTTTATTTATCATACTTGCATCATACAGGCCAAAACAAC
oAV543 5' TTCTCTATTCAAACGATCGTTGGTAACAAGAACGACGTTTATGTCATAAG
oAV544 5' CTTATGACATAAACGTCGTTCTTGTTACCAACGATCGTTTGAATAGAGAAGGTCGACGGATCCCCGGGTT
oAV545 5' TTTTAACAATAATTCTGCCTTACGCTTGCTAGTAATTGGATCCATCACCG
oAV546 5' CGGTGATGGATCCAATTACTAGCAAGCGTAAGGCAGAATTATTGTTAAAAGGTCGACGGATCCCCGGGTT
oAV547 5' AATAGAGTCTCTGATGTCGTCTGCATTTGGTAGTAACTCGATATACTGTA
oAV548 5' TACAGTATATCGAGTTACTACCAAATGCAGACGACATCAGAGACTCTATTGGTCGACGGATCCCCGGGTT
oAV549 5' CACCACCAAAATGTCAATTTTTTTGCCATTTTCTAAATAGTTTTCTTCACTTATCGATGAATTCGAGCTCGTT
oAV565 5' CTCCAGGATGTGTTGATATCAACGATGCCCTACATGCG
oAV566 5' CGCATGTAGGGCATCGTTGATATCAACACATCCTGGAG
oAV569 5' CGACAATTTGCGGACTCTTGGTACTACTTCTAGAAAGACTTGGGATGTCCGATC
oAV570 5' GCATTACGTCGTCTTGGCCACCAACGTGGTGTTAC
oAV571 5' GTAACACCACGTTGGTGGCCAAGACGACGTAATGC
oAV572 5' CGATTAATGACAGAAACGCGCGCGCTATAAGGAAAACCTGTCAATGG
oAV573 5' CCATGACAGGTTTTCCTTATAGCGCGCGCGTTTCTGTCATTAATCG
oAV574 5' CGTTCTTGTTACCAACGCTCGTTTGAATAGAGAAGC
oAV575 5' GCTTCTCTATTCAAACGAGCGTTGGTAACAAGAACG
oAV578 5' GACTTGTTTCTCACTGCATCTAGAACAATCTGGGGGACAA
oAV647 5' CGCAGAATTCATGTCAGTTCCCGCTATCG
oAV648 5' ATATACTCGAGTTAAATAGAGTCTCTGATGTCGTCTGCA
oAV662 5' CGCAGAATTCATGGGTAAGCATTACGTCG
oAV663 5' ATATAACTAGTAACAACATGCTTGCAGATGGTTTAAGCG
oAV664 5' ATATAACTAGTAACAACATGTGTCTTTCGAGAAGTTGTA
oAV678 5' ATATAACTAGTAACAACATGAAGATCGTAAGAGAACACTAT
oAV679 5' CAAGATCGTAAGAGCACACTACTTAAGATCGGACATC
oAV680 5' GATGTCCGATCTTAAGTAGTGTGCTCTTACGATCTTG
oAV681 5' CGTAAGAGAACACGCTTTAAGATCTGACATCCCATGTCTTTC
oAV682 5' GAAAGACATGGGATGTCAGATCTTAAAGCGTGTTCTCTTACG
oAV683 5' GTAAGAGAACACTATGCAAGATCTGACATCCCATGTCTTTC
oAV684 5' GAAAGACATGGGATGTCAGATCTTGCATAGTGTTCTCTTAC
oAV685 5' GAGAACACTATTTAGCATCGGATATCCCATGTCTTTCG
oAV686 5' CGAAAGACATGGGATATCCGATGCTAAATAGTGTTCTC
oAV687 5' CTATTTAAGATCGGCCATCCCATGTCTCTCGAGAAGTTGTACC
oAV688 5' GGTACAACTTCTCGAGAGACATGGGATGGCCGATCTTAAATAG
oAV689 5' CTATTTAAGATCGGACGCCCCATGTCTCTCGAGAAGTTGTAC
oAV690 5' GTACAACTTCTCGAGAGACATGGGGCGTCCGATCTTAAATAG
oAV691 5' GATCGGACATCCCAAGTCTTTCTAGAAGTTGTACCAAG
oAV692 5' CTTGGTACAACTTCTAGAAAGACTTGGGATGTCCGATC
oAV693 5' GATCGGACATCCCATGTCTTTCTAGAAGTAGTACCAAGTGTCCG
oAV694 5' CGGACACTTGGTACTACTTCTAGAAAGACATGGGATGTCCGATC
oAV695 5' CATCCCATGTCTTTCTAGAAGTTGTACCAAGAGTCCGCAAATTGTC
oAV696 5' GACAATTTGCGGACTCTTGGTACAACTTCTAGAAAGACATGGGATG
oAV720 5' ATATATCTAGAAACAACATGCTTGCAGATGGTTTAAGCG
oAV721 5' ATATAGGATCCTTAAATAGAGTCTCTGATGTCGTCTGCA
oAV722 5' ATATAGGATCCTAGATGGAAGATGCTTCAGTATC
oAV757 5' AATAGAGTCTCTGATGTCGTCTGCATTTGGTAGTAACTCGATATACTGTA
oAV758 5' TACAGTATATCGAGTTACTACCAAATGCAGACGACATCAGAGACTCTATTGGTCGACGGATCCCCGGGTT
oRP1055 5' TGTCAAATTCAACTAGTGGGTGGCAATGAATG
Table 2.3: Oligonucleotides used
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Northern oligos Sequence
oAV141 5' AATTGATCTATCGAGGAATTCC
oAV224 5' GTCTAGCCGCGAGGAAGG
oAV267 5' CTCTTGCTTCTCTGGAGAGATCGTCAGTC
oAV671 5' AAAATGGCGTGAGGTAGAGAGAAACCAGCG
oAV783 5' CGGATAAGAAAGCAACACCTGG
oAV784 5' GGTTGGCAAAGCAGC
oJA003 5' TGAGAAGGAAATGACGCT
oRP993 5' CGAACGACAAGCCTACTCG
Table 2.3: Oligonucleotides used (continued)
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described above. N-terminal truncations were generated similarly, except that the promoter was 
PCR amplified and cloned first, with the truncated coding region and 3’ flanking region cloned 
second. 
Site-directed mutations of Rrp44p were created using the QuikChange II Kit 
(Stratagene) and the oligonucleotides listed in Table 2.3. Each oligonucleotide also changes a 
restriction site to aid in screening. Following restriction digestion, putative mutations were 
verified by sequencing. To combine point mutations in the CR3 region and PIN domain of 
Rrp44p with the D551N mutation in the RNB domain, plasmids encoding each single mutation 
were digested with SacI and PshAI and ligated together. SacI cuts at the beginning of the 
promoter, whereas PshAI cuts at a unique site within the CSD2 domain. To generate the point 
mutations of the CR3 region and PIN domain in the 1-324 truncation, the promoter and truncated 
coding region were PCR amplified from the full-length point mutations and cloned. 
C-terminally TAP-tagged Rrp44 constructs were created using homologous 
recombination. To create a gapped plasmid, pAV473 was digested with SpeI, which cuts 3’ of 
the Rrp44p promoter. A portion of the coding region of Rrp44p was PCR amplified from 
pAV344 so that the 5’-end of the resulting PCR product had at least 50 nucleotides of homology 
to the Rrp44p promoter. The TAP tag and HIS3 marker were PCR amplified from a strain 
containing Rrp44p-TAP from the yeast TAP-tagged collection (Open Biosystems; 
Ghaemmaghami et al., 2003) so that the 5’-end of the resulting PCR product had at least 50 
nucleotides of homology to the Rrp44p coding region and that the 3’-end of the resulting PCR 
product had at least 50 nucleotides of homology to the 3’ UTR of Rrp44p. The gapped plasmid 
and both PCR products were transformed into yeast and subsequently rescued from yeast to 
verify the sequence of the plasmid. 
 Rrp44p GST fusion plasmids were generated by PCR amplifying the RRP44 coding 
region from the plasmids described above, digesting the PCR product with EcoRI and XhoI, and 
ligating them into pGEX-4T-1 (GE Healthcare). 
 
Yeast growth assays 
Complementation growth assays 
 Complementation growth assays were performed using rrp44 truncations and point 
mutations encoded on a LEU2 plasmid. These plasmids were transformed into an rrp44 deletion 
strain containing a URA3 plasmid that encoded wild-type RRP44. Transformants were then 
grown on SC –LEU –URA + 2% dextrose overnight at 30°C. Cultures were then diluted in the 
same selection media to an optical density at 600 nm of 0.8. Next, cells were serially diluted in 
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96-well plates by a factor of 5 and spotted onto media containing 5-fluoroorotic acid (5-FOA). 
These plates were incubated at 30°C for 2-20 days. 5-FOA selects for cells that have lost the 
URA3 plasmid. Therefore, cells that are viable on 5-FOA can lose the URA3 plasmid encoding 
wild-type RRP44, which suggests that the rrp44 truncation or point mutant can carry out the 
essential function of Rrp44p. 
 
Synthetic lethality growth assays 
 Synthetic lethality growth assays were performed essentially as described (van Hoof et 
al., 2000b). Briefly, plasmids encoding rrp44 truncations and point mutations were transformed 
into a dcp1-2, rrp44 deletion strain containing a URA3 plasmid encoding wild-type RRP44. 
Transformants were grown in SC –LEU –URA + 2% dextrose overnight at 23°C. Cultures were 
diluted in the same selection media to an optical density at 600 nm of 0.8. Next, cells were 
serially diluted in 96-well plates by a factor of 5 and spotted onto the same selection media. 
Plates were incubated at 23°C (permissive temperature), 30°C, and 37°C (non-permissive 
temperature) for 2-5 days. The basis of this assay is that one of the two general mRNA 
degradation pathways is required for viability. Cells with a functional 3’ to 5’ decay pathway are 
viable at all temperatures, whereas mutants in the 3’ to 5’ degradation pathway are synthetically 
lethal with dcp1-2 at the non-permissive temperature. 
 
His3-nonstop growth assays 
The his3-nonstop growth assay was performed essentially as described (van Hoof et al., 
2002). Briefly, rrp44 deletion strains containing LEU2 plasmids encoding rrp44 truncations and 
point mutations were transformed with a URA3 or LYS2 plasmid encoding a his3-nonstop 
reporter. This reporter contains a nonstop mutation at the end of the HIS3 open reading frame. 
Transformants were grown in SC –LEU –URA + 2% dextrose or SC –LEU –LYS + 2% dextrose 
overnight at 30°C. Cultures were diluted in the same selection media to an optical density at 600 
nm of 0.8. Next, cells were serially diluted in 96-well plates and spotted onto media lacking 
histidine, SC –HIS –LEU –URA or SC –HIS –LEU –LYS. The plates were incubated at 30°C 
for 2-5 days. In cells with a functional nonstop mRNA degradation pathway, the nonstop mRNA 
degradation machinery rapidly degrades the his3-nonstop transcript. In contrast, in cells that are 
not able to degrade the his3-nonstop transcript, histidine is made, and cells are viable on media 
lacking histidine. 
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Soluble Cell Lysate Preparation Using Glass Bead Lysis  
 Cell cultures of optical density at 600 nm of 0.8 were pelleted and resuspended in 250 
!L of IP50 buffer [50m! NaCl, 50m! Tris-HCl (pH 7.5), 2m! MgCl2, 0.1% Triton X, 
0.00714% "-mercaptoethanol, 0.1! PMSF, with complete EDTA-free protease inhibitors 
(Roche)]. 50 !L of glass beads were added to the cell suspension and agitated in a vortex mixer 
for 7 minutes at 4°C. Cell lysates were clarified by centrifugation at 4,500 x g for 7 minutes at 
4°C. 
 
Tandem Affinity Purification (TAP) 
Tandem affinity purifications were performed by adding 10 !L of IgG Sepharose 6 Fast 
Flow beads (Amersham Biosciences) to 200 !L of whole-cell lysates. After incubation for 1 
hour at 4°C, the supernatant was discarded and the beads were washed two times with 200 !L of 
IP50 buffer. The beads were washed two more times with 200 !L of IP1000 buffer [1 ! NaCl, 
50 m! Tris-HCl (pH 7.5), 2 m! MgCl2, 0.1% Triton X, 0.00714% "-mercaptoethanol, 0.1 ! 
PMSF, with complete EDTA-free protease inhibitors (Roche)]. The beads were then 
resuspended in 100 !L of IP50 buffer and 33.3 !L of 6X protein sample buffer [350 mM Tris 
HCl (pH 6.8), 36% glycerol, 10% SDS, 5% "-mercaptoethanol, 0.012% bromophenol blue] was 
added. Bound proteins were eluted from beads by boiling for 3 minutes at 95°C and were 
analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). 
 
SDS-PAGE and Western Blot analysis  
Proteins were separated by SDS-PAGE and transferred to nitrocellulose membranes 
(Bio-Rad) for immunodetection essentially as described (Laemmli, 1970; Towbin et al., 1979). 
Antibodies were diluted in a 5% solution of non-fat milk in TBST (0.684 M NaCl, 0.1 M Tris 
base). Anti-Protein A monoclonal antibody was purchased from Sigma and used at a dilution of 
1:1,000,000. Anti-Myc monoclonal antibody was used at a 1:1,000 dilution (kindly provided by 
E. Wagner, University of Texas Health Science Center at Houston, Houston, TX). Anti-Pgk1p 
monoclonal antibody was purchased from Invitrogen and used at a 1:6,000 dilution.  
 
Plasmid Rescue from Yeast 
 The plasmid rescue from yeast protocol was adapted from instructions provided by the 
S. Fields Laboratory (University of Washington, Seattle, WA) and by using the QIAprep Spin 
Miniprep Kit (Qiagen). Briefly, yeast strains were grown in a 5 mL overnight culture of YPD. 
Cells were then pelleted and resuspended in 250 !L of Qiagen buffer P1 and 250 !L of acid-
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washed glass beads. To disrupt the cell wall, the suspensions were agitated in a vortex mixer for 
7 minutes. Next, 250 !L of Qiagen buffer P2 was added and the suspensions were inverted 7 
times. To obtain clarified cell lysates, the reactions were centrifuged at maximum speed for 10 
minutes. The supernatant was transferred to a QIAprep spin column and spun at maximum speed 
for 1 minute. The column was washed once with 750 !L of Qiagen buffer PE by centrifuging the 
column at maximum speed for 1 minute. The supernatant was discarded and the column 
removed to a clean microcentrifuge tube. Plasmid DNA was eluted by adding 50 !L of sterile 
ddH2O, followed by incubated at 37°C for 5 minutes.  
 
Overexpression and Purification of Recombinant Rrp44p 
 Cell cultures of Rosetta (DE3) E. coli containing a plasmid encoding wild-type RRP44 
or rrp44 mutations were grown at 30°C in 2 L of Terrific Broth (TB) [1.2% Tryptone, 2.4% 
Yeast Extract, 54.0 mM K2HPO4, 16.2 mM KH2PO4] supplemented with ampicillin (200 µg/ml) 
and chloramphenicol (25 µg/ml) to an optical density at 600 nm of 1.2. To induce expression of 
rrp44, 0.2 mM of isopropyl "-D-1-thiogalactopyranoside (IPTG) was added to the cultures, 
which were then switched to 18°C for overnight incubation. Cell cultures were then pelleted and 
resuspended in 30 mL phosphate buffered saline (PBS) [37 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, 2 mM KH2PO4, 10 mM DTT, and 1 mM phenylmethylsulfonyl fluoride (PMSF); pH 
8]. Cell suspensions were then lysed using the French Press. Crude cell extracts were treated 
with 5 units of Benzonase (Sigma) for 30 minutes at 0°C and then clarified by a 30 minute 
centrifugation at 10,000 x g. Clarified cell lysates were loaded onto a GSTrapTM FF 1 ml column 
(GE Healthcare) equilibrated in GST binding buffer [50 mM Tris-HCl (pH 8.5), 10 mM DTT]. 
Proteins were eluted with a 0-1610 mM glutathione gradient in GST Binding buffer and 
fractionated into 2 mL aliquots. The fractions containing purified protein were pooled and loaded 
onto a gel filtration column [Superdex 75 10/300 GL or a Superose 12 10/300 GL (GE 
Healthcare), depending on the protein size] equilibrated with gel filtration buffer [20 mM Tris-
HCl, 150 mM NaCl, 5mM MgCl2 and 10 mM DTT buffer (pH 8)]. The eluted proteins were 
loaded onto a Vivaspin 500 Centrifugal Concentrator column (Vivaspin) and concentrated by 
centrifugation at 4,500 x g at 15°C until approximately 100 !L of concentrated protein remained. 
Protein concentration was determined by spectrophotometry using a Nanodrop 
spectrophotometer. Glycerol [50% (v/v)] was added to the final fraction, which was stored at -
20°C. 
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 RNase assays 
 500 nM of Rrp44p GST-fusion recombinant proteins were incubated with 200 nM of 32P 
5’-end labeled A30 oligonucleotide in a buffer consisting of 20 mM HEPES (pH 7.5), 150 mM 
NaCl, 3 mM MnCl2, 1 mM DTT for the times indicated. Reactions were subject to denaturing 
urea-polyacrylamide gel electrophoresis for single nucleotide separation.  
 
Determining the processing of the 5.8S rRNA and the degradation of the 5’ ETS of the pre-
rRNA precursor 
 Monitoring of 5.8S rRNA processing and 5’ ETS degradation was carried out essentially 
as described (Allmang et al., 1999b). Briefly, GAL::rrp44 strains containing LEU2 plasmids 
encoding rrp44 truncations and point mutations were grown in SC –LEU + 2% galactose 
overnight at 30°C. Cultures were diluted in the same selection media to an optical density at 600 
nm of 0.2 and grown to an optical density at 600 nm of 0.8. The medium was replaced with SC –
LEU + 4% glucose to inhibit expression of the endogenous RRP44 allele. At the time points 
indicated, 2 mL cell aliquots were pelleted. RNA was isolated and subject to denaturing urea-
polyacrylamide gel electrophoresis, followed by Northern blot analysis (see below).  
 
Stability of pgk1pG-nonstop mRNA 
To determine the half-life of the pgk1pG-nonstop reporter, yeast strains were grown in 
SC –URA + 2% galactose overnight at 30°C. Cultures were diluted in the same selection media 
to an optical density at 600 nm of 0.2 and grown to an optical density at 600 nm of 0.8. The 
medium was replaced with SC –URA + 4% glucose. At the time points indicated, 2 mL cell 
aliquots were pelleted. RNA was isolated and subjected to formaldehyde agarose gel 
electrophoresis, followed by Northern blot analysis (see below).  
  
RNA Isolation 
 RNA isolations were performed essentially as described (Caponigro et al., 1993). Cell 
pellets were resuspended in 150 !L of LET [25 mM Tris (pH 8), 100 mM LiCl, 20 mM EDTA], 
150 !L of phenol equilibrated with LET, and 250 !L of acid-washed glass beads in a 2 mL tube.  
To disrupt the cell wall, cell suspensions were agitated in a vortex mixer for 5 minutes. Next, 
250 !L of chloroform and 250 !L of diethyl pyrocarbonate-treated (DEPC) water were added. 
To clarify the cell suspensions, the reactions were centrifuged at maximum speed for 2 minutes. 
The aqueous phase was transferred to a fresh 2 mL tube containing 400 !L of phenol-chloroform 
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equilibrated with LET. Samples were again centrifuged at maximum speed for 2 minutes. The 
aqueous phase was transferred to a fresh 2 mL tube containing 400 !L of chloroform. Samples 
were again centrifuged at maximum speed for 2 minutes. The aqueous phase was transferred to a 
fresh 2 mL tube containing 1 mL 95% EtOH and 40 !L of 3M NaAc. To precipitate the RNA, 
samples were incubated at -80°C for at least 30 minutes and then centrifuged at maximum speed 
for 30 minutes. RNA pellets were dried in a concentration/drying system and resuspended in 100 
!L of DEPC-treated water.  
 
Northern Blot Analysis and Quantitation of Gene Expression  
Northern blot analysis was performed essentially as described (Meaux and van Hoof, 
2006). Blots were hybridized with 32P 5’-end labeled oligonucleotides specific for the 5.8S 
rRNA (oJA003), 5’ ETS (oRP993), pgk1pG-nonstop (oRP141), GAL7 (oAV267), ACT1 
(oAV671), the 5’- and 3’-ends of PGK1 and pgk1-SL (oAV784 and oAV783, respectively) and 
the RNA subunit of the signal recognition particle (oRP100). The oligonucleotide sequences are 
listed in Table 2.3. Signals were detected and quantitated using a STORM PhosphorImager 
(Amersham), and corrected for loading by quantitating the RNA subunit of the signal recognition 
particle, SCR1, or ACT1. 
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Chapter 3: The PIN domain of Rrp44p has endoribonuclease activity 
and is essential for exosome function. 
 
 
 
 
 
 
 
 
 
NOTE: This Chapter is derived from work that was published in 2009: “The exosome contains domains 
with specific endoribonuclease, exoribonuclease and cytoplasmic mRNA decay activities.” Nature 
Structural and Molecular Biology. 16 (1): 56 – 62. I am the primary author on this paper and was 
involved in preparing the original manuscript. I performed all of the experiments described in this 
Chapter with the exception of the biochemical nuclease assays that were performed by our collaborators, 
Drs. Ana Barbas and Cecilia Arraiano (Instituto de Tecnologia Química e Biológica [ITQB]; Lisbon, 
Portugal). I have been given permission by the publisher of Nature Structural and Molecular Biology, the 
Nature Publishing Group, to reproduce any/all of my manuscript in print or electronically for the 
purposes of my dissertation. 
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INTRODUCTION 
Rrp44p is the only catalytic subunit of the core exosome, with its 3’ to 5’ 
exoribonuclease activity contributed by the RNB domain. Besides the RNB domain, Rrp44p 
contains four other domains, three of which are putative RNA binding domains. The fourth 
domain, PIN, has not yet been characterized in eukaryotic Rrp44p.  
 PIN domains are named for their homology with the N-terminus of the bacterial type IV 
pilus biosynthetic protein, PilT (Wall and Kaiser, 1999), and are ubiquitous in all three kingdoms 
of life. These domains are approximately 100 residues in length and display a sequence 
conservation of four acidic residues (Clissold and Ponting, 2000; Makarova et al., 1999). The 
acidic residue conservation seen in PIN domains commonly occurs in enzymes that ligate 
divalent cations, such as nucleases (Clissold and Ponting, 2000). Although the conserved 
residues of the PIN domain are spread across the primary sequence of the protein, the active site 
residues come together and are thought to bind Mg2+ or Mn2+. The central channel formed by the 
PIN domain is large enough to accommodate ssDNA or RNA, but not dsDNA (Daines et al., 
2007; Fatica et al., 2004).  
Bioinformatic analysis of PIN domains predicted a fold similar to the FLAP 5’ to 3’ 
exonuclease family of proteins, which includes T4 bacteriophage RNase H (Clissold and 
Ponting, 2000). Recent structural analysis of archaeal PIN domain-containing proteins, PAE2754 
and AF0591, confirmed these predictions, showing a fold similar to the nuclease domain of T4 
RNase H. In addition, PAE2754 its conserved acidic residues had a similar spatial arrangement, 
suggesting that these residues may also coordinate a metal ion for catalysis. In vitro experiments 
confirmed that these enzymes have Mg2+-dependent exonuclease activity on ssDNA, similar to 
T4 RNase H (Arcus et al., 2004; Levin et al., 2004).  
Importantly, several of the conserved acidic residues of PIN domains are present at the 
same structural position in eukaryotic PIN domain-containing proteins, which suggests that these 
proteins may also coordinate a divalent cation and exhibit nuclease activity. Recently three 
eukaryotic PIN domain-containing proteins, S. cerevisiae Nob1p and Utp24p and H. sapiens 
SMG6, were shown to have endoribonuclease activity on ssRNA, with Nob1p and SMG6 
dependent on Mn2+ for activity. Importantly, mutations of the third conserved acidic residue in 
these proteins abolished PIN domain-mediated endonuclease activity in vitro and in vivo 
(Bleichert et al., 2006; Fatica et al., 2004; Glavan et al., 2006). Ribonuclease activity has also 
been demonstrated in bacterial PIN domain-containing proteins (Daines et al., 2007). Several of 
these proteins are found in toxin-antitoxin systems, where the RNase activity of the PIN domain 
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is responsible for degrading the labile antitoxin, resulting in a toxic effect (Anantharaman and 
Aravind, 2003; Gerdes et al., 2005).  
PIN domain containing-proteins have nuclease activity in all three kingdoms of life, 
suggesting that this nuclease activity plays an important cellular role. To determine whether the 
PIN domain of S. cerevisiae Rrp44p also has nuclease activity, GST-fusions of Rrp44p were 
purified from E. coli and incubated with several RNA substrates. Here, the data indicate that the 
PIN domain of yeast Rrp44p has Mn2+-dependent endoribonuclease activity that is not sequence 
specific. Additionally, the PIN domain is needed for viability. Data also suggest that while yeast 
cells require at least one of the nuclease activities of Rrp44p to survive, either activity is 
sufficient for viability. Lastly, the exoribonuclease, but not endoribonuclease, activity of Rrp44p 
is required for a functional nuclear exosome. 
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RESULTS 
The PIN domain of Rrp44p has endoribonuclease activity. 
Truncated Rrp44p, which includes the CR3 region and PIN domain (residues 1-235), 
was purified as a Glutathione S-transferase (GST) fusion from E. coli. Truncated Rrp44p was 
incubated individually with a 32P 5’- and 3’-end labeled A30 oligonucleotide. Exonucleolytic 
degradation would yield labeled mononucleotides with only one of the substrates, whereas 
truncated Rrp44p showed a similar pattern of labeled oligonucleotides with both substrates 
(Schaeffer et al., 2009). This indicates that the PIN domain of Rrp44p acts as an endonuclease.  
 Truncated Rrp44p was also incubated individually with a 32P 5’-end labeled U30 
oligonucleotide and an in vitro transcribed, 32P internally labeled 5’ ETS substrate. Truncated 
Rrp44p was active on both, and on an A30 oligonucleotide, indicating that PIN domain 
endoribonuclease activity of Rrp44p is not sequence specific (Schaeffer et al., 2009).  
 Mutation of the third conserved acidic residue, Aspartate 171, abolished the 
endoribonuclease activity of Rrp44p (Lebreton et al., 2008; Schaeffer et al., 2009; Schneider et 
al., 2009), which has also been shown for other PIN domain-containing proteins (Bleichert et al., 
2006; Fatica et al., 2004; Glavan et al., 2006).  
 
The PIN domain of Rrp44p is needed for viability. 
 To determine whether the endoribonuclease activity of Rrp44p was needed for cell 
survival, C-terminal truncations of RRP44 were generated. These mutants were transformed into 
an rrp44 deletion strain that is complemented by full-length, wild-type RRP44 on a plasmid with 
a URA3 marker (rrp44# [RRP44, URA3]). Transformants were then spotted onto media 
containing 5-fluoroorotic acid (5-FOA) and grown for several days. Growth of the rrp44 mutants 
was compared to two controls, empty vector and wild-type RRP44 (Figure 3.1A). In cells that 
contain a wild-type URA3 gene, the URA3 gene product (orotine-5’-monophosphate 
decarboxylase) converts 5-FOA to 5-fluorouracil, which is toxic to cells (Boeke et al., 1987). 
Since 5-FOA is used to select for cells that have lost the wild-type RRP44, URA3 plasmid, only 
one mutant copy of rrp44 remains in the cell. Therefore, growth on 5-FOA indicates that mutant 
Rrp44p can carry out the protein’s essential function.   
A C-terminal truncation that lacks the exoribonucleolytic RNB domain, but contains the 
CR3 region and PIN domain (residues 1-235), allowed for slow growth (Figure 3.1A(Schaeffer 
et al., 2009). This result is not surprising given that it has been previously shown that a point 
mutant that inactivates the catalytic activity of the RNB domain, D551N, also has a slow growth 
phenotype (Amblar and Arraiano, 2005; Dziembowski et al., 2007). The slight growth observed 
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upon deletion of the RNB domain suggests that the D551N mutant is not viable only because of 
some low-level exonuclease activity in vivo. Instead, growth of the C-terminal truncation that 
lacks the RNB domain suggests that exonuclease activity is not crucial for the essential function 
of Rrp44p, or the exosome. A C-terminal truncation that lacks a portion of the PIN domain 
(residues 1-203) does not support viability (Figure 3.1A; Schaeffer et al., 2009). This lack of 
complementation is not due to a lack of expression as both C-terminal truncations are expressed 
(Figure 3.1B). This suggests that the PIN domain is required for viability, and thus, the essential 
function of Rrp44p. 
 
At least one nuclease activity of Rrp44p is needed for viability. 
 To determine whether the endonuclease activity of the PIN domain of Rrp44p is needed 
for viability, a catalytically inactive endonuclease point mutation (D171A) was generated and 
transformed into an rrp44# [RRP44, URA3] strain. Transformants were then spotted onto media 
containing 5-FOA and grown for several days. Growth of the D171A mutant was compared to 
empty vector, wild-type RRP44 and the catalytically inactive exonuclease point mutant, D551N. 
The D171A mutant (Figure 3.2A), or mutants in the three other conserved acidic residues of the 
PIN domain (Figure 3.2B), had no obvious growth phenotype. In contrast, the D551N mutant 
had a slow growth phenotype (Figure 3.2A; Lebreton et al., 2008; Schaeffer et al., 2009; 
Schneider et al., 2009), which has been previously shown in mutants that inactivate Rrp44p 
exonuclease activity (Amblar and Arraiano, 2005; Dziembowski et al., 2007). These findings 
suggest that neither of the nuclease activities of Rrp44p is required for viability.  
To determine whether cells require at least one nuclease activity of Rrp44p to survive, 
the double catalytically inactive point mutation (D171A, D551N) was generated and transformed 
into an rrp44# [RRP44, URA3] strain. Transformants were then spotted onto media containing 
5-FOA and grown for several days. Growth of the D171A, D551N mutant was compared to 
empty vector, wild-type RRP44, the D171A mutant, and the D551N mutant. Combining the 
viable D171A mutant, or mutants in the other three conserved acidic residues of the PIN domain, 
with the D551N mutant resulted in no growth (Figure 3.2A and B; Lebreton et al., 2008; 
Schaeffer et al., 2009; Schneider et al., 2009). Similarly, combining the viable PIN mutations 
with a viable C-terminal truncation that lacks the exonucleolytic RNB domain, residues 1-324, 
also resulted in no growth (Figure 3.2C; Schaeffer et al., 2009). These results suggest that either 
nuclease active site is sufficient for viability, however, simultaneous inactivation of both of the 
catalytic sites results in a nonfunctional Rrp44p, and thus, no cell growth.  
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A. 
B. 
Figure 3.1: The PIN domain of Rrp44p is needed for viability.  
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Figure 3.1: The PIN domain of Rrp44p is needed for viability. A, An rrp44 deletion strain 
complemented by full-length RRP44 on a plasmid with a URA3 marker was transformed with 
plasmids encoding each of the depicted truncations. Transformants were spotted onto media 
containing 5-fluoroorotic acid (5-FOA) and control media (SC –LEU–URA + 2% dextrose), and 
grown for several days. Growth of the rrp44 mutants was compared to two control strains, empty 
vector and wild-type RRP44. Growth on 5-FOA indicates that truncated Rrp44p can carry out 
the essential function of Rrp44p. B, Whole-cell lysates were obtained from strains containing the 
C-terminally TAP-tagged Rrp44p truncations described in (A) and were analyzed by Western 
blot analysis with antibodies specific to Protein A to detect Rrp44p and to Pgk1p as a loading 
control. Expression of the Rrp44p truncated proteins was compared to wild-type Rrp44p.  
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Figure 3.2: At least one nuclease activity of Rrp44p is needed for viability.  
A. 
B. 
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C. 
Figure 3.2: At least one nuclease activity of Rrp44p is needed for viability.  
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Figure 3.2: At least one nuclease activity of Rrp44p is needed for viability. An rrp44 
deletion strain complemented by full-length RRP44 on a plasmid with a URA3 marker was 
transformed with plasmids encoding the depicted mutations. Transformants were spotted onto 
media containing 5-FOA and control media (SC –LEU–URA + 2% dextrose), and grown for 
several days. Growth of the rrp44 mutants was compared to two controls, empty vector and 
wild-type RRP44. Growth on 5-FOA indicates that mutated Rrp44p can carry out the essential 
function of the Rrp44p.  
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The exoribonuclease activity of Rrp44p is needed for both the RNA processing and RNA 
degradation activities of the nuclear exosome. 
 The nuclear exosome processes the 7S rRNA precursor to form the mature 5.8S rRNA 
and degrades the 5’ external transcribed spacer (5’ ETS) of the 35S rRNA precursor (Allmang et 
al., 1999a; Allmang et al., 1999b; Mitchell et al., 1997; Mitchell et al., 1996). In RNA 
processing, an RNA precursor is trimmed to form a mature, stable, small RNA. In RNA 
degradation, however, an RNA is cleaved many times to yield nucleotide monophosphates. This 
type of cleavage would require an efficient and processive enzyme that is able to degrade an 
RNA substrate to completion. Therefore, the endonuclease activity of the PIN domain of Rrp44p 
may be sufficient for nuclear exosome-mediated RNA processing, whereas the exonuclease 
activity of the RNB may be required for nuclear exosome-mediated RNA decay.  
To test this hypothesis, several C-terminal truncations of RRP44 were generated and 
transformed into a strain that contains endogenous RRP44 under the control of the galactose 
promoter (GAL::rrp44). In the presence of galactose, endogenous RRP44 is actively transcribed, 
however, transcription of GAL::rrp44 is shut off in the presence of dextrose. Therefore, to 
inhibit expression of endogenous RRP44, these strains were grown in the presence of dextrose. 
RNA processing and degradation in the rrp44 truncations was compared to two controls, a strain 
containing wild-type RRP44 and an rrp6 deletion strain. Rrp6p is a nuclear exosome cofactor 
and is required for nuclear RNA processing and degradation (Briggs et al., 1998). RNA was then 
isolated from these strains and subjected to denaturing urea-polyacrylamide gel electrophoresis. 
To determine if these strains were defective in RNA processing and/or RNA degradation, 
Northern blot analysis was performed using probes specific to the 7S rRNA precursor and to the 
5’ ETS, respectively. C-terminal truncations lacking the exonucleolytic RNB domain of Rrp44p 
caused the 7S precursor of the 5.8S rRNA to accumulate (Figure 3.3A, above) and caused a 20 to 
24 fold increase in the accumulation of the 5’ ETS (Figure 3.3A, middle; Lebreton et al., 2008; 
Schaeffer et al., 2009; Schneider et al., 2009). This suggests that the exonucleolytic RNB domain 
is needed for efficient nuclear RNA processing and degradation, but does not exclude the 
possibility that the endonuclease activity of Rrp44p is also required. 
To test whether the endonuclease activity of the PIN domain is also needed for nuclear 
RNA processing and/or degradation, plasmids encoding the catalytically inactive endo- and 
exonuclease point mutations (D171A and D551N, respectively), as well as the double 
catalytically inactive point mutation (D171A, D551N) were transformed into GAL::rrp44. These 
strains were grown in the presence of galactose then shifted to media containing dextrose for the 
times indicated. Similar to the results obtained with the rrp44 C-terminal truncations, 7S 
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processing and 5’ ETS degradation intermediates accumulated in the D551N mutant and in the 
D171A, D551N mutant. There were no similar degradation or processing intermediates in the 
D171A mutant (Figure 3.B; Schaeffer et al., 2009; Schneider et al., 2009). Thus, both the RNA 
processing and degradation functions of the nuclear exosome require the exonuclease activity of 
the RNB domain of Rrp44p.  
 
The exonuclease activity of Rrp44p may have some overlapping functions with the nuclear 
exosome cofactor, Rrp6p. 
Rrp44p exonuclease activity and the nuclear exosome cofactor, Rrp6p, are involved in 
maintaining a functional nuclear exosome (Briggs et al., 1998; Dziembowski et al., 2007; 
Lebreton et al., 2008; Schaeffer et al., 2009; Schneider et al., 2009). To determine whether the 
endo- and/or exonuclease activities of Rrp44p were redundant with Rrp6p in the nucleus, the 
D171A and D551N point mutations were combined with an rrp6 deletion. Briefly, plasmids 
encoding the D171A and D551N point mutations were transformed into an rrp6 and rrp44 
deletion strain to generate the rrp6# D171A and rrp6# D551N strains, respectively. Because 
RRP44 is essential, this strain is being complemented by wild-type RRP44 on a plasmid with a 
URA3 marker. Transformants were then spotted onto media containing 5-FOA and grown at 
three different temperatures (23°C, 30°C, 37°C) for several days. 5-FOA selects for cells that 
had lost the wild-type RRP44, URA3 plasmid, therefore, the D171A and D551N point mutations 
were the only copies of RRP44 in the cell. Although this particular rrp6 deletion strain can grow 
at temperatures up to 37°C, its optimal growth temperature is at 25°C (Schneider et al., 2009). 
Additionally, other rrp6 deletion strains are temperature-sensitive (Allmang et al., 1999b). 
Growth of the rrp6# D171A and rrp6# D551N strains at all three temperatures was compared to 
two controls, an rrp6 and rrp44 deletion strain (rrp6# rrp44#) and an rrp6 deletion strain. The 
D551N mutant was synthetically sick with an rrp6 deletion at all three temperatures, with the 
most severe growth defect at 37°C, whereas the rrp6# D171A strain had no observable growth 
defect (Figure 3.4). This suggests that the exonuclease activity of Rrp44p may have some 
overlapping functions with Rrp6p.  
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B. 
Figure 3.3: The exonuclease activity of Rrp44p is needed for both the RNA processing 
and RNA degradation activities of the nuclear exosome.  
A. 
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C. 
Figure 3.3: The exonuclease activity of Rrp44p is needed for both the RNA processing 
and RNA degradation activities of the nuclear exosome.  
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Figure 3.3: The exonuclease activity of Rrp44p is needed for both the RNA processing and 
RNA degradation activities of the nuclear exosome. A, The indicated Rrp44p truncations were 
expressed in a GAL::rrp44 strain. RNA was isolated from cultures grown in dextrose (to inhibit 
expression of the GAL::rrp44 gene) and analyzed by Northern blot analysis with probes that 
hybridize to the 7S precursor of 5.8S rRNA (above), the 5’ ETS of the rRNA (middle) and the 
RNA subunit of the signal recognition particle (SCR1; below). The relative levels of the 7S pre-
rRNA and the 5’ ETS were normalized for loading using the SCR1 signal and are indicated 
under the above and middle blots. B, rrp44 alleles containing the D171A mutation, the D551N 
mutation or the D171A D551N double mutation was introduced into a GAL::rrp44 strain. 
Cultures were first grown in media containing galactose and then incubated in media containing 
dextrose for the indicated time (in hours). RNA was isolated from these cultures and analyzed by 
Northern blot analysis with probes that hybridize to the 5.8S rRNA (above), the 5’ ETS of the 
rRNA (middle) and SCR1 (below). In both (A) and (B), RNA processing and RNA degradation 
in the rrp44 mutants was compared to two control strains, wild-type RRP44 and an rrp6 
deletion. C, A growth analysis of the strains described (B). The strains were grown in selective 
glucose media at 30°C to analyze growth. 
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Figure 3.4: The exonuclease activity of Rrp44p may have some overlapping functions 
with the nuclear exosome cofactor, Rrp6p.  
53 
Figure 3.4: The exonuclease activity of Rrp44p may have some overlapping functions with 
the nuclear exosome cofactor, Rrp6p. An rrp44 deletion strain or an rrp6 and rrp44 deletion 
strain was transformed with plasmids encoding each of the depicted mutations. Transformants 
were spotted onto media containing 5-FOA and grown for several days at the indicated 
temperatures. Growth of the rrp6 and rrp44 mutants was compared to two controls, an rrp6 and 
rrp44 deletion strain and an rrp6 deletion strain. Growth at 37°C would suggest that the nuclease 
activities of Rrp44p are not redundant with Rrp6p.  
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DISCUSSION 
Implications of two nuclease active sites in the catalytic subunit of the exosome 
The data presented in this Chapter were published as the first report of a second nuclease 
active site in eukaryotic Rrp44p. Thirteen years after the discovery of the exosome (Mitchell et 
al., 1997), this breakthrough finding has revealed that it is possible for the exosome to cleave 
RNA internally as well as from the 3’-end.  
It was widely accepted that Rrp44p had only 3’ to 5’ exoribonuclease activity. There are 
at least two reasons why the catalytically inactive exonuclease mutant, D551N, had no nuclease 
activity in vitro. First, the previously reported Rrp44p nuclease assays were performed using 
conditions that are favorable for 3’ to 5’ exonuclease activity (Tris buffer supplemented with 
Mg2+; Dziembowski et al., 2007; Liu et al., 2006; Lorentzen et al., 2008). When a C-terminal 
Rrp44p truncation that lacks the exonucleolytic RNB domain is tested in this buffer combination, 
there is no observable endonuclease activity (Schaeffer et al., 2009). Second, robust 
endonuclease activity was observed using truncated Rrp44p proteins, with much less activity 
seen with full-length Rrp44p (Schaeffer et al., 2009). This may suggest that the C-terminal 
domains of Rrp44p regulate the activity of the PIN domain. Nonetheless, the endonuclease 
activity of truncated Rrp44p, under conditions that are favorable for PIN domain activity 
(HEPES buffer supplemented with Mn2+), is similar to the exonuclease activity of full-length 
Rrp44p under conditions that are amenable to RNB domain activity (Schaeffer et al., 2009). 
Therefore, although endonuclease activity had not been previously identified, it is robust and 
physiologically relevant under certain conditions and/or on RNA substrates that have not yet 
been determined.  
The presence of two nuclease active sites in Rrp44p may indicate that the endo- and 
exonucleolytic domains act on different RNA substrates. Under this hypothesis, the 
endonucleolytic PIN domain may act on previously uncharacterized substrates, meaning that 
there may be more exosome substrates than previously thought. Additionally, the Rrp44p 
endonuclease may be responsible for an endonucleolytic cleavage event in an RNA processing 
and/or RNA degradation pathway where the endonuclease has not yet been identified. 
Alternatively, the presence of two catalytic sites may increase the overall efficiency of RNA 
processing and/or RNA degradation. Under this hypothesis, the endo- and exonuclease activities 
of Rrp44p do not have separate substrates, but rather can act together on most or all exosome 
substrates.  
 Combining RNases into a single RNA degradation machine is not unique in nature. In 
the E. coli degradosome, the RNase E endoribonuclease is combined with the 3’ to 5’ 
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exoribonuclease activity of PNPase (Carpousis et al., 1994; Py et al., 1994). In metazoan 
processing bodies (P-bodies), the Argonaute endoribonuclease is combined with several 
exoribonucleolytic deadenylation factors and the 5’ to 3’ exoribonuclease activity of Xrn1p 
(Andrei et al., 2005; Bashkirov et al., 1997; Cougot et al., 2004; Ingelfinger et al., 2002; Liu et 
al., 2005; Zheng et al., 2008). Because this combination has evolved multiple times 
independently, it likely offers a fundamental advantage to the cell. 
 
The nuclease activities of Rrp44p may be functionally redundant. 
The results shown in this Chapter also indicate that while cells require at least one 
nuclease activity of Rrp44p to survive, either is sufficient. This suggests that the Rrp44p 
endonuclease is active and is important in vivo. Additionally, this suggests that these nuclease 
activities are redundant for the essential function of Rrp44p. Such functional redundancy is not 
an unprecedented theme for RNases, and is similar to what is found in Rrp44p and Rrp6p in 
yeast (Dziembowski et al., 2007), the 5’ to 3’ exoribonuclease, Xrn1p, and the exosome in yeast 
(Anderson and Parker, 1998; Johnson and Kolodner, 1995), and several exoribonucleases in E. 
coli (Andrade et al., 2009; Deutscher and Li, 2001). 
Although either nuclease activity is sufficient for viability, a C-terminal truncation 
lacking a portion of the endonucleolytic PIN domain cannot support growth. This result may 
indicate that the PIN domain, in addition to having nuclease activity, may also serve as a 
platform for crucial protein-protein interactions. The C-terminal region of the PIN domain 
(residues 203-235) may be needed for interaction with the core exosome and/or for interactions 
with a previously unidentified exosome cofactor. In support of this, it has been recently shown 
that the PIN domain of Rrp44p is important for exosome interaction (Schneider et al., 2009). 
Alternatively, this region may be needed to make critical contacts with an RNA substrate.  
 
Rrp44p exoribonuclease activity and the nuclear exosome cofactor, Rrp6p, are needed for 
a functional nuclear exosome. 
Lastly, the data presented here indicate that the exonuclease activity of Rrp44p is needed 
for a functional nuclear exosome, namely the RNA processing of the 7S precursor to form the 
mature 5.8S rRNA and the degradation of the 5’ ETS. However, it was recently published that 
the endonuclease activity of Rrp44p is needed for 5’ ETS degradation (Lebreton et al., 2008). 
This observation may be explained by the use of a different parental strain (W303) from what 
was used in this work (BY4741). Additionally, another study, in which the BY4741 strain was 
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used, confirmed the results presented here (Schneider et al., 2009). Therefore, the Rrp44p 
endonuclease may behave differently in different strain backgrounds.  
The results shown here indicate that the exonuclease activities of Rrp44p and Rrp6p may 
have some overlapping functions. It is important to note that while the D551N mutant was 
synthetically sick with an rrp6 deletion in this study, a previous study found that abolishing the 
exonuclease activity of Rrp44p in an rrp6 deletion strain did not support viability. This 
observation can be explained by the use of a different parental strain (W303) from what was 
used in this work (BY4741). In support of the work presented here, another study, in which the 
BY4741 strain was used, confirmed the results shown here- the rrp6! D551N strain had a slow 
growth phenotype when compared to a wild-type strain, an rrp6 deletion, and the D551N mutant 
(Schneider et al., 2009). Therefore, the Rrp44p and Rrp6p exonucleases seem to behave 
differently in different strain backgrounds. Accordingly, recent data suggest that the functional 
interactions between Rrp44p and Rrp6p are important for only certain Rrp6p substrates 
(Callahan and Butler, 2008). 
The involvement of the Rrp44p endonuclease in other nuclear RNA processing and 
degradation reactions has not yet been tested. The possibility exists that the endonuclease 
activity of Rrp44p is needed for the processing of snRNA and/or snoRNA precursors. The 
Rrp44p endonuclease may also be involved in one of the multiple nuclear RNA surveillance 
pathways needed to degrade abnormally processed rRNA, tRNA, snRNA, snoRNA, and/or 
mRNA (see Chapter 7). 
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Chapter 4: The exoribonuclease activity of Rrp44p is required for 
exosome-mediated mRNA decay. 
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INTRODUCTION 
 The eukaryotic exosome is a ten subunit complex that is involved in multiple RNA 
processing and RNA degradation reactions in both the nucleus and cytoplasm. The cytoplasmic 
exosome is strictly involved in mRNA degradation, where it degrades two types of transcripts. In 
one pathway, the exosome degrades normal transcripts to allow the cell to rapidly change mRNA 
levels, and ultimately protein levels, in response to a particular signal (Anderson and Parker, 
1998). In mRNA surveillance, the exosome degrades aberrant transcripts in order to maintain the 
fidelity of gene expression. These types of aberrant mRNAs include host transcripts that lack 
termination codons (Frischmeyer et al., 2002; van Hoof et al., 2002) or poly(A) tails (Meaux and 
van Hoof, 2006), host transcripts that stall translation elongation (Doma and Parker, 2006) or 
contain premature termination codons  (Gatfield and Izaurralde, 2004; Mitchell and Tollervey, 
2003; Takahashi et al., 2003), and viral mRNAs (Guo et al., 2007).  
 In eukaryotes, normal transcripts are degraded by one of two pathways (Figure 1.2). In 
both cases, deadenylation, or removal of the poly(A) tail is the initiating and rate-limiting step 
(Muhlrad and Parker, 1992; Shyu et al., 1991). Degradation of the poly(A) tail triggers 5’ to 3’ 
mRNA decay in yeast. In this pathway, the 5’ cap is removed by the decapping complex, Dcp1p 
and Dcp2, which then allows the 5’ to 3’ exoribonuclease, Xrn1p, to degrade the transcript from 
the 5’-end (Decker and Parker, 1993; Hsu and Stevens, 1993; Muhlrad et al., 1994). Following 
deadenylation, mRNA can also be degraded from the 3’-end, a process catalyzed by the exosome 
(Anderson and Parker, 1998; Mukherjee et al., 2002; Rodgers et al., 2002). Inactivation of both 
mRNA decay pathways results in loss of viability, underscoring the importance of mRNA 
turnover (Anderson and Parker, 1998). 
 In cytoplasmic mRNA surveillance pathways, the exosome degrades aberrant 
transcripts. One example of an mRNA surveillance pathway is the degradation of mRNAs that 
lack termination codons, termed nonstop transcripts, in the nonstop mRNA degradation pathway 
(Figure 1.3; Frischmeyer et al., 2002; van Hoof et al., 2002). Nonstop transcripts can arise from 
mistakes in gene expression, including premature polyadenylation, due to inaccurate 3’-end 
formation or through the use of a cryptic polyadenylation site (Bucheli et al., 2007). In the 
current nonstop decay model, the translating ribosome reads through the poly(A) tail and stalls at 
the 3’-end. The cytoplasmic exosome cofactor, Ski7p, is then believed to recognize the ribosome 
with an empty A-site and recruit the exosome to rapidly exonucleolytically degrade the transcript 
from the 3’-end (van Hoof et al., 2002).  
 Transcripts that stall translation elongation, perhaps due to secondary structure, are also 
degraded by the cytoplasmic exosome in an RNA surveillance pathway termed no-go decay 
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(Figure 1.4 and Figure 4.6). In the current model of no-go decay, a ribosome that stalls during 
translation elongation is recognized by two paralogs of translation release factors, Hbs1p and 
Dom34p. The transcript is then endonucleolytically cleaved near the stalled ribosome, releasing 
a 5’- and 3’-degradation fragment. The 5’-fragment is degraded by the cytoplasmic exosome, 
whereas the 3’-degradation fragment is degraded by the 5’ to 3’ exoribonuclease, Xrn1p, in the 
5’ to 3’ mRNA degradation pathway (Doma and Parker, 2006). The endoribonuclease 
responsible for the initial cleavage event, and freeing of the ribosome, has not yet been 
identified.  
 The exosome subunit believed to be involved in these cytoplasmic mRNA degradation 
reactions is Rrp44p, as it is the only catalytically active subunit (Dziembowski et al., 2007). 
Specifically, the exonuclease activity of Rrp44p may be involved in general 3’ to 5’ mRNA 
degradation, nonstop mRNA decay, and in the degradation of the 5’-fragment in no-go decay. 
Additionally, the endonuclease activity of Rrp44p may be needed for the initial cleavage event in 
no-go decay. To determine whether the nuclease activities of Rrp44p are involved in these 
cytoplasmic mRNA degradation reactions, strains containing C-terminal truncations and 
catalytically inactive point mutations of Rrp44p were generated. The degradation of several 
representative reporter transcripts was then analyzed in these mutants. Here, the data indicate 
that the exonucleolytic RNB domain is required for exosome-mediated 3’ to 5’ mRNA decay. 
Interestingly, the data also suggest that neither the endo- or exonuclease activities of Rrp44p are 
needed for the degradation of nonstop transcripts and that the endonuclease activity of Rrp44p is 
not required for endonucleolytic cleavage in no-go decay. Additionally, the results suggest that 
the endonuclease activity of Rrp44p is not redundant with Ski7p in nonstop decay. 
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RESULTS 
The exonuclease activity of Rrp44p is needed for exosome-mediated 3’ to 5’ mRNA decay. 
To determine whether the endo- and/or exonuclease activities of Rrp44p were needed for 
general 3’ to 5’ decay, a synthetic lethality growth assay was performed (van Hoof et al., 2000b). 
The basis of this assay is that at least one of the two mRNA decay pathways is required for 
viability. Therefore, mutants in the 3’ to 5’ decay pathway are synthetically lethal with mutants 
in the 5’ to 3’ decay pathway (Anderson and Parker, 1998). Briefly, plasmids encoding the 
individual catalytically inactive Rrp44p nuclease point mutations, D171A and D551N, were 
transformed into an rrp44 deletion strain that contains a temperature-sensitive allele of dcp1 
(dcp1-2), generating the dcp1-2 D171A and dcp1-2 D551N strains. Dcp1p is a subunit of the 
decapping complex needed for 5’ to 3’ mRNA decay (Coller and Parker, 2004). These strains 
also contain a plasmid encoding wild-type RRP44 and URA3 marker. Transformants were then 
spotted onto media containing 5-FOA to select for cells that had lost the wild-type RRP44, URA3 
plasmid. Therefore, the D171A and D551N point mutations were the only copies of RRP44 in 
the cell. The dcp1-2 D171A and dcp1-2 D551N strains were then spotted onto selection media 
and grown at three different temperatures (23°C, 30°C, 37°C) for several days. Growth of these 
strains at the non-permissive temperature for dcp1-2 (37°C) was compared to two control strains. 
The first control was a ski7 deletion strain that also contained the dcp1-2 allele (dcp1-2 ski7#). 
Ski7p is a cytoplasmic exosome cofactor that is required for general 3’ to 5’ decay (Araki et al., 
2001; van Hoof et al., 2000b). The second control strain contained only the dcp1-2 mutant. 
While the dcp1-2 D171A strain had no detectable growth phenotype, the D551N mutant was 
synthetically lethal with dcp1-2 at the non-permissive temperature (Figure 4.1A). In support of 
this finding, it has also been shown that deletion of Xrn1p, the 5’ to 3’ exoribonuclease, is also 
synthetically lethal with the D551N mutant (Schneider et al., 2009). Combined, these data 
suggest that the exonuclease activity, but not endonuclease activity, of Rrp44p is needed for 
exosome-mediated 3’ to 5’ mRNA decay.  
 To further test the importance of Rrp44p exonuclease activity in general 3’ to 5’ mRNA 
decay, the stability of an endogenous mRNA, GAL7, was measured. GAL7 is a galactose 
metabolism gene and is expressed in media containing galactose. The degradation of the GAL7 
mRNA reporter was measured in the dcp1-2 D171A and dcp1-2 D551N strains. GAL7 stability 
in these strains was compared to two control strains, dcp1-2 and dcp1-2 ski7#. Briefly, these 
strains were grown in liquid media containing galactose at the permissive temperature for dcp1-2 
(23°C) and then shifted to the non-permissive temperature (37°C) for one hour. The strains were 
then grown in media containing dextrose to shut off transcription of GAL7. RNA was isolated 
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from these strains and subject to agarose formaldehyde gel electrophoresis. Northern blot 
analysis was then performed using probes specific to GAL7, and SCR1 as a loading control. In 
the dcp1-2 strain, GAL7 was unstable since the 3’ to 5’ decay pathway was still functional. 
Conversely, in the dcp1-2 ski7! strain, GAL7 was more than 4-times more stable, as neither the 
5’ to 3’ or 3’ to 5’ mRNA decay pathway was functional. GAL7 was unstable in the dcp1-2 
D171A strain, however, GAL7 was 2-times more stable in the dcp1-2 D551N strain as compared 
to the dcp1-2 strain (Figure 4.1B and C). Although the exonuclease mutant stabilizes GAL7, 
there is some residual mRNA decay of the reporter in the dcp1-2 D551N strain. This may be 
explained by incomplete inactivation of the dcp1-2 allele, residual activity of the D551N mutant, 
or the presence of an exonuclease that is redundant with Rrp44p. Overall, these results suggest 
that, similar to the data obtained in the synthetic lethality growth assay, the exonuclease activity 
of Rrp44p is needed for the general 3’ to 5’ decay activity of the cytoplasmic exosome. 
 
Neither of the nuclease activities of Rrp44p are required to degrade nonstop transcripts. 
 To determine whether the exonuclease activity of Rrp44p is required to degrade nonstop 
mRNAs, the stability of a representative nonstop transcript was measured in a strain that lacks 
the exonucleolytic RNB domain of Rrp44p. Briefly, the GAL::pgk1pG-nonstop reporter was 
transformed into an rrp44 deletion strain that is complemented with a C-terminal truncation of 
Rrp44p that lacks the RNB domain.  
This reporter contains a nonstop mutation in the PGK1 (3-phosphoglycerate kinase) 
open reading frame and is a known substrate of the nonstop decay pathway (van Hoof et al., 
2002). Because this reporter is under the control of the galactose promoter, the pgk1pG-nonstop 
transcript is expressed in media containing galactose, however, transcription is rapidly shut off in 
media containing dextrose. This reporter also has a poly-guanine tract (pG) in order to 
differentiate between the stability of the reporter and the endogenous transcript.  
The stability of the nonstop transcript in the rrp44 deletion strain that lacks the RNB 
domain was compared to two control strains, a strain containing wild-type Rrp44p and a ski7 
deletion strain. These strains were grown in liquid media containing galactose and then shifted to 
media containing dextrose to shut off transcription of the GAL::pgk1pG-nonstop reporter. RNA 
was isolated from these strains and subject to agarose formaldehyde gel electrophoresis. 
Northern blot analysis was then performed using probes specific to pgk1pG, and to SCR1 as a 
loading control. In the wild-type strain, GAL::pgk1pG-nonstop was unstable since the nonstop 
mRNA decay pathway was still functional. Conversely, when the nonstop decay pathway was 
inactivated in the ski7 deletion strain, the nonstop transcript was 7-times more stable. In the 
62 
A. 
Figure 4.1: The exonuclease activity of Rrp44p is needed for exosome-mediated 3’ to 5’ 
mRNA degradation. 
B. 
C. 
63 
Figure 4.1: The exonuclease activity of Rrp44p is needed for exosome-mediated 3’ to 5’ 
mRNA degradation. A, An rrp44 deletion strain containing a plasmid encoding wild-type 
RRP44 and a URA3 marker, as well as a temperature-sensitive allele of dcp1 (dcp1-2), was 
transformed with plasmids encoding the depicted mutations. Transformants were spotted onto 
media containing 5-FOA and grown for several days at the indicated temperatures. Growth of 
the dcp1-2 rrp44 mutants was compared to two control strains, a ski7 deletion strain that also 
contains the dcp1-2 allele (dcp1-2 ski7!) and a strain containing only the dcp1-2 mutant. Growth 
on 5-FOA at 37°C, the non-permissive temperature of the dcp1-2 allele, indicates that mutated 
Rrp44p can carry out exosome-mediated 3’ to 5’ mRNA degradation. B, RNA was isolated from 
each strain described in (A) and analyzed by Northern blot analysis with probes that hybridize to 
GAL7 and SCR1. The half-life GAL7 was normalized for loading using the SCR1 signal and are 
as indicated (in minutes). C, A graphical representation of the half-life of the GAL7 transcript. 
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strain that lacked the RNB domain of Rrp44p, GAL::pgk1pG-nonstop was as unstable as it was 
in the wild-type strain (Figure 4.2A and B), which suggests that exonucleolytic RNB domain of 
Rrp44p is not needed for the degradation of nonstop transcripts. 
In order to determine whether the endonuclease activity of the PIN domain is needed for 
nonstop decay, the his3-nonstop growth assay was performed. Briefly, another representative 
nonstop reporter, his3-nonstop, was transformed into rrp44 deletion strains that were 
individually complemented with the D171A and D551N mutants. The his3-nonstop growth assay 
is counter-intuitive in that in strains that have defects in nonstop decay, the his3-nonstop reporter 
is stable, which allows cells to grow on media lacking histidine. In contrast, cells that have a 
functional nonstop decay pathway rapidly degrade the his3-nonstop transcript, resulting in a lack 
of growth on media lacking histidine (van Hoof et al., 2002). The growth of the catalytically 
inactive point mutants on media lacking histidine was compared to two controls, a wild-type 
strain and a ski7 deletion strain. Similar to the wild-type strain, both of the catalytically inactive 
point mutants were viable on media lacking histidine (Figure 4.3A). These results suggest that 
neither of the nuclease activities of Rrp44p are involved in degrading nonstop transcripts. 
The his3-nonstop growth assay is an indirect measure of whether the nonstop decay 
pathway is functional. A more direct way to test for a functional nonstop decay pathway is to 
measure the stability of a representative nonstop mRNA. Therefore, the stability of the 
GAL::pgk1pG-nonstop transcript was measured in strains containing the catalytically inactive 
point mutants of Rrp44p. The stability of the nonstop transcript in the rrp44 point mutants was 
compared to two controls, a strain containing wild-type Rrp44p and a ski7 deletion strain. These 
strains were grown in liquid media containing galactose and then shifted to media containing 
dextrose to shut off transcription of the GAL::pgk1pG-nonstop reporter. RNA was isolated from 
these strains and subject to agarose formaldehyde gel electrophoresis. Northern blot analysis was 
then performed using probes specific to pgk1pG, and to ACT1 as a loading control. Similar to 
what was observed in the his3-nonstop growth assay, the GAL::pgk1pG-nonstop transcript was 
as unstable in both of the catalytically inactive point mutants as it was in the wild-type strain 
(Figure 4.3B and C). Combined, these results indicate that neither of the nuclease activities of 
Rrp44p are needed for the degradation of nonstop transcripts. 
 
The endonuclease activity of Rrp44p is not redundant with Ski7p in nonstop mRNA 
degradation. 
 In the current model of nonstop mRNA degradation, the C-terminus of Ski7p recognizes 
the ribosome with an empty A-site and recruits the exosome to rapidly degrade the nonstop 
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Figure 4.2: The exonuclease activity of Rrp44p is not needed for nonstop mRNA 
degradation.  
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Figure 4.2: The exonuclease activity of Rrp44p is not needed for nonstop mRNA 
degradation. A, An rrp44 deletion strain complemented by a plasmid encoding a C-terminal 
truncation of Rrp44p that lacks the exonucleolytic RNB domain was transformed with the 
GAL::pgk1pG-nonstop reporter. The stability of the transcript in the rrp44 mutant strain was 
compared to two control strains, wild-type RRP44 and a ski7 deletion. Cultures were first grown 
in media containing galactose and then incubated in media containing dextrose (to inhibit 
transcription of the GAL::pgk1pG-nonstop reporter) for the indicated time (in minutes). RNA 
was isolated from these strains and analyzed by Northern blot analysis with probes that hybridize 
to PGK1 and SCR1. The half-life of the GAL::pgk1pG-nonstop transcript was normalized for 
loading using the SCR1 signal and are as indicated (in minutes). B, A graphical representation of 
the half-life of the GAL::pgk1pG-nonstop transcript.  
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Figure 4.3: Neither of the nuclease activities of Rrp44p are needed to degrade nonstop 
transcripts.  
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Figure 4.3: Neither of the nuclease activities of Rrp44p are needed to degrade nonstop 
transcripts. A, An rrp44 deletion strain containing the D171A mutant or the D551N mutant was 
transformed with a his3-nonstop reporter. Transformants were spotted onto media containing, or 
lacking, histidine and grown for several days. Growth of the rrp44 mutants was compared to two 
control strains, wild-type RRP44 and a ski7 deletion. Growth on media lacking histidine 
indicates that the nonstop mRNA degradation machinery is not functional. B, An rrp44 deletion 
strain complemented by a plasmid encoding the D171A mutation or the D551N mutation was 
transformed with the GAL::pgk1pG-nonstop reporter. The stability of the transcript in the rrp44 
mutant strains was compared to two control strains, wild-type RRP44 and a ski7 deletion. 
Cultures were first grown in media containing galactose and then incubated in media containing 
dextrose (to inhibit transcription of the GAL::pgk1pG-nonstop reporter) for the indicated time (in 
minutes). RNA was isolated from these strains and analyzed by Northern blot analysis with 
probes that hybridize to PGK1 and ACT1. The half-life of the GAL::pgk1pG-nonstop transcript 
was normalized for loading using the ACT1 signal and are as indicated. C, A graphical 
representation of the half-life of the GAL::pgk1pG-nonstop transcript.  
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transcript from the 3’-end (Figure 1.3; van Hoof et al., 2002). One unexpected issue with this 
model is that the 3’-end of the mRNA should be inaccessible to the exosome because it is 
presumably buried inside of the ribosome. One solution to this problem may be that Ski7p 
triggers ribosome disassembly. The C-terminus of Ski7p is similar to eRF3, and eRF1 and eRF3 
are thought to trigger ribosome disassembly at termination codons. Therefore, the C-terminus of 
Ski7p may be needed to remove the stalled ribosome to allow the nonstop transcript to be 
degraded. Consistent with this idea, a C-terminal truncation of Ski7p that lacks the region 
homologous to eRF3 partially inhibits nonstop decay (van Hoof et al., 2002). This partial 
inhibition suggests that ribosome disassembly by Ski7p is one way, although not the only way, a 
stalled ribosome can be removed from a nonstop transcript. A second solution may be that the 
Rrp44p endonuclease cleaves the transcript near the ribosome, allowing for the 3’-end of the 
mRNA to be accessible. A third solution is a combination of the two, where either the C-
terminus of Ski7p or the endonuclease activity of Rrp44p remove the ribosome (Figure 4.4). This 
third model predicts that a strain containing a C-terminal truncation of Ski7p and the 
catalytically inactive endonuclease point mutant of Rrp44p, D171A, would completely block 
nonstop decay.  
 To test whether the C-terminus of Ski7p and the endonuclease activity of Rrp44p were 
redundant in nonstop mRNA decay, a his3-nonstop growth assay was performed. In this assay, a 
representative nonstop reporter, his3-nonstop, was transformed into a strain containing a C-
terminal truncation of Ski7p (as the only copy of Ski7p) and the D171A mutant of Rrp44p (as 
the only copy of Rrp44p). This reporter contains a nonstop mutation in the HIS3 open reading 
frame and is a known substrate of the nonstop decay pathway. The basis for this assay is that in a 
strain that is defective in nonstop mRNA decay, the his3-nonstop reporter will be stable, thus 
allowing cells to synthesize histidine and grow on media lacking histidine. In contrast, in a wild-
type strain, where the nonstop decay machinery is functional, the reporter will be rapidly 
degraded and cells will be inviable on media lacking histidine (van Hoof et al., 2002). Growth of 
the strain containing a C-terminal truncation of Ski7p and the D171A mutant of Rrp44p on 
media lacking histidine was compared to several controls, a wild-type strain, a ski7 deletion 
strain, a strain lacking the C-terminus of Ski7p, and a strain containing only the D171A mutant 
of Rrp44p. Since the C-terminus of Ski7p is involved in nonstop decay, the strain lacking the C-
terminus of Ski7p was able to grow on media lacking histidine. Because the N-terminus of Ski7p 
is needed for general 3’ to 5’ mRNA decay, the ski7 deletion strain grew even better on media 
lacking histidine, indicating a stronger defect in nonstop mRNA decay. The strain containing a 
C-terminal truncation of Ski7p and the D171A mutant had the same growth phenotype on media 
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Figure 4.4: Schematic representation of ribosome disassembly in nonstop mRNA 
degradation.  
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Figure 4.4: Schematic representation of ribosome disassembly in nonstop mRNA 
degradation. In the first model, the stalled ribosome is removed, and subsequently 
disassembled, by Ski7p. In the second model, endonucleolytic cleavage by Rrp44p removes the 
ribosome. In the third model, ribosome disassembly is mediated by both Ski7p and the 
endonuclease activity of Rrp44p, with either being sufficient.  
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lacking histidine as the strain containing a C-terminal truncation of Ski7p (Figure 4.5). This 
suggests that the endonuclease activity of Rrp44p is not redundant with the C-terminus of Ski7p 
for ribosome disassembly in nonstop decay.  
 
The Rrp44p endonuclease in not responsible for endonucleolytic cleavage in no-go decay. 
 To determine whether the endonuclease activity of Rrp44p is involved in the no-go 
decay pathway, the steady-state level of a representative no-go decay transcript was measured in 
strains that lack Rrp44p endonuclease activity. Because the endonucleolytic 5’- and 3’-cleavage 
fragments can only be detected in strains that lack a functional cytoplasmic exosome and 5’ to 3’ 
mRNA degradation pathway, respectively, a plasmid encoding the catalytically inactive 
endonuclease point mutant, D171A, was transformed into two different strains, a ski7 and rrp44 
deletion strain and an xrn1 and rrp44 deletion strain to generate the ski7# D171A and xrn1# 
D171A strains, respectively. These strains also contain a plasmid that encodes wild-type RRP44 
and a URA3 marker. Transformants were then spotted onto media containing 5-FOA and grown 
for several days to obtain cells that could lose the wild-type RRP44, URA3 plasmid. Thus, the 
ski7! D171A and xrn1! D171A strains contained only one copy of Rrp44p. These strains were 
then transformed with the GAL::pgk1-SL reporter, and as a control, a plasmid encoding wild-
type GAL::PGK1. The GAL::pgk1-SL reporter contains a stem loop in the pgk1 (3-
phosphoglycerate kinase) open reading frame, which creates a stable secondary structure that is 
known to stall translation elongation (Figure 4.6A; Doma and Parker, 2006).  
 As a control, degradation of the pgk1-SL transcript was analyzed in three control strains, 
each complemented by a plasmid encoding wild-type RRP44: an rrp44 deletion strain (Wild-
type), a ski7 and rrp44 deletion strain (ski7!), and an xrn1 and rrp44 deletion strain (xrn1!). 
Cultures of these strains were grown in media containing galactose and then RNA was isolated 
and subjected to agarose formaldehyde gel electrophoresis. Northern blot analysis was then 
performed using probes specific to the 5’-end of the pgk1 open reading frame, the 3’-end of the 
pgk1 open reading frame just downstream of the stem loop, and to SCR1 as a loading control. If 
the Rrp44p endonuclease is responsible for endonucleolytic cleavage of the pgk1-SL transcript, 
the 5’- and 3’-degradation fragments should not be detectable in the ski7! D171A and xrn1! 
D171A strains, respectively. The data presented here, however, show that the 5’-fragment is 
present at the same levels in the ski7! D171A strain as in the ski7! control strain (Figure 4.6B). 
Similarly, the 3’-fragment is present in both the xrn1! and xrn1! D171A strains (Figure 4.6C).  
 The 3’-degradation fragment is also present in the wild-type strain (Figure 4.6C). This 
may suggest that the stem-loop structure can block Xrn1p. It is not yet known whether this 
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Figure 4.5: The endonuclease activity of Rrp44p is not redundant with Ski7p in nonstop 
mRNA degradation.  
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Figure 4.5: The endonuclease activity of Rrp44p is not redundant with Ski7p in nonstop 
mRNA degradation. A strain containing a C-terminal truncation of Ski7p and the D171A point 
mutant of Rrp44p was transformed with the his3-nonstop reporter. Transformants were spotted 
onto media containing, or lacking, histidine and grown for several days. Growth of the ski7 and 
rrp44 mutants was compared to several controls, a wild-type strain, a strain containing the 
D171A mutant, a strain lacking the C-terminus of Ski7p, and a ski7 deletion strain. Growth on 
media lacking histidine indicates that the nonstop mRNA degradation machinery is not 
functional. 
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Figure 4.6: The Rrp44p endonuclease is not responsible for endonucleolytic cleavage 
in no-go decay.  
A. 
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Figure 4.6: The Rrp44p endonuclease is not responsible for endonucleolytic cleavage 
in no-go decay.  
B. 
C. 
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Figure 4.6: The Rrp44p endonuclease is not responsible for endonucleolytic cleavage in no-
go decay. A, In the current model of no-go decay, a translating ribosome stalls during translation 
elongation, possibly due to secondary structure in the transcript. The stalled ribosome is then 
thought to be recognized by the eRF3 and eRF1 paralogs, Hbs1p and Dom34p, respectively. The 
transcript is then endonucleolytically cleaved, possibly by the Rrp44p endonuclease, which 
releases the stalled ribosome and generates a 5’- and 3’-degradation fragment. The 5’- and 3’-
degradation fragments are degraded by the cytoplasmic exosome and the 5’ to 3’ 
exoribonuclease, Xrn1p, respectively. B and C, A ski7! (B) and xrn1! (C) strain containing the 
rrp44 D171A mutant were transformed with the GAL::PGK1 and GAL::pgk1-SL reporters. The 
degradation of the GAL::PGK1 and GAL::pgk1-SL transcripts in these strains were compared to 
three control strains, wild-type, a ski7! strain (B), and an xrn1! strain (C). RNA was isolated 
from cultures grown in galactose and analyzed by Northern blot analysis with probes that 
hybridize to the regions 5’- (B) or 3’- (C) of the stem-loop stall site, as illustrated (A). 
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degradation fragment arises by decapping followed by 5’ to 3’ degradation by Xrn1p, or by 
endonucleolytic cleavage. Despite the presence of this fragment in the wild-type strain, the 3’ 
degradation fragment detected in the xrn1! strain must be produced by endonucleolytic 
cleavage, which suggests that at least some of the 3’-degradation fragment detected in the wild-
type strain is produced by endonucleolytic cleavage.  
The presence of the 5’- and 3’-degradation fragments in the ski7! D171A and xrn1! 
D171A strains suggest that the endonuclease activity of Rrp44p is not needed for the initial 
endonucleolytic cleavage event in no-go decay. These results, however, do not exclude the 
possibility that the exonuclease activity of Rrp44p is responsible for complete degradation of the 
5’-degradation fragment. 
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DISCUSSION 
 The data presented in this Chapter analyze the roles of the nuclease activities of Rrp44p 
in the cytoplasmic exosome. Here, the exonuclease activity of Rrp44p is shown to be responsible 
for exosome-mediated 3’ to 5’ mRNA decay. This finding is supported by a previous study that 
showed that the D551N mutant of Rrp44p is synthetically lethal with a deletion of Xrn1p, the 
exoribonuclease involved in the 5’ to 3’ mRNA decay pathway (Schneider et al., 2009). 
Therefore, these data indicate that mRNA turnover is an essential process that is mediated by at 
least two key exoribonucleases, and that the endonuclease activity of Rrp44p contributes little to 
the degradation of normal transcripts. 
 The data presented here also show that the nuclease activities of Rrp44p are not needed 
for nonstop mRNA decay and that the endonuclease activity of Rrp44p is not needed for no-go 
decay.  
 
Implications for nonstop mRNA degradation  
 The data shown here indicate that neither the endo- or exonuclease activities of Rrp44p 
are involved in degrading nonstop transcripts. This observation could be explained by one of 
three possibilities. First, the Rrp44p nucleases may be redundant in nonstop decay. This idea is 
difficult to test, however, because the double catalytically inactive point mutant (D171A, 
D551N) is not viable. Therefore, alternative means must be used to test whether nonstop 
transcripts are degraded when both the endo- and exonuclease activities of Rrp44p are abolished 
(see Chapter 7).  
A second explanation is that nonstop decay is independent of the known catalytic 
activities of the cytoplasmic exosome. Under this hypothesis, a different nuclease would be 
responsible for the degradation of nonstop transcripts.  
Lastly, a small fraction of the nuclear-localized exosome cofactor, Rrp6p, may associate 
with the cytoplasmic exosome to degrade nonstop transcripts. In this case, a small amount of 
Rrp6p activity may be enough for a functional nonstop mRNA decay pathway. In support of this, 
the human homolog of Rrp6p has been shown to localize to the nucleus and the cytoplasm in 
human cell lines (Lejeune et al., 2003). Additionally, Rrp6p has been shown to interact with the 
cytoplasmic exosome cofactor, Ski7p (Collins et al., 2007; Peng et al., 2003). In this explanation, 
however, the 3’-end of the nonstop transcript would still be buried in the ribosome. In this 
model, an unknown endonuclease may cleave the nonstop transcript near the ribosome, allowing 
the 3’-end to be accessible to Rrp6p. 
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The finding that the endonuclease activity of Rrp44p is not redundant with the C-
terminus of Ski7p for ribosome disassembly suggests that either Ski7p functions alone or that 
another protein functions with Ski7p to free stalled ribosomes from a nonstop transcript. Because 
a C-terminal truncation of Ski7p only partially inhibits nonstop decay (van Hoof et al., 2002), it 
is more likely that another protein or endoribonuclease work with Ski7p in ribosome 
disassembly.  
 As will be discussed in the next Chapter, a different mutation in Rrp44p does stabilize 
nonstop reporter transcripts (see Figure 5.7). Thus, Rrp44p is required for nonstop mRNA 
degradation, and the most likely explanation is that the endo- and exonuclease activities of 
Rrp44p are redundant for nonstop decay (see Chapter 7). 
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Chapter 5: The CR3 region, a putative zinc binding site of Rrp44p, is 
important for exosome activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTE: I performed all of the experiments described in this Chapter with the exception of the biochemical 
nuclease assay that was performed by our collaborators, Filipa Reis and Dr. Cecilia Arraiano (Instituto 
de Tecnologia Química e Biológica [ITQB]; Lisbon, Portugal) – as denoted in the figure legend 
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INTRODUCTION 
 Rrp44p is the catalytic subunit of the exosome and has two nuclease active sites. The 
PIN domain of Rrp44p has endonuclease activity and the RNB domain has 3’ to 5’ exonuclease 
activity. In addition to these two domains, a CR3 region is in the N-terminus and three putative 
RNA binding domains are spread throughout the protein. The CR3 region consists of three 
conserved cysteine residues (C47, C52, and C55) and is present in most eukaryotic homologs of 
Rrp44p that have a PIN domain. Currently, no information exists on the CR3 region in Rrp44p 
or in any other protein. Although it has been proposed that this region is important for protein-
protein interactions (Ponting et al., 2000), no data exist to support this.  
 Recently the crystal structure of Rrp44p was published, however, the first 33 residues of 
the protein were not included (Bonneau et al., 2009). Therefore, it is not yet known whether the 
CR3 region consists of more than the three cysteine residues or if this region has a unique fold. 
For this reason, the three cysteine residues will be referred to as only the CR3 region. Further 
examination of the crystal structure of Rrp44p shows that two of the three cysteines are modeled 
to form a disulfide bond (C52 and C55; Figure 5.1A and B; Bonneau et al., 2009). However, 
because of the low resolution of the structure (3 Angstroms), the electron density is not defined 
enough to determine which residues, if any, form a disulfide bond. Another striking feature of 
the structure is that the three cysteines of the CR3 region are in close proximity to histidine 184 
(H184; Figure 5.1A and B). This spatial organization is consistent with the coordination of a zinc 
ion, which may be needed, directly or indirectly, for protein stabilization, interaction with the 
exosome, and/or for Rrp44p nuclease activity. Indeed preliminary evidence suggests that Rrp44p 
endonuclease activity is stimulated by the addition of zinc (Filipa Reis and Dr. Cecilia Arraiano, 
personal communication). Interestingly, H184 is present in all eukaryotic homologs of Rrp44p 
that have a CR3 region. 
 Several studies have shown multiple interactions between Rrp44p and the exosome. In 
the first report, yeast two-hybrid data suggested an interaction between the CR3 region and the 
PIN domain of human Rrp44p with human Rrp43p, a subunit of the PH ring in the exosome 
(Lehner and Sanderson, 2004). In another study, a cryo-EM structure of the yeast exosome 
predicted that the CR3 region and the PIN domain of Rrp44p interact with Rrp41p, another 
subunit of the PH ring. This study also predicted major contacts between the cold shock domains 
(CSDs) of Rrp44p, and to a lesser extent the RNB domain, with Rrp45p, another PH ring subunit 
(Wang et al., 2007). Lastly, the most recent study suggests that the PIN domain of Rrp44p 
mediates interaction with the core exosome (Schneider et al., 2009). It is not yet known whether 
this region consists of only the PIN domain or includes both the CR3 region and PIN domain. 
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Figure 5.1: The three cysteines of the CR3 region and histidine 184 (H184) of Rrp44p 
have the proper geometry for the coordination of a zinc atom.  
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Figure 5.1: The three cysteines of the CR3 region and histidine 184 (H184) of Rrp44p have 
the proper geometry for the coordination of a zinc atom. A, Side view of the S. cerevisiae 
Rrp44p structure (Bonneau et al., 2009). The N- and C-termini are shown in red. The three 
cysteines of the CR3 region (C47, C52, C55) and H184 are shown in yellow. A disulfide bond is 
shown between C52 and C55 of the CR3 region. The zoomed-in view shows only the N-
terminus of Rrp44p and better depicts the spatial organization between the three cysteines of the 
CR3 region and H184. B, The electron density of the N-terminus of Rrp44p is shown in blue 
mesh. The three cysteines of the CR3 region and H184 are shown in yellow. The disulfide bond 
between C52 and C55 is shown in orange and the nitrogen atoms of H184 are shown in blue 
(Bonneau et al., 2009). This figure was created by Sean Johnson (Utah State University, Utah). 
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Combined these studies suggest that the CR3 region and PIN domain of Rrp44p are important 
for exosome interaction. More importantly, these studies suggest that multiple regions of Rrp44p 
are needed for Rrp44p to interact with the exosome.  
 To determine the role(s) of the CR3 region of Rrp44p in the exosome, a triple CR3 
mutant was generated, in which the three cysteine residues of the CR3 region were mutated. This 
triple CR3 mutant was then used to assay the interaction between Rrp44p and the exosome as 
well as exosome function. The data presented here are the first report of a CR3 region being 
needed for the formation of a complex in vivo and for enzymatic activity in vitro. Specifically, 
the data suggest that the CR3 region is needed for optimal cell growth and is needed for Rrp44p 
to interact with the exosome. The data presented here also show that the CR3 region is needed 
for Rrp44p endonuclease activity and for a functional cytoplasmic exosome. Importantly, these 
results also indicate that the modeled disulfide bond between the second and third cysteine 
residue of the CR3 region is not needed for exosome function. 
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RESULTS 
Mutating the three conserved cysteine residues of Rrp44p results in a slow growth 
phenotype.  
To determine whether the CR3 region was needed for cell survival, a triple CR3 mutant 
was generated, where the three cysteine residues were mutated to serine (C47S, C52S, C55S). 
The CR3 mutant was then transformed into an rrp44# [RRP44, URA3] strain. Transformants 
were spotted onto media containing 5-FOA and grown for several days. Growth of the CR3 
mutant was compared to two controls, empty vector and wild-type RRP44. As compared to wild-
type, the triple CR3 mutant allowed for only slow growth (Figure 5.2A). This suggests that the 
CR3 region is needed for optimal growth, however, this phenotype could be due to decreased 
expression of the triple CR3 mutant protein (Figure 5.3).  
 
The CR3 region is necessary, but may not be sufficient, for Rrp44p to interact with the 
exosome. 
 To determine whether the CR3 region of Rrp44p mediated interaction with the exosome, 
wild-type Rrp44p and the triple CR3 mutant were C-terminally TAP-tagged. Wild-type and 
mutant Rrp44p were purified using IgG sepharose beads specific to the Protein A portion of the 
TAP tag. Proteins bound to Rrp44p were eluted and analyzed using sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). Whole cell lysates were obtained from the 
Rrp44p strains and were compared to the bound fraction. The interaction of wild-type Rrp44p 
and the CR3 mutant with the exosome was compared to empty vector. Unlike wild-type Rrp44p, 
the triple CR3 mutant was unable to interact with the exosome, suggesting that this region is 
necessary for exosome interaction (Figure 5.3). Because the CR3 region alone was not tested for 
exosome interaction, it is not yet known whether this region is sufficient for Rrp44p to associate 
with exosome. Additionally, previous studies indicate that other regions of Rrp44p are also 
needed for exosome interaction (Lehner and Sanderson, 2004; Schneider et al., 2009; Wang et 
al., 2007). 
 
The CR3 region is needed for efficient Rrp44p endonuclease activity in vivo and in vitro.  
 To determine whether the CR3 region was needed for the endonuclease activity of 
Rrp44p, the triple CR3 mutant was tested in three different assays. First, the triple CR3 mutant 
combined with the catalytically inactive exonuclease point mutant, D551N, was tested for 
complementation of an rrp44 deletion strain. Briefly, a plasmid containing the triple CR3 and 
D551N mutations was transformed into an rrp44# [RRP44, URA3] strain. Transformants were 
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Figure 5.2: Mutating the three conserved cysteine residues of Rrp44p results in a slow 
growth phenotype.  
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Figure 5.2: Mutating the three conserved cysteine residues of Rrp44p results in a slow 
growth phenotype. An rrp44 deletion strain complemented by full-length RRP44 on a plasmid 
with a URA3 marker was transformed with plasmid encoding the triple CR3 mutation. 
Transformants were spotted onto media containing 5-FOA and control media (SC –LEU–URA + 
2% dextrose), and grown for several days. Growth of the triple CR3 mutant was compared to 
two controls, empty vector and wild-type RRP44. Growth on 5-FOA indicates that the CR3 
region is not needed for the essential function of Rrp44p.  
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Figure 5.3: The CR3 region of Rrp44p is needed for interaction with the exosome.  
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Figure 5.3: The CR3 region of Rrp44p is needed for interaction with the exosome. The C-
terminal TAP-tagged triple CR3 mutant was purified using IgG sepharose beads. Prior to 
purification, whole-cell lysates were isolated (left). Purified proteins were eluted by boiling the 
beads (right). Interaction of the triple CR3 mutant with the exosome was compared to two 
controls, wild-type Rrp44p and empty vector. Whole-cell lysates and purified proteins were 
analyzed by Western blot analysis with antibodies specific to Protein A (above) to detect 
Rrp44p, Rrp4p (middle) to detect interaction with the exosome, and Pgk1p (below) as a loading 
control. The asterisk in the middle blot indicates a nonspecific protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
91 
spotted onto media containing 5-FOA and grown for several days. Growth of the CR3, D551N 
strain was compared to two controls, empty vector and wild-type RRP44. If the CR3 region was 
needed for Rrp44p endonuclease activity, the CR3 mutant should be synthetically lethal with 
D551N because cells lacking both the endo- and exonuclease activities of Rrp44p are not viable 
(Lebreton et al., 2008; Schaeffer et al., 2009; Schneider et al., 2009). Indeed, the CR3, D551N 
mutant did not support viability (Figure 5.4A). This suggests that the CR3 region may be needed 
for the endonuclease activity of Rrp44p. 
 To further test the genetic interaction between the CR3 region and the endonucleolytic 
PIN domain of Rrp44p, the triple CR3 mutation was generated in a C-terminal truncation of 
Rrp44p that lacks the exonucleolytic RNB domain. This truncation was also tested for 
complementation of an rrp44# [RRP44, URA3] strain. Again, if the CR3 region was needed for 
Rrp44p endonuclease activity, the CR3 mutant should be synthetically lethal with a truncation 
lacking the exoribonucleolytic domain because cells lacking both the endo- and exonuclease 
activities of Rrp44p are not viable (Lebreton et al., 2008; Schaeffer et al., 2009; Schneider et al., 
2009). Similar to the results obtained with the CR3, D551N mutant, the CR3 truncation lacking 
exonuclease activity did not support viability (Figure 5.4B). This further suggests that the CR3 
region is needed for Rrp44p endonuclease activity. 
To more directly test the importance of the CR3 region in PIN domain nuclease activity, 
two mutant, truncated Rrp44p proteins were tested for endonuclease activity in vitro. In the first 
mutant, the CR3 mutation was again combined with a C-terminal truncation of Rrp44p that 
lacked the exonucleolytic RNB domain (residues 1-235). In the second truncation, both the CR3 
region and the RNB domain were removed, leaving only the PIN domain (residues 84-235). 
Both of the Rrp44p truncated proteins were purified as GST fusions from E. coli and incubated 
individually with a 32P 5’-end labeled A30 oligonucleotide. Degradation of the RNA substrate in 
the Rrp44p mutants was compared to two controls, a reaction that did not contain any protein 
(control) and a C-terminal truncated Rrp44p that lacked the RNB domain but had an intact CR3 
region and PIN domain (residues 1-235; Wild-type). The efficiency of endonucleolytic cleavage 
was reduced in both of the Rrp44p mutants, with a more severe defect seen in the Rrp44p 
truncation that lacked the CR3 region and RNB domain (Figure 5.4C).  Combined, these results 
indicate that the CR3 region of Rrp44p is needed for efficient endonuclease activity. 
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B. 
A. 
Figure 5.4: The CR3 region of Rrp44p is needed for endonuclease activity in vivo and 
in vitro.  
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Figure 5.4: The CR3 region of Rrp44p is needed for endonuclease activity in vivo and 
in vitro.  
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Figure 5.4: The CR3 region of Rrp44p is needed for endonuclease activity in vivo and in 
vitro. A and B, An rrp44 deletion strain complemented by full-length RRP44 on a plasmid with 
a URA3 marker was transformed with plasmids encoding each of the depicted mutations or 
truncations. Transformants were spotted onto media containing 5-FOA and control media (SC –
LEU–URA + 2% dextrose), and grown for several days. Growth of the rrp44 mutants was 
compared to two controls, empty vector and wild-type Rrp44p. Growth on 5-FOA would suggest 
that the CR3 region is not needed for Rrp44p endonuclease activity. C, The depicted Rrp44p 
mutants were purified as GST-fusion recombinant proteins from E. coli and incubated with a 5’-
end labeled A30 oligonucleotide for the time indicated (in minutes). Reactions were subjected to 
denaturing urea-polyacrylamide gel electrophoresis for single nucleotide separation. This 
experiment was performed by F. Reis in the laboratory of Dr. Cecilia Arraiano. 
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The CR3 region of Rrp44p genetically interacts with the nuclease activities of the exosome.  
The CR3 region genetically interacts with the exonucleolytic RNB domain of Rrp44p.   
To determine whether the CR3 region was needed for Rrp44p exonuclease activity, the 
triple CR3 mutant was tested in three different assays. First, a plasmid containing the triple CR3 
mutation and the catalytically inactive endonuclease point mutation, D171A, was tested for 
complementation of an rrp44# [RRP44, URA3] strain. Growth of the CR3, D171A mutant strain 
was compared to two controls, empty vector and wild-type RRP44. If the CR3 region was 
needed for Rrp44p exonuclease activity, the triple CR3 mutant should be synthetically lethal 
with D171A because cells lacking both the endo- and exonuclease activities of Rrp44p are not 
viable (Lebreton et al., 2008; Schaeffer et al., 2009; Schneider et al., 2009). Indeed, the CR3, 
D171A mutant did not support viability (Figure 5.5A). This suggests that the CR3 region 
genetically interacts with the exonucleolytic RNB domain of Rrp44p, and that the CR3 region 
may also be needed for exonuclease activity.  
To further test the functional interaction between the CR3 region and the RNB domain, a 
synthetic lethality growth assay was performed using the triple CR3 mutant. Briefly, a plasmid 
encoding the triple CR3 point mutation was transformed into an rrp44 deletion strain that 
contains a temperature-sensitive allele of dcp1 (dcp1-2) and a plasmid encoding wild-type 
RRP44 and a URA3 marker, generating the dcp1-2 CR3 mutant strain. Dcp1p is a subunit of the 
decapping complex needed for 5’ to 3’ mRNA decay (Coller and Parker, 2004). The basis of this 
assay is that at least one of the two mRNA decay pathways is required for viability (Anderson 
and Parker, 1998). Therefore, if the CR3 region of Rrp44p is needed for 3’ to 5’ decay pathway, 
the triple CR3 mutant should be synthetically lethal with dcp1-2. The dcp1-2 CR3 strain was 
then spotted onto media containing 5-FOA and grown at three different temperatures (23°C, 
30°C, 37°C) for several days. Growth of this strain at the non-permissive temperature for dcp1-2 
(37°C) was compared to two control strains. The first control was a ski7 deletion strain that also 
contained the dcp1-2 allele (dcp1-2 ski7#). Ski7p is a cytoplasmic exosome cofactor that is 
required for general 3’ to 5’ decay (Araki et al., 2001; van Hoof et al., 2000b). The second 
control strain contained only the dcp1-2 mutant. The triple CR3 point mutant was synthetically 
lethal with dcp1-2 at the non-permissive temperature (Figure 5.5B), again indicating a genetic 
interaction between the CR3 region and RNB domain of Rrp44p. 
Because the synthetic lethality growth assay used above is only an indirect measure of 3’ 
to 5’ mRNA degradation, the stability of an endogenous mRNA, GAL7, was measured in the 
dcp1-2 CR3 mutant strain. GAL7 is a galactose metabolism gene and is expressed in media 
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containing galactose. GAL7 stability in the dcp1-2 CR3 mutant strain was compared to two 
control strains, a strain containing the dcp1-2 mutant and the dcp1-2 ski7# strain. Briefly, these 
strains were grown in liquid media containing galactose at the permissive temperature for dcp1-2 
(23°C) and then shifted to the non-permissive temperature (37°C) for one hour. The strains were 
then grown in media containing dextrose to shut off transcription of GAL7. RNA was isolated 
from these strains and subject to agarose formaldehyde gel electrophoresis. Northern blot 
analysis was then performed using probes specific to GAL7, and SCR1 as a loading control. In 
the dcp1-2 strain, GAL7 was unstable since the 3’ to 5’ decay pathway was still functional. 
Conversely, in the dcp1-2 ski7! strain, GAL7 was more than 4-times more stable, as neither the 
5’ to 3’ or 3’ to 5’ mRNA decay pathway was functional. Similar to the dcp1-2 ski7! control 
strain, GAL7 was more than 4-times more stable in the dcp1-2 CR3 strain than the dcp1-2 strain 
alone. (Figure 5.5C and D). Since the exonuclease activity of Rrp44p is known to degrade 
mRNAs, these results suggest that the CR3 region of Rrp44p may be needed for the exonuclease 
activity of Rrp44p. 
 
The CR3 region genetically interacts with the nuclear exosome cofactor, Rrp6p.  
The catalytically inactive mutant of Rrp44p, D551N, is synthetically sick upon deletion 
of Rrp6p, a nuclear exosome cofactor. This indicates that the RNB domain of Rrp44p genetically 
interacts with Rrp6p. To determine whether the CR3 region of Rrp44p also genetically interacts 
with Rrp6p, a plasmid encoding the triple CR3 mutation was transformed into an rrp44 and rrp6 
deletion strain, generating the rrp6# CR3 mutant. This strain also contains a plasmid encoding 
wild-type RRP44 and a URA3 marker. Transformants were then spotted onto media containing 
5-FOA and grown at three different temperatures (23°C, 30°C, 37°C) for several days. Although 
this particular rrp6 deletion strain can grow at temperatures up to 37°C, its optimal growth 
temperature is at 25°C (Schneider et al., 2009). Additionally, other rrp6 deletion strains are 
temperature-sensitive (Allmang et al., 1999b). Growth of the rrp6# CR3 strain at all three 
temperatures was compared to two controls, an rrp6 and rrp44 deletion strain and an rrp6 
deletion strain. If the CR3 region genetically interacts with Rrp6p, the triple CR3 mutant should 
be synthetically sick or synthetically lethal with an rrp6 deletion. Indeed, the triple CR3 mutant 
was synthetically sick with an rrp6 deletion at lower temperatures, and synthetically lethal with 
an rrp6 deletion at 37°C (Figure 5.6). Combined, these results indicate that the CR3 region 
genetically interacts with the exonucleolytic RNB domain of Rrp44p and with Rrp6p.  
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Figure 5.5: The CR3 region of Rrp44p genetically interacts with the exonucleolytic 
RNB domain of Rrp44p.  
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Figure 5.5: The CR3 region of Rrp44p genetically interacts with the exonucleolytic 
RNB domain of Rrp44p.  
D. 
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Figure 5.5: The CR3 region of Rrp44p genetically interacts with the exonucleolytic RNB 
domain of Rrp44p. A, An rrp44 deletion strain complemented by full-length RRP44 on a 
plasmid with a URA3 marker was transformed with plasmids encoding each of the depicted 
mutations. Transformants were spotted onto media containing 5-FOA and control media (SC –
LEU–URA + 2% dextrose), and grown for several days. Growth of the rrp44 mutants was 
compared to two controls, empty vector and wild-type RRP44. Growth on 5-FOA would suggest 
that the CR3 region is not needed for Rrp44p exonuclease activity. B, An rrp44 deletion strain 
containing a plasmid encoding wild-type RRP44 and a URA3 marker, as well as a temperature-
sensitive allele of dcp1 (dcp1-2), was transformed with a plasmid encoding the triple CR3 
mutation. Transformants were spotted onto media containing 5-FOA and grown for several days 
at the indicated temperatures. Growth of the dcp1-2 rrp44 triple CR3 mutant was compared to 
two control strains, a ski7 deletion strain that also contains the dcp1-2 allele (dcp1-2 ski7!) and a 
strain containing only the dcp1-2 mutant. Growth on 5-FOA at 37°C, the non-permissive 
temperature of the dcp1-2 allele, would suggest that the CR3 region of Rrp44p does not 
genetically interact with the exonucleolytic RNB domain.  
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Figure 5.6: The CR3 region of Rrp44p genetically interacts with the nuclear exosome 
cofactor, Rrp6p.  
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Figure 5.6: The CR3 region of Rrp44p genetically interacts with the nuclear exosome 
cofactor, Rrp6p. An rrp44 deletion strain or an rrp6 and rrp44 deletion strain was transformed 
with a plasmid encoding the triple CR3 mutation. Transformants were spotted onto media 
containing 5-FOA and grown for several days at the indicated temperatures. Growth of the rrp6 
and rrp44 mutants was compared to two controls, an rrp6 and rrp44 deletion strain and an rrp44 
deletion strain. Growth at 37°C would suggest that the CR3 region of Rrp44p does not 
genetically interact with Rrp6p.  
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The CR3 region of Rrp44p is important in nonstop mRNA degradation. 
The data presented in Chapter 4 indicate that neither the endo- or exonuclease activities 
of Rrp44p are needed for a functional nonstop mRNA degradation pathway. The CR3 region has 
already been shown to be needed for both of the Rrp44p nuclease activities. Therefore, if these 
nucleases are redundant in nonstop decay, then the triple CR3 mutant should be unable to 
degrade nonstop transcripts. In order to test the effects of the triple CR3 mutant in nonstop 
decay, a his3-nonstop growth assay was performed. In this assay, the his3-nonstop reporter was 
transformed into an rrp44! strain that was complemented by the triple CR3 mutant. The basis 
for this assay is that the his3-nonstop reporter is stable in a strain that is defective in nonstop 
mRNA decay, thus allowing cells to make histidine and grow on media lacking histidine (van 
Hoof et al., 2002). The growth of the triple CR3 mutant on media lacking histidine was 
compared to two controls, a wild-type strain and a ski7 deletion strain. In addition to being 
required for general 3’ to 5’ mRNA decay, Ski7p is needed for the degradation of nonstop 
transcripts (Frischmeyer et al., 2002). Similar to the ski7 deletion strain, the triple CR3 mutant 
did not support growth on media lacking histidine (Figure 5.7A). These results suggest that the 
CR3 region is needed for a functional nonstop mRNA decay pathway. 
Because the his3-nonstop growth assay is an indirect measure of whether the nonstop 
decay pathway is functional, a more direct assay was used. Specifically, the stability of the 
GAL::pgk1pG-nonstop transcript was measured in a strain containing the triple CR3 mutant of 
Rrp44p. The stability of the nonstop transcript in this strain was compared to two controls, a 
strain containing wild-type Rrp44p and a ski7 deletion strain. These strains were grown in liquid 
media containing galactose and then shifted to media containing dextrose to shut off 
transcription of the GAL::pgk1pG-nonstop reporter. RNA was isolated from these strains and 
subject to agarose formaldehyde gel electrophoresis. Northern blot analysis was then performed 
using probes specific to pgk1pG, and to ACT1 as a loading control. The GAL::pgk1pG-nonstop 
transcript was as stable in the triple CR3 mutant as it was in the ski7 deletion strain (Figure 5.7B 
and C). Combined, these results indicate that the CR3 region of Rrp44p is needed for the 
degradation of nonstop transcripts. 
 
The disulfide bond of the CR3 region is not needed for optimal cell growth. 
A disulfide bond is modeled to form between the second and third residues of the CR3 
region (Bonneau et al., 2009). To determine if this disulfide bond is needed for optimal cell 
growth, the three individual cysteine residues of the CR3 region were mutated to serine. The 
individual cysteine mutants were then transformed into an rrp44# [RRP44, URA3] strain. 
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Figure 5.7: The CR3 region of Rrp44p is needed for nonstop mRNA degradation.  
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Figure 5.7: The CR3 region of Rrp44p is needed for nonstop mRNA degradation. A, An 
rrp44 deletion strain complemented by a plasmid encoding the triple CR3 mutant was 
transformed with the his3-nonstop reporter. Transformants were spotted onto media containing, 
or lacking, histidine and grown for several days. Growth of the triple CR3 mutant was compared 
to two control strains, wild-type RRP44 and a ski7 deletion. Growth on media lacking histidine 
indicates that the nonstop mRNA degradation machinery is not functional. B, An rrp44 deletion 
strain complemented by a plasmid encoding the triple CR3 mutant was transformed with the 
GAL::pgk1pG-nonstop reporter. The stability of the transcript in the triple CR3 mutant was 
compared to two control strains, wild-type RRP44 and a ski7 deletion. Cultures were first grown 
in media containing galactose and then incubated in media containing dextrose (to inhibit 
transcription of the GAL::pgk1pG-nonstop reporter) for the indicated time (in minutes). RNA 
was isolated from these strains and analyzed by Northern blot analysis with probes that hybridize 
to PGK1 and ACT1. The half-life of the GAL::pgk1pG-nonstop transcript was normalized for 
loading using the ACT1 signal and are as indicated (in minutes). C, A graphical representation of 
the half-life of the GAL::pgk1pG-nonstop transcript.  
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Transformants were spotted onto media containing 5-FOA and grown for several days. Growth 
of the individual cysteine mutants was compared to three controls, empty vector, wild-type 
RRP44, and the triple CR3 mutant. As compared to wild-type and the triple CR3 mutant, the 
individual cysteine mutants had an intermediate growth phenotype- their growth was not as 
robust as wild-type but was not as slow as the triple CR3 mutant. In particular, the C55S mutant 
had a growth phenotype similar to wild-type Rrp44p (Figure 5.8). This suggests that the disulfide 
bond modeled between C52 and C55 of the CR3 region is not needed for optimal growth. These 
results do not exclude the possibility that the disulfide bond exists between C47 and C52 of the 
CR3 region. 
 
The disulfide bond of the CR3 region is not important in nonstop mRNA degradation. 
Because the CR3 region is needed for nonstop mRNA decay, the role of the disulfide 
bond between the second and third cysteine residues of the CR3 region was tested in this mRNA 
surveillance pathway. Briefly, the his3-nonstop reporter was transformed into rrp44 deletion 
strains that were complemented by the individual cysteine mutants. In this assay, cells with a 
non-functional nonstop mRNA degradation pathway are viable on media lacking histidine, 
whereas wild-type cells are inviable on media lacking histidine because they are able to rapidly 
degrade the his3-nonstop transcript. The growth of the individual cysteine mutants on media 
lacking histidine was compared to three controls, a wild-type strain, a ski7 deletion strain, and 
the triple CR3 mutant. In contrast to the triple CR3 mutant, the individual cysteine mutants were 
viable on media lacking histidine (Figure 5.9). This suggests that the nonstop decay defect of the 
triple CR3 mutant is not due to the lack of a disulfide bond between the second and third 
cysteine residues of the CR3 region and that nonstop decay does not require a disulfide bond in 
the CR3 region of Rrp44p. 
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Figure 5.8: The disulfide bond of the CR3 region is not needed for optimal cell growth.  
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Figure 5.8: The disulfide bond of the CR3 region is not needed for optimal cell growth. An 
rrp44 deletion strain complemented by full-length RRP44 on a plasmid with a URA3 marker was 
transformed with plasmids encoding each of the depicted mutations. Transformants were spotted 
onto media containing 5-FOA and control media (SC –LEU–URA + 2% dextrose), and grown 
for several days. Growth of the rrp44 mutants was compared to two controls, empty vector and 
wild-type RRP44. Growth on 5-FOA indicates that mutated Rrp44p can carry out the essential 
function of Rrp44p.  
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Figure 5.9: The disulfide bond of CR3 region is not needed for nonstop mRNA 
degradation. 
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Figure 5.9: The disulfide bond of the CR3 region is not needed for nonstop mRNA 
degradation. rrp44 deletions strain complemented by plasmids encoding the depicted mutations 
were transformed with the his3-nonstop reporter. Transformants were spotted onto media 
containing, or lacking, histidine and grown for several days. Growth of the rrp44 mutants was 
compared to three control strains, wild-type RRP44, a ski7 deletion, and the triple CR3 mutant. 
Growth on media lacking histidine indicates that the nonstop mRNA degradation machinery is 
not functional. 
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DISCUSSION 
The CR3 region may be a putative zinc binding domain.  
The spatial organization of the three cysteines of the CR3 region and histidine 184 
(H184; Figure 5.1A and B) suggests that these residues may coordinate a zinc ion. Therefore, the 
defects seen in the triple CR3 mutant may be explained by the lack of this coordination. The 
presence of a zinc ion may be directly or indirectly required for Rrp44p protein 
expression/stabilization, Rrp44p nuclease activity, and/or may be needed for Rrp44p to interact 
with the exosome. Specifically, there are several ways in which this coordination may impact the 
interaction between Rrp44p and the exosome and/or exosome function, none of which are 
mutually exclusive. 
One possibility is that the lack of coordination may decrease the expression or 
stabilization of the Rrp44p protein, which in turn reduces cell growth and may decrease the 
interaction between Rrp44p and the exosome. Specifically, the coordination of a zinc ion may be 
needed for the correct folding of the CR3 region, and thus Rrp44p. Under this hypothesis, the 
lack of a functional exosome may be a secondary consequence of Rrp44p protein misfolding. 
Another possibility is that the lack of a zinc ion may interfere with Rrp44p endo- and/or 
exonuclease activity. If the coordination of zinc is important for both of these nuclease activities, 
this may explain why the triple CR3 mutant has a slow growth phenotype. Additionally, if these 
nuclease activities are redundant in nonstop mRNA decay, this could also explain the nonstop 
decay defect observed in the triple CR3 mutant. In support of this, preliminary evidence suggests 
that Rrp44p endonuclease activity is stimulated by the addition of zinc (Filipa Reis and Dr. 
Cecilia Arraiano, personal communication). For a more detailed explanation as to how the 
coordination of zinc may influence the CR3 region of Rrp44p, and thus the exosome, see 
Chapter 7. 
 Interestingly, the data presented here also show that the disulfide bond modeled between 
the second and third residues of the CR3 region is not required for optimal cell growth or for 
nonstop mRNA degradation. Because of the low resolution of the latest crystal structure of 
Rrp44p, the electron density is not defined enough to determine which residues, if any, of the 
CR3 region form a disulfide bond. Therefore, the results shown here, combined with the low 
resolution of the crystal structure, indicate that the disulfide bond of the CR3 region is not 
biologically important and suggests that it may not be present in the N-terminus of Rrp44p. In 
addition, a stable disulfide bond is unlikely to form in the reducing environment of the nucleus 
or cytoplasm.  
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The CR3 region is one of many regions of Rrp44p that is needed for exosome interaction.  
 The observation that the CR3 region mediates interaction between Rrp44p and the 
exosome is not surprising given that this interaction was predicted in human Rrp44p (Lehner and 
Sanderson, 2004) and by a cryo-EM structure of the yeast exosome (Wang et al., 2007). In the 
most recent study to show an interaction between Rrp44p and the core exosome, the authors 
concluded that the PIN domain of Rrp44p is needed for exosome interaction. In the study, 
however, it is not clear whether the region of Rrp44p that interacts with the exosome consists of 
only the PIN domain or the CR3 region and PIN domain. Additionally, the interaction detected 
when just the PIN domain was used (residues 86-203) was much weaker than in full-length 
Rrp44p (Schneider et al., 2009), which suggests that more than just the PIN domain is needed for 
Rrp44p to interact with the exosome. Additionally, the lack of interaction seen when a deletion 
of the PIN domain was used (a deletion of residues 86-203), could be explained by a transient 
interaction of mutant Rrp44p with the exosome or it may be an artifact of the 
immunoprecipitation conditions that were used. This latter possibility is likely since the 
interaction between Rrp44p and the exosome is salt-sensitive (Allmang et al., 1999b). 
 Since Rrp44p only loosely associates with the exosome (Allmang et al., 1999b), 
interaction of the CR3 mutant with the core exosome was tested under low and high salt 
conditions (50 mM and 1 M NaCl, respectively). The inability of the CR3 mutant to interact with 
the exosome, even under low salt conditions, further supports the importance of this region in 
mediating interaction with the exosome. 
 The data presented here, combined with the three previous studies on Rrp44p-exosome 
interaction, suggest that the CR3 region of Rrp44p is just one region of the protein that is needed 
to interact with the exosome. Specifically, five of the six domains of Rrp44p have been 
implicated in exosome interaction (Lehner and Sanderson, 2004; Schneider et al., 2009; Wang et 
al., 2007).  
 
The functional interaction between the CR3 region and the PIN domain of Rrp44p 
 The observation that the triple CR3 mutant was synthetically lethal with the D551N 
mutant and with a C-terminal truncation of Rrp44p that lacked the RNB domain, suggests that 
the CR3 region is needed for the endonuclease activity of Rrp44p. One possible reason for this is 
that the CR3 region may be needed for the 5’-end dependency exhibited by the PIN domain. It 
has been previously shown that the Rrp44p endonuclease more efficiently degrades an RNA 
substrate that contains a 5’ monophosphate than a 5’ hydroxyl (Schaeffer et al., 2009). Indeed 
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preliminary evidence suggests that the CR3 region is important in differentiating between the 5’-
ends of RNA substrates (Filipa Reis and Dr. Cecilia Arraiano, personal communication).  
 Another possibility is that the CR3 region is indirectly needed for Rrp44p endonuclease 
activity. Specifically, the coordination of a zinc ion between the CR3 region and H184 may be 
needed for a functional endonuclease active site. In the triple CR3 mutant, the CR3 region may 
be folded in such a way that precludes coordination of zinc, which may, therefore, decrease the 
endonuclease activity of Rrp44p. In support of this, H184 is on the same alpha-helix as D171, 
the active site residue of the endonucleolytic PIN domain.  
The finding that the triple CR3 mutant is synthetically lethal with the D551N mutant and 
with a C-terminal truncation of Rrp44p may also be explained by a lack of protein expression, 
since the CR3 mutant is expressed at lower levels than wild-type Rrp44p. To determine whether 
the lack of growth is an artifact of expression, the CR3, D551N mutant and the triple CR3 
mutant combined with a C-terminal truncation that lacks the RNB domain will be C-terminally 
TAP-tagged and expression of the mutant proteins will be analyzed. Regardless of whether these 
CR3 mutant proteins are expressed, the CR3 region is needed for efficient endonucleolytic 
cleavage in vitro. Additionally, the genetic interaction between the CR3 region and PIN domain 
is supported by the close proximity of the three cysteine residues and the active site of the PIN 
domain in the crystal structure (Bonneau et al., 2009). 
 
The functional interaction between the CR3 region and the RNB domain of Rrp44p 
 The observation that the triple CR3 mutant was synthetically lethal with the D171A 
mutant suggests that the CR3 region is needed for exonuclease activity of Rrp44p. Although the 
CR3 region and the active site of the RNB domain are not in close proximity in the crystal 
structure, the CR3 region may be needed to interact with cytoplasmic exosome cofactors that are 
required for 3’ to 5’ mRNA degradation (see Chapter 7). Another possible explanation is that the 
CR3, D171A mutant is not expressed. A potential decrease in expression, coupled with a loss of 
exosome interaction, may explain the lack of complementation by the CR3, D171A mutant.  
 
The CR3 region has a novel role in nonstop mRNA degradation. 
 The defect in nonstop decay seen in the triple CR3 mutant can be explained by several 
possibilities. In the first two explanations, it is assumed that the endo- and exonuclease activities 
of Rrp44p are redundant in nonstop decay. If this were the case, the nonstop decay defect is not 
surprising given that the CR3 region seems to be important for both of the nuclease activities of 
Rrp44p. Therefore, if the Rrp44p nuclease active sites have decreased nuclease activities in a 
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triple CR3 mutant, nonstop transcripts would be stabilized. Alternatively, it may be that the 
reduced expression of the triple CR3 mutant causes a reduction in the nuclease activities of 
Rrp44p, again resulting in the inability of Rrp44p to degrade nonstop transcripts (see Chapter 7).  
 If the nuclease activities of Rrp44p are not redundant in nonstop mRNA decay another 
unidentified nuclease is responsible for the degradation of nonstop transcripts. It may be that the 
CR3 region of Rrp44p is needed to recruit this nuclease. Under this hypothesis, if the triple CR3 
mutant cannot recruit the nonstop decay nuclease, nonstop transcripts would be stabilized. 
 One more possibility, that does not require that the nuclease activities of Rrp44p be 
redundant in nonstop decay, is that the CR3 region of Rrp44p may interact with the nonstop 
mRNA decay machinery. In this model, abolishing this interaction would inactivate the nonstop 
decay pathway prior to mRNA degradation (see Chapter 7).  
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Chapter 6: The far N-terminus of Rrp44p is important for exosome 
function. 
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INTRODUCTION 
 The eukaryotic exosome is involved in the 3’-end processing and 3’-end degradation of 
various RNAs in the nucleus and the cytoplasm. The nuclear exosome processes RNA precursors 
to form small, stable, mature RNAs, including the 5.8S rRNA (Mitchell et al., 1997; Mitchell et 
al., 1996). The nuclear exosome also degrades RNA, specifically the 5’ external transcribed 
spacer (5’ ETS) of the 35S rRNA precursor (Allmang et al., 1999a). In contrast to the nuclear 
exosome, the cytoplasmic exosome is solely involved in mRNA degradation. Here, the exosome 
degrades normal and aberrant transcripts as a means of regulating and maintaining the fidelity of 
gene expression, respectively. Specifically, the cytoplasmic exosome is involved in degrading 
nonstop transcripts, or mRNAs that lack termination codons (Frischmeyer et al., 2002; van Hoof 
et al., 2002). Several studies suggest that the essential function of Rrp44p, and the exosome, is in 
the nucleus because none of the known cytoplasmic exosome functions are required for viability. 
 Although the exosome contains 10 subunits, only one subunit, Rrp44p, is catalytically 
active (Dziembowski et al., 2007; Liu et al., 2006; Mamolen and Andrulis, 2009). Rrp44p 
consists of six putative domains, two of which have nuclease activity. The N-terminal PIN 
domain has endoribonuclease activity (Lebreton et al., 2008; Schaeffer et al., 2009; Schneider et 
al., 2009) and the C-terminal RNB domain has 3’ to 5’ exoribonuclease activity (Dziembowski 
et al., 2007). Three of the six domains are putative RNA binding domains and are spread 
throughout the protein. Lastly, the CR3 region, which may not fit the classical definition of a 
domain, lies in the N-terminus of Rrp44p and seems to be important for most, if not all, of the 
known functions of the exosome (see Chapter 5). Previous studies on Rrp44p have focused only 
on the protein’s endo- and exonuclease activities. Therefore, the far N-terminus of Rrp44p, 
specifically residues 1-46, has not yet been characterized. Recently, the crystal structure of 
Rrp44p was published, however, the structure lacked the first 33 residues (Bonneau et al., 2009). 
Bioinformatic analysis suggests that the far N-terminus of Rrp44p contains a linker region that 
consists of residues 34 to 46, with six of these residues highly conserved in eukaryotic Rrp44p 
homologs (Figure 6.1A). Importantly, four of these highly conserved residues have been 
implicated in exosome interaction (Bonneau et al., 2009). 
 Because the exosome is present in both the nucleus and the cytoplasm, at least one 
subunit requires a nuclear localization signal (NLS). Of the ten subunits, only Rrp44p has a 
putative NLS, in fact, it has four putative NLSs spread throughout the protein. It is not yet 
known which, if any, of these NLSs are required for Rrp44p, or any of the other exosome 
subunits, to localize to the nucleus. In support of the importance of the NLSs in Rrp44p, 
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Drosophila Rrp44p requires a C-terminal NLS for nuclear localization (Graham et al., 2009). It 
may be that the four putative NLSs of yeast Rrp44p are redundant for localization. 
 To determine the function of the far N-terminus of Rrp44p, specifically residues 1-46, 
and whether this region is needed for the essential function of Rrp44p, several N-terminal 
truncations and point mutations were generated and assayed for exosome function in vivo. The 
data here show that the far N-terminus of Rrp44p, specifically a linker region consisting of 
conserved residues, including residues 34 to 46, is needed for viability. In addition, at least the 
first 33 residues of the far N-terminus are needed for Rrp44p to interact with the exosome. 
Combining N-terminal mutants with catalytically inactive nuclease mutants of Rrp44p suggests 
that the N-terminus is not needed for the endo- or exonuclease activities of Rrp44p. Lastly, the 
data presented here suggest at least one of the putative NLSs of Rrp44p is required for viability.   
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RESULTS 
A conserved stretch of residues in the far N-terminus of Rrp44p is needed for viability. 
 To determine whether the far N-terminus of Rrp44p, specifically residues 1-46, is 
needed for cell survival, plasmids encoding N-terminal truncations were generated and 
transformed into an rrp44# [RRP44, URA3] strain. Transformants were then spotted onto media 
containing 5-FOA and grown for several days. Growth of the rrp44 truncations was compared to 
two controls, empty vector and wild-type RRP44. N-terminal truncations that lack up to the first 
33 residues of Rrp44p had no obvious growth phenotype, with the smallest complementing 
truncation encoding residues 34-1001. In contrast, N-terminal truncations that lack the first 46 
residues (47-1001), or more, did not support viability (Figure 6.1B). This lack of 
complementation is not due to a lack of protein expression, as both the 34-1001 and 47-1001 
truncations are expressed at levels similar to wild-type (Figure 6.2). This suggests that the linker 
region, or residues 34 to 46, of Rrp44p is required for cell survival.  
 To determine whether the lack of complementation seen in 47-1001 truncation can be 
attributed to the lack of one of the conserved residues of the linker region, plasmids encoding 
point mutations in six of the most conserved residues were generated and tested for 
complementation of an rrp44# [RRP44, URA3] strain. Transformants were then spotted onto 
media containing 5-FOA and grown for several days. Growth of the Rrp44p point mutants was 
compared to two controls, empty vector and wild-type RRP44. Similar to wild-type, the point 
mutants had no obvious growth defects (Figure 6.1C). Therefore, although residues 34 to 46 of 
the linker region are needed for viability, point mutants in the most conserved residues of this 
region have no effect on cell growth. 
 
The N-terminus of Rrp44p is necessary, but may not be sufficient, for Rrp44p to interact 
with the exosome.  
 One explanation for why the linker region, or residues 34 to 46, is needed for viability is 
that this region is needed for Rrp44p to interact with the core exosome. Indeed, four of the most 
highly conserved residues of this region have been implicated in exosome interaction (Bonneau 
et al., 2009). To test whether this region mediates interaction with the exosome in vivo, wild-type 
Rrp44p and the N-terminal truncations of Rrp44p, 34-1001 and 47-1001, were C-terminally 
TAP-tagged. Wild-type and the truncated Rrp44p proteins were purified using IgG sepharose 
beads specific to the protein A portion of the TAP tag. Proteins bound to the Rrp44p proteins 
were eluted and analyzed using SDS-PAGE. Whole cell lysates from the wild-type and truncated 
Rrp44p strains were compared to the bound fractions from these strains. The interaction of the 
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Figure 6.1: Residues 34 to 46 of Rrp44p are needed for viability. A, A schematic 
representation of the N-terminus (residues 18 to 55) of Rrp44p. Conservation is indicated by the 
height of each amino acid. B, An rrp44 deletion strain complemented by full-length RRP44 on a 
plasmid with a URA3 marker was transformed with plasmids encoding each of the depicted 
truncations. Transformants were spotted onto media containing 5-FOA and control media (SC –
LEU–URA + 2% dextrose), and grown for several days. Growth of the rrp44 truncations was 
compared to two controls, empty vector and wild-type RRP44. Growth on 5-FOA indicates that 
truncated Rrp44p can carry out the essential function of Rrp44p. C, An rrp44 deletion strain 
complemented by full-length RRP44 on a plasmid with a URA3 marker was transformed with 
plasmids encoding each of the depicted mutations. Transformants were spotted onto media 
containing 5-FOA and control media (SC –LEU–URA + 2% dextrose), and grown for several 
days. Growth of the rrp44 mutants was compared to two controls, empty vector and wild-type 
RRP44. Growth on 5-FOA indicates that mutated Rrp44p can carry out the essential function of 
Rrp44p. 
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wild-type and truncated Rrp44p proteins with the exosome was compared to empty vector. In 
contrast to wild-type, both of the N-terminal truncated Rrp44p proteins were unable to interact 
with the exosome suggesting that at least the first 33 residues of Rrp44p residues are needed for 
exosome interaction (Figure 6.2). Because this region alone was not tested for exosome 
interaction, it is not yet known whether this region is sufficient for Rrp44p to interact with the 
exosome. Additionally, previous studies indicate that other regions of Rrp44p are also needed for 
exosome interaction (Lehner and Sanderson, 2004; Schneider et al., 2009; Wang et al., 2007). 
The results presented so far indicate that deletion of the first 33 residues disrupts exosome 
interaction, but not exosome function. 
  
Several residues in the N-terminus of Rrp44p are needed for an essential function that also 
requires the C-terminus of Rrp44p. 
 To determine whether the N-terminus of Rrp44p is needed for the protein’s 
endonuclease activity, an N-terminal truncation and N-terminal point mutants were tested for 
whether they were synthetically lethal with mutants of Rrp44p that lack exonuclease activity. If 
the N-terminus of Rrp44p is needed for endonuclease activity, the combination of N-terminal 
truncations/point mutants with a mutant lacking exonuclease activity should not complement an 
rrp44# [RRP44, URA3] strain because cells lacking both the endo- and exonuclease activities of 
Rrp44p are not viable (Lebreton et al., 2008; Schaeffer et al., 2009; Schneider et al., 2009).  
 To determine whether the first 33 residues of the far N-terminus of Rrp44p are needed 
for the protein’s endonuclease activity, the catalytically inactive exonuclease point mutant, 
D551N, was generated in the 34-1001 truncation (D551N 34-1001) and tested for 
complementation of an rrp44# [RRP44, URA3] strain. Growth of the D551N 34-1001 mutant 
strain was compared to four controls, empty vector, wild-type RRP44, the 34-1001 truncation, 
and the D551N mutant. The D551N 34-1001 mutant did have a slight growth defect when 
compared to a strain containing the 34-1001 truncation and a strain containing the D551N 
mutant, however, deletion of the first 33 residues was not synthetically lethal with the D551N 
mutant (Figure 6.3A). This suggests that the first 33 residues of Rrp44p are not needed for the 
protein’s endonuclease activity. 
 To determine whether any of the six conserved residues of the linker region in the far N-
terminus of Rrp44p (E38, Y40, L41, R42, D44, and I45), are needed for endonuclease activity, 
point mutations in these residues were generated in a C-terminal Rrp44p truncation that lacks 
exonuclease activity. These truncations were then tested for complementation of an rrp44# 
[RRP44, URA3] strain. Growth of the rrp44 mutant truncations was compared to two controls, 
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Figure 6.2: The N-terminus of Rrp44p is needed for interaction with the exosome. 
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Figure 6.2: The N-terminus of Rrp44p is needed for interaction with the exosome. C-
terminal TAP-tagged Rrp44p mutants were purified using IgG sepharose beads. Prior to 
purification, whole-cell lysates were isolated (left). Purified proteins were eluted by boiling the 
beads (right). Interaction of the Rrp44p truncated proteins with the exosome was compared to 
two controls, wild-type Rrp44p and empty vector. Whole-cell lysates and purified proteins were 
analyzed by Western blot analysis with antibodies specific to Protein A (above) to detect 
Rrp44p, Rrp4p (middle) to detect interaction with the exosome, and Pgk1p (below) as a loading 
control. The asterisk in the middle blot indicates a nonspecific protein. 
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empty vector and wild-type RRP44. Three of the six point mutants (Y40A, L41A, and R42A) 
were synthetically lethal with a truncation lacking exonuclease activity, whereas the other three 
point mutants exhibited no growth defect when combined with a C-terminal truncation of 
Rrp44p (Figure 6.3B and C). This suggests that some of the six conserved residues of the linker 
region in the far N-terminus of Rrp44p may be needed for PIN domain endonuclease activity. 
 To further test the genetic interaction between these three conserved residues and the 
endonucleolytic PIN domain, the Y40A, L41A, and R42A mutants were combined, individually, 
with the D551N mutant and tested for complementation of an rrp44# [RRP44, URA3] strain. In 
contrast to the results obtained when these point mutants were generated in a truncation lacking 
the exonucleolytic RNB domain, the Y40A, L41A, and R42A mutants were not synthetically 
lethal with the D551N mutant (Figure 6.3C). These results suggest that the three conserved 
residues of the linker region in the far N-terminus of Rrp44p are likely not required for the 
endonuclease activity of the protein but rather for an essential function of Rrp44p that also 
requires the C-terminus of the protein (see Discussion) 
 
The first 33 residues of Rrp44p do not genetically interact with the exonuclease activities of 
the exosome. 
The first 33 residues are not needed for exosome-mediated 3’ to 5’ mRNA degradation. 
 To determine whether the first 33 residues of Rrp44p are needed for the protein’s 
exonuclease activity, the N-terminal truncation, 34-1001, was tested in two different assays. 
First, the catalytically inactive endonuclease point mutant, D171A, was generated in the 34-1001 
truncation (D171A 34-1001) and tested for complementation of an rrp44# [RRP44, URA3] 
strain. Growth of the D171A 34-1001 mutant was compared to two controls, empty vector and 
wild-type RRP44. If the first 33 residues are needed for the exonuclease activity of Rrp44p, a 
truncation lacking these residues should be synthetically lethal with D171A because cells lacking 
both the endo- and exonuclease activities of Rrp44p are not viable (Lebreton et al., 2008; 
Schaeffer et al., 2009; Schneider et al., 2009). Similar to wild-type Rrp44p, the D171A 34-1001 
mutant had no obvious growth defect (Figure 6.4A), suggesting that the first 33 residues of 
Rrp44p are not needed for the exonuclease activity of the protein’s RNB domain.  
To further test the functional interaction between the first 33 residues of Rrp44p and the 
RNB domain, a synthetic lethality growth assay was performed. Briefly, a plasmid encoding 
residues 34-1001 was transformed into an rrp44 deletion strain that also contained a 
temperature-sensitive allele of dcp1 (dcp1-2) and a plasmid encoding wild-type RRP44 and a 
URA3 marker, generating the dcp1-2 34-1001 strain. Dcp1p is a subunit of the decapping 
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Figure 6.3: Several residues in the N-terminus of Rrp44p are needed for an essential 
function that also requires the C-terminus of Rrp44p. 
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Figure 6.3: Several residues in the N-terminus of Rrp44p are needed for an essential 
function that also requires the C-terminus of Rrp44p. An rrp44 deletion strain complemented 
by full-length RRP44 on a plasmid with a URA3 marker was transformed with plasmids 
encoding each of the depicted mutations. Transformants were spotted onto media containing 5-
FOA and control media (SC –LEU–URA + 2% dextrose), and grown for several days. Growth of 
the rrp44 mutants was compared to empty vector and wild-type RRP44. Growth on 5-FOA 
would suggest that mutated Rrp44p can carry out the essential function of Rrp44p. 
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complex needed for 5’ to 3’ mRNA decay (Coller and Parker, 2004). The basis of this assay is 
that at least one of the two mRNA decay pathways is required for viability (Anderson and 
Parker, 1998). Therefore, if the first 33 residues of Rrp44p are needed for a functional 3’ to 5’ 
decay pathway, a truncation lacking these residues should be synthetically lethal with the dcp1-2 
mutant. The dcp1-2 34-1001 strain was then spotted onto media containing 5-FOA and grown at 
three different temperatures (23°C, 30°C, 37°C) for several days. Growth of the strain at the non-
permissive temperature for dcp1-2 (37°C) was compared to two control strains. The first control 
was a ski7 deletion strain that also contained the dcp1-2 allele. Ski7p is a cytoplasmic exosome 
cofactor that is required for general 3’ to 5’ decay (Araki et al., 2001; van Hoof et al., 2000b). 
The second control strain contained only the dcp1-2 mutant. The N-terminal truncation was not 
synthetically lethal with dcp1-2 at the non-permissive temperature (Figure 6.4B), again 
indicating that these residues are not needed for Rrp44p exonuclease activity. 
 
The first 33 residues of Rrp44p do not genetically interact with the nuclear exosome cofactor, 
Rrp6p.   
The catalytically inactive exonuclease mutant of Rrp44p, D551N, is synthetically sick 
upon deletion of Rrp6p, a nuclear exosome cofactor. This indicates that the RNB domain of 
Rrp44p genetically interacts with Rrp6p. To determine whether the first 33 residues of Rrp44p 
also genetically interact with Rrp6p, a plasmid encoding residues 34-1001 was transformed into 
an rrp44 and rrp6 deletion strain, generating the rrp6# 34-1001 mutant. This strain also contains 
a plasmid encoding wild-type RRP44 and a URA3 marker. Transformants were then spotted onto 
media containing 5-FOA and grown at three different temperatures (23°C, 30°C, 37°C) for 
several days. Although this particular rrp6 deletion strain can grow at temperatures up to 37°C, 
its optimal growth temperature is at 25°C (Schneider et al., 2009). Additionally, other rrp6 
deletion strains are temperature-sensitive (Allmang et al., 1999b). Growth of the rrp6# 34-1001 
strain at all three temperatures was compared to two controls, an rrp6 and rrp44 deletion strain 
and rrp6 deletion strain. The 34-1001 truncation was not synthetically sick or lethal with an rrp6 
deletion at any of the three temperatures (Figure 6.5). These results suggest that the first 33 
residues of Rrp44p do not genetically interact with Rrp6p.  
 
The first 33 residues of Rrp44p are not needed for nonstop mRNA degradation. 
Thus far, the data presented here indicate that neither the endo- or exonuclease activities 
of Rrp44p are needed for a functional nonstop mRNA degradation pathway, however, the CR3 
region is needed for the degradation of nonstop transcripts. To determine whether the first 33 
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Figure 6.4: The first 33 residues of Rrp44p are not needed for exosome-mediated 3’ to 
5’ mRNA degradation.  
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Figure 6.4: The first 33 residues of Rrp44p are not needed for exosome-mediated 3’ to 5’ 
mRNA degradation. A, An rrp44 deletion strain complemented by full-length RRP44 on a 
plasmid with a URA3 marker was transformed with plasmids encoding each of the depicted 
mutations. Transformants were spotted onto media containing 5-FOA and control media (SC –
LEU–URA + 2% dextrose), and grown for several days. Growth of the rrp44 mutants was 
compared to two controls, empty vector and wild-type RRP44. Growth on 5-FOA indicates that 
mutated Rrp44p can carry exosome-mediated 3’ to 5’ mRNA degradation. B, An rrp44 deletion 
strain containing a plasmid encoding wild-type RRP44 and a URA3 marker, as well as a 
temperature-sensitive allele of dcp1 (dcp1-2), was transformed with a plasmid encoding residues 
34 to 1001. Transformants were spotted onto media containing 5-FOA and grown for several 
days at the indicated temperatures. Growth of the dcp1-2 rrp44 34-1001 mutant was compared to 
two control strains, a ski7 deletion strain that also contains the dcp1-2 allele (dcp1-2 ski7!) and a 
strain containing only the dcp1-2 mutant. Growth on 5-FOA at 37°C, the non-permissive 
temperature of the dcp1-2 allele, indicates that the first 33 residues of Rrp44p are not needed for 
exosome-mediated 3’ to 5’ mRNA degradation.  
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Figure 6.5: The first 33 residues of Rrp44p do not genetically interact with the nuclear 
exosome cofactor, Rrp6p.  
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Figure 6.5: The first 33 residues of Rrp44p do not genetically interact with the nuclear 
exosome cofactor, Rrp6p. An rrp44 deletion strain or an rrp6 and rrp44 deletion strain was 
transformed with a plasmid encoding residues 34 to 1001. Transformants were spotted onto 
media containing 5-FOA and grown for several days at the indicated temperatures. Growth of 
the rrp6 34-1001 mutant was compared to two controls, an rrp6 and rrp44 deletion strain and an 
rrp44 deletion strain. Growth at 37°C indicates that the first 33 residues of Rrp44p do not 
genetically interact with Rrp6p. 
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residues of Rrp44p are also needed for nonstop decay, a his3-nonstop growth assay was 
performed. In this assay, the his3-nonstop reporter was transformed into an rrp44 deletion strain 
that was complemented by the 34-1001 truncation. The basis for this assay is that the his3-
nonstop reporter is stable in a strain that is defective in nonstop mRNA decay, thus allowing 
cells to make histidine and grow on media lacking histidine (van Hoof et al., 2002). The growth 
of the 34-1001 truncation on media lacking histidine was compared to two controls, a wild-type 
strain and a ski7 deletion strain. Similar to the wild-type strain, the 34-1001 truncation did not 
support viability on media lacking histidine (Figure 6.6). These results suggest that the first 33 
residues of Rrp44p are not needed for a functional nonstop mRNA decay pathway. 
 
The first 33 residues of Rrp44p are not required for the RNA processing or RNA 
degradation activities of the nuclear exosome. 
 The nuclear exosome processes the 7S rRNA precursor to form the mature 5.8S rRNA 
and degrades the 5’ external transcribed spacer (5’ ETS) of the 35S rRNA precursor (Allmang et 
al., 1999a; Allmang et al., 1999b; Mitchell et al., 1997; Mitchell et al., 1996). To test whether the 
first 33 residues of Rrp44p are needed for these nuclear RNA processing and/or degradation 
reactions, RNA was isolated from an rrp44 deletion strain that was complemented with the 34-
1001 truncation. RNA was also isolated from three controls, a strain containing an rrp6 deletion, 
a strain containing wild-type RRP44, and a strain containing the D551N mutant. Rrp6p, a 
nuclear exosome cofactor, is required for nuclear RNA processing and degradation (Briggs et al., 
1998). The RNA from these strains was then subject to denaturing urea-polyacrylamide gel 
electrophoresis. To determine if these strains were defective in RNA processing and/or 
degradation, Northern blot analysis was performed using probes specific to the 7S rRNA 
precursor and to the 5’ ETS, respectively. Intermediates of 5.8S rRNA processing and 5’ ETS 
degradation accumulate in an rrp6 deletion strain and in the D551N mutant, since Rrp6p and the 
exonuclease activity of Rrp44p have been shown to be required for a functional nuclear 
exosome. In contrast to these strains, the 5.8S rRNA and the 5’ ETS were efficiently processed 
and degraded, respectively, in the strain containing the 34-1001 truncation (Figure 6.7). This 
suggests that the first 33 residues of Rrp44p are not needed for the RNA processing and 
degradation functions of the nuclear exosome.  
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Figure 6.6: The first 33 residues of Rrp44p are not needed for nonstop mRNA 
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Figure 6.6: The first 33 residues of Rrp44p are not needed for nonstop mRNA degradation. 
An rrp44 deletion strain complemented by a plasmid encoding residues 34 to 1001 was 
transformed with the his3-nonstop reporter. Transformants were spotted onto media containing, 
or lacking, histidine and grown for several days. Growth of rrp44 truncation was compared to 
two controls strains, a ski7 deletion and wild-type RRP44. Growth on media lacking histidine 
indicates that the nonstop mRNA degradation machinery is not functional.  
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Figure 6.7: first 33 residues of Rrp44p are not needed for the RNA processing or RNA 
degradation activities of the nuclear exosome.  
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Figure 6.7: The first 33 residues of Rrp44p are not needed for the RNA processing or RNA 
degradation activities of the nuclear exosome. The indicated rrp44 mutants were expressed in 
an rrp44 deletion strain. RNA was isolated and analyzed by Northern blot analysis with probes 
that hybridize to the 7S precursor of 5.8S rRNA (above), the 5’ ETS of the rRNA (middle) and 
the RNA subunit of the signal recognition particle (SCR1; below). RNA processing and RNA 
degradation in the rrp44 mutants was compared to two control strains, an rrp6 deletion and wild-
type RRP44. The relative levels of the 7S pre-rRNA and the 5’ ETS were normalized for loading 
using the SCR1 signal.  
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At least one of the putative nuclear localization signals (NLSs) of Rrp44p is needed for 
viability. 
The exosomes’ presence in the nucleus suggests that at least one exosome subunit has an 
NLS. Indeed, Rrp44p has four putative NLSs spread throughout the protein. The first NLS is in 
the far N-terminus of Rrp44p, while the second and third are in the cold shock domains (CSD1 
and CSD2, respectively). The fourth putative NLS is in the C-terminal S1 domain, one of the 
three putative RNA binding domains (Figure 6.8A). To determine whether these NLSs are 
required for viability, an N- and C-terminal truncation of Rrp44p were generated. Specifically, 
the N-terminal truncation, 13-1001, lacks the first putative NLS and the C-terminal truncation, 1-
235, lacks the second, third, and fourth putative NLS. These truncations were transformed into 
an rrp44# [RRP44, URA3] strain. Transformants were then spotted onto media containing 5-
FOA and grown for several days. Growth of the rrp44 truncations was compared to two controls, 
empty vector and wild-type RRP44. The 13-1001 truncation had no obvious growth defect, 
whereas the 1-235 truncation had a slow growth phenotype (Figure 6.8B). The slow growth of 
the 1-235 truncation has been previously reported (see Chapter 3; Schaeffer et al., 2009) and is 
likely due to a lack of Rrp44p exonuclease activity. These results suggest that none of the 
putative NLSs of Rrp44p are required for viability, but does not exclude the possibility that these 
NLSs are redundant.  
 To determine whether cells require at least one putative NLS to survive, an N- and C-
terminal truncation, 13-235, was generated and tested for complementation of an rrp44# 
[RRP44, URA3] strain. Growth of the 13-235 truncation was compared to four controls, empty 
vector, wild-type RRP44, the 13-1001 truncation, and the 1-235 truncation. The 13-235 
truncation resulted in no growth (Figure 6.8B), however, this lack of complementation was not 
due to a lack of protein expression, as the 13-235 truncation was expressed at levels higher than 
wild-type Rrp44 (Figure 6.8C). These results suggest that any of the putative NLSs of Rrp44p 
are sufficient for viability, however, the absence of all putative NLSs results in a nonfunctional 
Rrp44p, and thus, no cell growth.  
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Figure 6.8: At least one of the putative localization signals (NLSs) of Rrp44p is needed 
for viability.  
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Figure 6.8: At least one of the putative localization signals (NLSs) of Rrp44p is needed for 
viability. A, A schematic representation of the putative NLSs of Rrp44p. B, An rrp44 deletion 
strain complemented by full-length RRP44 on a plasmid with a URA3 marker was transformed 
with plasmids encoding each of the depicted truncations. Transformants were spotted onto media 
containing 5-FOA and control media (SC –LEU –URA + 2% dextrose), and grown for several 
days. Growth of the rrp44 truncations was compared to two controls, empty vector and wild-type 
RRP44. Growth on 5-FOA indicates that truncated Rrp44p can carry out the essential function of 
Rrp44p. C, Whole-cell lysate was obtained from a strain containing the C-terminally TAP-
tagged 13-235 Rrp44p truncation described in (A) and was analyzed by Western blot analysis 
with antibodies specific to Protein A to detect Rrp44p and to Pgk1p as a loading control. 
Expression of the Rrp44p truncated protein was compared to wild-type Rrp44p.  
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DISCUSSION 
Residues 34 to 46 are needed for the essential function of Rrp44p. 
 The results shown in this Chapter indicate that while the first 33 residues of Rrp44p are 
not essential, conserved residues 34 to 46 of the linker region are required for viability. Further 
analysis showed that although deletion of the linker results in a lack of cell growth, mutating six 
of the most conserved residues of this region had no effect on cell viability. These differences in 
growth may be because the residues of the linker region participate in redundant protein-protein 
interactions that are required for viability. In support of this, the N-terminus of Rrp44p is needed 
for interaction with the exosome (see Chapter 5; Lehner and Sanderson, 2004; Schneider et al., 
2009; Wang et al., 2007). 
An alternate explanation for why the 47-1001 truncation fails to support viability is that 
this truncated protein may be non-functional. Although this N-terminal truncation is expressed, 
there is a possibility that the protein is misfolded, and thus, causes a decrease in protein function.  
 
The N-terminus is one of many regions of Rrp44p that are needed for exosome interaction. 
 Since both the 34-1001 and 47-1001 truncations do not interact with the exosome, the 
data presented here can be interpreted in one of two ways. It may be that only the first 33 
residues of Rrp44p are needed to bind the core exosome. Alternatively, this region and the linker 
region (residues 1 to 46) may be required for exosome interaction (see Chapter 7). In support of 
this, four of the most conserved residues of the linker region have been implicated in exosome 
interaction (Bonneau et al., 2009). 
Because Rrp44p loosely associates with the exosome (Allmang et al., 1999b), interaction 
of the N-terminal truncations of Rrp44p with the exosome was tested under low and high salt 
conditions (50 mM and 1 M, respectively). The inability of both truncations to interact with the 
exosome, even under low salt conditions, suggests that at least the first 33 residues of Rrp44p are 
necessary for exosome association. 
 The observation that the 34-1001 truncation has no obvious growth defect, but is unable 
to interact with the exosome, may mean that association of Rrp44p with the exosome is not 
required for viability. In support of this, Rrp44p does not co-purify with exosomes in humans, 
Arabidopsis, or trypanosomes (Allmang et al., 1999b; Chekanova et al., 2002; Estevez et al., 
2001). Additionally, human Rrp44p can complement a yeast rrp44 mutant (Shiomi et al., 1998). 
Alternatively, the interaction between Rrp44p and the exosome may be essential, with multiple 
regions of Rrp44p redundant in exosome interaction. In support of this, it has been previously 
shown that, in addition to the N-terminus of Rrp44p, the CR3 region (Lehner and Sanderson, 
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2004; Schneider et al., 2009), nuclease domains, and CSDs (Wang et al., 2007) of Rrp44p are 
needed for exosome interaction. Therefore, it seems that the N-terminus is just one of many 
regions/domains that mediates the interaction between Rrp44p and the exosome. 
 
The functional interaction between the N-terminus and the nuclease domains of Rrp44p 
The first 33 residues, and at least three of the six conserved residues of the linker region 
(E38, D44, and I45), are not needed for endonuclease activity. Mutations of the other three linker 
residues (Y40, L41, and R42), however, are synthetically lethal with a C-terminal truncation that 
lacks the exonucleolytic RNB domain of Rrp44p but not with the D551N mutant that abolishes 
Rrp44p exonuclease activity. A mutant that is synthetically lethal with an Rrp44p mutant that 
lacks exonuclease activity may be in a residue or region that is needed for endonuclease activity. 
This genetic interaction can occur because cells require at least one nuclease activity of Rrp44p 
to survive. Therefore, although the results of these growth assays differ, it is possible that Y40, 
L41, and R42 are needed for the endonuclease activity of Rrp44p (see Chapter 7).  
Another explanation as to why the Y40A, L41A, and R42A mutants are synthetically 
lethal with a C-terminal truncation that lacks the RNB domain is that these linker residues and 
the RNB domain make redundant contacts with the core exosome or exosome cofactor. If the 
interaction between Rrp44p and the exosome/exosome cofactor is required for viability, 
mutating these linker residues alone, or in combination with D551N, would still allow Rrp44p to 
associate with the exosome/exosome cofactor and, therefore, would not affect viability. In 
contrast, mutating these residues in a truncation that lacks the RNB domain may mean that 
Rrp44p is no longer able to interact with the exosome/exosome cofactor, resulting in a synthetic 
lethal phenotype (see Chapter 7).  
 While the functional interaction between the N-terminus of Rrp44p and the 
endonucleolytic PIN domain is still unclear, the data presented in this Chapter indicate that the 
first 33 residues of Rrp44p are not needed for exonuclease activity. Specifically, two different 
growth assays show that there is no genetic interaction between these residues and the RNB 
domain of Rrp44p.  
 
The essential function of Rrp44p is likely to be in the nucleus.  
Although the essential function of Rrp44p and the exosome is not yet known, the finding 
that Rrp44p requires at least one putative NLS for viability suggests that the essential function of 
Rrp44p is in the nucleus. Despite the lack of growth in a strain containing a truncation that lacks 
all four putative NLSs, 13-235, the data presented here do not exclude the possibility that this 
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truncated protein can still localize to the nucleus. Even if this truncated protein does localize to 
the nucleus, it would still be unclear why this truncation is unable to support cell growth. 
In support of the essential function of Rrp44p being in the nucleus, none of the known 
cytoplasmic exosome functions are essential. The data presented here do not exclude the 
possibility, however, that an unidentified cytoplasmic exosome function is required for viability. 
In contrast to the known functions of cytoplasmic exosome, the end products of RNA processing 
by the nuclear exosome are required for viability, specifically the formation of the 5.8S rRNA. 
Several studies, however, suggest that 5.8S rRNA processing is not the essential function of 
Rrp44p, namely because when Rrp44p is depleted or the exonuclease activity of Rrp44p is 
abolished, 5.8S rRNA is still produced. Likewise, depleting Rrp44p results in defects in snRNA, 
snoRNA, and tRNA processing, however, there these mature RNAs are always produced 
(Allmang et al., 1999a; Allmang et al., 1999b; de la Cruz et al., 1998; Dziembowski et al., 2007; 
LaCava et al., 2005; Lebreton et al., 2008; Mitchell et al., 1997; Mitchell et al., 1996; Schaeffer 
et al., 2009; Schneider et al., 2009; van Hoof et al., 2000a). This suggests that there are 
redundant pathways to process these RNAs.  
 The nuclear exosome is also involved in the degradation of aberrantly processed RNAs, 
including rRNA, sn/snoRNA, tRNA and mRNA. It is possible that the essential function of 
Rrp44p is the degradation of aberrant RNAs in the nucleus. In support of this, the degradation of 
these RNAs requires the TRAMP complex, a nuclear cofactor complex that is also required for 
cell viability (Castano et al., 1996; Inoue et al., 2000; Liang et al., 1996).  
 Because the nuclear RNAs targeted for processing and degradation by Rrp44p are 
crucial in many aspects of gene expression, including splicing and translation, there are likely 
redundant pathways to ensure these nuclear RNAs are efficiently processed and rapidly 
degraded, when needed. Because Rrp44p is needed for the processing and degradation of a 
variety of nuclear RNAs, the essential function of Rrp44p may be a combination of nuclear RNA 
processing reactions and/or the degradation of multiple RNAs, instead of just one specific RNA 
substrate. For a more detailed discussion of the essential function of Rrp44p, see Chapter 7. 
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SUMMARY AND FUTURE DIRECTIONS 
The endoribonucleolytic PIN domain of Rrp44p is required for cell survival. 
The N-terminus of Rrp44p contains a PIN domain, which prior to this study, had not 
been characterized in eukaryotic Rrp44p. PIN domain-containing proteins in other organisms 
have nuclease activity. Specifically, these enzymes coordinate a divalent cation and catalyze the 
cleavage of DNA or ssRNA (Arcus et al., 2004; Bleichert et al., 2006; Daines et al., 2007; Fatica 
et al., 2004; Glavan et al., 2006; Levin et al., 2004). Because Rrp44p has the conserved acidic 
residues of the PIN domain active site, it was hypothesized that the PIN domain of Rrp44p may 
have nuclease activity. Through a collaboration with Dr. Cecilia Arraiano’s laboratory (Instituto 
de Tecnologia Química e Biológica [ITQB]; Lisbon, Portugal), the data presented here show that 
the PIN domain of Rrp44p has endoribonuclease activity. It is likely that this second nuclease 
active site was not previously identified because it is detectable under different conditions than 
the exoribonuclease activity of Rrp44p. Despite three separate studies that have identified the 
endonuclease activity of Rrp44p (Lebreton et al., 2008; Schaeffer et al., 2009; Schneider et al., 
2009), the substrates of the PIN domain have not yet been identified. The endo- and exonuclease 
activities of Rrp44p either act on separate substrates or on some of the same substrates. 
Additionally, the endonuclease activity may prefer RNA substrates that have not yet been 
identified as exosome substrates. 
Although the catalytic activity of the PIN domain is not required for viability, the C-
terminus of the PIN domain, specifically residues 203 to 235, is needed for cell survival. This 
may be because this region is needed for interaction with the core exosome, an exosome 
cofactor, and/or an RNA substrate. In support of this, the PIN domain of Rrp44p has been shown 
to mediate interaction with the exosome (Schneider et al., 2009).  
 
The exonuclease activity of Rrp44p is needed for a functional nuclear and cytoplasmic 
exosome.  
 When it was discovered in 2007, the catalytically active RNB domain of Rrp44p was 
shown to be responsible for the 3’ to 5’ exonuclease activity of the exosome (Dziembowski et 
al., 2007). In support of this, the data presented here also show that the exonuclease activity of 
Rrp44p is needed for exosome-mediated 3’ to 5’ mRNA degradation. Because of the importance 
of this nuclease activity in general mRNA turnover, these findings reveal that Rrp44p is a key 
post-transcriptional regulator of eukaryotic gene expression. 
 In addition to the important role the exonuclease activity of Rrp44p plays in the 
cytoplasm, the results presented here also indicate that the exonuclease activity is needed for 
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metabolism of the yeast 35S rRNA precursor in the nucleus. Specifically, the catalytic activity of 
the RNB domain of Rrp44p is needed for the degradation of the 5’ ETS and for the processing of 
the 7S pre-rRNA to form the mature 5.8S rRNA species. Importantly, other studies corroborate 
these findings (Dziembowski et al., 2007; Lebreton et al., 2008; Schneider et al., 2009). In 
further support of a role for the exonuclease activity of Rrp44p in the nucleus, the catalytic RNB 
domain of Rrp44p genetically interacts with the nuclear exosome cofactor, Rrp6p. Rrp6p also 
possesses exoribonuclease activity and is needed for many of the RNA processing and 
degradation reactions that occur in the nucleus (Allmang et al., 1999a; Briggs et al., 1998; 
Butler, 2002; Fatica et al., 2000; van Hoof et al., 2000a). The genetic interaction between these 
two nucleases suggests that they may have overlapping functions, however, a recent study 
suggests that the physical interaction between Rrp44p and Rrp6p is needed for the metabolism of 
only a few Rrp6p substrates (Callahan and Butler, 2008).   
 
Determining the RNA substrates of the endo- and exonuclease activities of Rrp44p 
It is not yet known whether the endo- and exonuclease activities of Rrp44p are involved 
in the other RNA processing and degradation reactions of the exosome. Specifically, the nuclear 
exosome is involved in processing RNA precursors to form small, stable, mature RNA species, 
as well as in the degradation of improperly processed forms of these, and other, RNAs. In 
contrast, the cytoplasmic exosome is strictly involved in mRNA degradation, where it is 
involved in general mRNA decay to rid the cell of transcripts that are no longer needed, and in 
mRNA surveillance, where it degrades aberrant transcripts that can have potentially deleterious 
effects on the cell. Future studies of Rrp44p should focus on the involvement of its nuclease 
activities in these cellular RNA processing and degradation reactions. 
 
Determining the cytoplasmic RNA substrates of Rrp44p 
 In addition to its role in general mRNA turnover, the cytoplasmic exosome is involved 
in RNA surveillance pathways, in which it rapidly degrades aberrant transcripts. An example of 
this is the nonsense-mediated decay (NMD) pathway. Here, transcripts that contain premature 
termination codons (PTCs) are targeted for degradation by the cytoplasmic exosome (Mitchell 
and Tollervey, 2003; Takahashi et al., 2003). To determine whether the nuclease activities of 
Rrp44p are involved in this RNA surveillance pathway, the stability of a representative PTC-
containing transcript should be measured in strains containing the catalytically inactive nuclease 
point mutants. Briefly, the GAL::pgk1pG-PTC reporter should be transformed into rrp44 
deletion strains that are complemented by the D171A and D551N mutants. The GAL::pgk1pG-
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PTC reporter contains a premature termination codon in the open reading frame of 3-
phosphoglycerate kinase (PGK1) and a polyguanine (pG) tract to distinguish between the 
reporter and the endogenous transcript (Takahashi et al., 2003). Because this reporter is under 
the control of the galactose promoter, the GAL::pgk1pG-PTC transcript is expressed in media 
containing galactose, however, its transcription is rapidly shut off in media containing dextrose. 
Therefore, to determine the stability of the transcript, strains initially grown in galactose should 
be shifted to media containing dextrose. As a control, the stability of the GAL::pgk1pG-PTC 
transcript in these strains should be compared to the stability of the reporter in two control 
strains, a wild-type strain and a strain with a defective cytoplasmic exosome. RNA should then 
be isolated from these strains at various times and subjected to agarose formaldehyde gel 
electrophoresis, followed by Northern blot analysis. To determine whether strains containing the 
catalytically inactive nuclease point mutants are defective in NMD, blots should be hybridized 
with a probe specific to pgk1pg, and SCR1 as a loading control. Stabilization of the 
GAL::pgk1pG-PTC transcript in strains containing the D171A and/or D551N mutants would 
suggest that the endo- and/or exonuclease activities of Rrp44p are needed for NMD. 
The cytoplasmic exosome also has an antiviral function, whereby the exosome is 
thought to degrade unadenylated viral RNA, including the L-A virus and the M satellite RNA. M 
satellite RNA encodes a protein toxin, which is secreted from cells, and ultimately kills 
surrounding uninfected cells. The antiviral activity of the exosome was initially discovered in a 
screen for “superkiller” mutants, or mutants that are able to more efficiently kill surrounding 
cells (Toh and Wickner, 1980). This screen identified the SKI genes, several of which encode 
exosome subunits and cytoplasmic exosome cofactors, including Ski7p and the Ski complex. 
Because the Ski proteins are involved in mRNA degradation, it is thought that the exosomes 
antiviral activity stems from its ability to degrade viral RNAs (Brown et al., 2000; Meaux and 
van Hoof, 2006).  
To test whether the nuclease activities of Rrp44p are needed for viral RNA degradation, 
and thus the antiviral activity of the exosome, a killer assay should be performed (Figure 7.1; 
Schaeffer et al., 2008). In this assay, infected, toxin-producing cells that contain the D171A or 
D551N mutant should be spotted on a lawn of uninfected cells. As a control, (i) an uninfected 
strain, (ii) a wild-type, toxin-producing strain, and (iii) a ski7 deletion strain should also be 
spotted on the lawn of uninfected cells. The premise of this assay is that infected cells secrete the 
killer toxin that then kills the surrounding uninfected cells, thus creating a halo, or zone of 
clearance. In this assay, the uninfected control strain would not create a halo. In contrast, the ski7 
deletion strain, a known “superkiller” strain, would produce a halo larger than the wild-type, 
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Figure 7.1: Schematic representation of the yeast killer assay. 
B. 
A. 
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Figure 7.1: Schematic representation of the yeast killer assay. The involvement of the 
nuclease activities of Rrp44p in viral RNA degradation should be analyzed using the killer assay. 
First, a lawn of uninfected cells should be plated. Next, tester strains, including (i) an uninfected 
strain (ii) a wild-type, infected strain (iii) a ski7 deletion strain and (iv) infected strains 
containing the catalytically inactive rrp44 nuclease mutants (rrp44*; rrp44 D171A or rrp44 
D551N) should be spotted on the lawn of uninfected cells. Infected cells secrete a killer toxin 
that then kills the surrounding uninfected cells, thus creating a halo, or zone of clearance. The 
ski7 deletion strain, a known “superkiller” strain, produces a halo larger than the wild-type, 
infected strain.  
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infected strain. If the halo produced by the strain containing the D171A and/or D551N mutants is 
similar to the ski7" strain, this would suggest that the endo- and/or exonuclease activities of 
Rrp44p are required for viral RNA degradation and may, therefore, be needed for the antiviral 
function of the exosome.  
 
Determining the nuclear RNA substrates of Rrp44p 
The exonuclease activity of Rrp44p is required for 5.8S rRNA processing and for the 
degradation of the 5’ ETS, whereas the endonuclease activity does not seem to be required for 
the metabolism of the 35S rRNA precursor. The data presented here, however, do not exclude 
the possibility that the nuclease activities of Rrp44p are needed for the other RNA processing 
and degradation reactions of the nuclear exosome (Table 7.1). In addition to processing and 
degrading the 35S rRNA precursor, the nuclear exosome processes and degrades snRNAs and 
three different types of snoRNAs, including those that are independently transcribed, snoRNAs 
that are intron-derived, and polycistronic snoRNAs (Allmang et al., 1999a; Allmang et al., 
1999b; de la Cruz et al., 1998; Mitchell et al., 1997; van Hoof et al., 2000a). The nuclear 
exosome is also involved in RNA surveillance, whereby it rapidly degrades aberrantly processed 
forms of these RNAs (Egecioglu et al., 2006; LaCava et al., 2005). The exosome also maintains 
the fidelity of gene expression by degrading unspliced mRNAs (Bousquet-Antonelli et al., 2000) 
and cryptic unstable transcripts (CUTs), which are the result of transcription of intergenic 
regions (Davis and Ares, 2006).  
To determine if the nuclease activities of Rrp44p are needed for these nuclear RNA 
processing and degradation reactions, RNA should be isolated from a strain containing the 
D171A mutant and a strain containing the D551N mutant. As a control, RNA should also be 
isolated from a wild-type strain and a strain with a defective nuclear exosome. The RNA from 
these strains should be subjected to denaturing urea-polyacrylamide gel electrophoresis, 
followed by Northern blot analysis. To determine if the Rrp44p nuclease activities are needed for 
the processing and/or degradation of snRNAs, snoRNAs, unspliced mRNA, and/or CUTs, blots 
should be hybridized with probes specific to known nuclear exosome substrates including: (i) 
three snRNAs, U1, U4, and U5 (ii) at least one of each of the different types of snoRNAs, 
including snR33, U18, and U14 (iii) the intron of a typically spliced mRNA, such as RP51A and 
(iv) a CUT, such as SGR1. The presence of RNA processing and/or degradation intermediates in 
strains containing the D171A and/or D551N mutants would suggest that the endo- and/or 
exonuclease activities of Rrp44p are needed for these nuclear RNA metabolism reactions. 
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In addition to degrading improperly processed snRNAs, and snoRNAs, the nuclear 
exosome also degrades improperly modified tRNAs, including the initiator tRNAiMet (Table 7.1). 
This hypomodified tRNA accumulates in cells that have a defective m1A methyltransferase, 
which results in a lack methylation of adenosine at position 58 of the T$C loop (Kadaba et al., 
2004; Kadaba et al., 2006). To test whether the endo- and/or exonuclease activities of Rrp44p are 
needed to degrade these transcripts, the D171A and D551N mutants should be separately 
combined with a temperature-sensitive mutant of the m1A methyltransferase, trm6-504. RNA 
should be isolated from a wild-type strain, a strain containing only the trm6-504 mutant, a strain 
containing the D171A trm6-504 double mutant, and a strain containing the D551N trm6-504 
double mutant. The RNA from these strains should be subjected to denaturing urea-
polyacrylamide gel electrophoresis, followed by Northern blot analysis with a probe specific to 
the initiator tRMAiMet. The presence of hypomodified tRNAiMet in strains containing the D171A 
and/or D551N mutants would suggest that the endo- and/or exonuclease activities of Rrp44p are 
needed for the degradation of improperly modified tRNAs. 
Lastly, the nuclear exosome is involved in degrading mRNAs that have defects in 3’-end 
processing (Table 7.1; Libri et al., 2002; Torchet et al., 2002). These types of transcripts 
accumulate in cells that are defective in transcription termination, mRNA cleavage, or 
polyadenylation. To test whether the nucleases activities of Rrp44p are needed to degrade these 
transcripts, the D171A and the D551N mutants should be separately combined with a 
temperature-sensitive mutant of rna14.1, which encodes an mRNA cleavage and 
polyadenylation factor, CFI (Minvielle-Sebastia et al., 1994; Minvielle-Sebastia et al., 1991). A 
strain containing only the rna14.1 mutant does not accumulate 3’-extended transcripts due to the 
rapid degradation of these aberrant mRNAs by the nuclear exosome. In contrast, a strain 
containing rna14.1 and an exosome mutant, does accumulate these transcripts (Torchet et al., 
2002). To determine whether the endo- and/or exonuclease activities of Rrp44p degrade these 
aberrant mRNAs, RNA should be isolated from a strain containing only the rna14.1 mutant, a 
strain that contains the rna14.1 mutant that also lacks a functional nuclear exosome, a strain 
containing the D171A rna14.1 double mutant, and a strain containing the D551N rna14.1 double 
mutant. The RNA from these strains should be subjected to denaturing urea-polyacrylamide gel 
electrophoresis, followed by Northern blot analysis. Specifically, blots should be hybridized with 
a probe specific to HSP104, a transcript known to be processed at its 3’-end by CFI (Libri et al., 
2002). The presence of 3’-extended HSP104 species in strains containing the D171A and/or 
D551N mutants would suggest that the endo- and/or exonuclease activities of Rrp44p are needed 
for the degradation of mRNAs that have defects in 3’-end processing. 
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Global approaches to determining the RNA substrates of Rrp44p 
 The approaches described above should be useful in determining if the nuclease 
activities of Rrp44p are needed to degrade specific RNA substrates, however, these approaches 
are limited to only known nuclear exosome substrates. Therefore, two more global approaches 
should be taken to determine the substrates of nuclease activities of Rrp44p. First, a tiling 
microarray should be performed on a wild-type strain, a strain containing the D171A mutant, and 
a strain containing the D551N mutant. Comparing the results from the catalytically inactive 
nuclease mutants to the wild-type strain will yield RNA substrates that are upregulated in the 
nuclease mutants, and are therefore, degraded by the Rrp44p endo- and/or exonuclease. 
Another approach to detect the RNA substrates of the Rrp44p nucleases is to examine 
the genetic interactions that occur in a wild-type strain but do not occur in strains containing the 
D171A or D551N mutants. To do this, a heterozygote diploid-based synthetic lethality analysis 
with microarrays (dSLAM) should be performed (Figure 7.2; Pan et al., 2007). Specifically, the 
D171A and D551N mutants should be introduced, individually, into a population of 
approximately 6000 heterozygous diploid Yeast Knockout (YKO) mutants. The heterozygote 
diploid double mutants should then be sporulated and the resultant haploid double mutants 
should be studied for synthetic lethality by microarray analysis. Briefly, the unique 20 nucleotide 
sequences flanking the deletion cassette of the YKO mutants, termed “molecular barcodes”, 
should be PCR amplified with a Cy3-labeled primer from the haploid double mutants 
(Experiment) and a Cy5-labeled primer from the haploid single knockout mutants (Control). 
Both PCR products should be hybridized to a microarray chip containing each of the “molecular 
barcodes”. A synthetic lethal interaction should be observed by high Control-to-Experiment Cy5 
hybridization signal intensity (Pan et al., 2004). 
 
The CR3 region of Rrp44p may be a putative zinc binding domain. 
 The N-terminus of Rrp44p contains a CR3 region that contains three conserved cysteine 
residues (C47, C52, and C55). Despite extensive functional analyses of Rrp44p over the past 
three years, no information exists on the CR3 region in Rrp44p or in any other protein. Further 
complicating the study of this region is the lack of structural data on the N-terminus of Rrp44p. 
Although there are two published crystal structures of the catalytic subunit, neither contain the 
N-terminus in its entirety. Because of the lack of functional and structural data on this region, it 
is still not known how the CR3 region functions in Rrp44p, or the exosome, whether this region 
adopts a unique fold, or if this region consists of more than three cysteine residues.  
 Despite the lack of the entire N-terminus, the latest crystal structure of Rrp44p (Bonneau 
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Figure 7.2: Schematic representation of the heterozygote diploid-based synthetic 
lethality analysis with microarrays (dSLAM) technique. 
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Figure 7.2: Schematic representation of the heterozygote diploid-based synthetic lethality 
analysis with microarrays (dSLAM) technique. The genetic interactions of the Rrp44p 
nucleases should be analyzed using dSLAM. Specifically, a plasmid encoding the catalytically 
inactive nuclease point mutations of RRP44 (rrp44*; rrp44 D171A or rrp44 D551N) should be 
transformed into a population of approximately 6000 heterozygous diploid Yeast Knockout 
(YKO) mutants. The heterozygote diploid double mutants should then be sporulated and 
haploids should be selected. To determine whether the double mutants are synthetically lethal, 
the unique 20-nucleotide sequences flanking the deletion cassette of the YKO mutants, termed 
“molecular barcodes”, should be PCR amplified. In the double mutants, a Cy3-labeled primer 
should be used for amplification whereas a Cy5-labeled primer should be used to PCR amplify 
the “molecular barcodes” in the single mutants. Both PCR products should be hybridized to a 
microarray chip containing each of the “molecular barcodes”. A synthetic lethal interaction 
should be observed by high Cy5 hybridization signal intensity.  
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et al., 2009) provided at least two interesting findings. First, the second and third residues of the 
CR3 region are modeled to form a disulfide bond, however, the data presented here suggest that 
the disulfide bond is not required for the function of Rrp44p, or the exosome. In addition, the 
electron density of the crystal structure of Rrp44p is not defined enough to determine whether 
the residues of the CR3 region form a disulfide bond with each other or with other residues of 
Rrp44p. The second interesting observation of the Rrp44p crystal structure is that the three 
cysteine residues of the CR3 region are in close proximity to histidine 184 (H184). This spatial 
organization is consistent with coordination of a zinc ion, however, no metal ion was present in 
the crystal structure. The lack of a metal ion may be an artifact of the protein purification 
conditions that were used, and does not exclude the possibility that the CR3 region and H184 
coordinate a metal. To determine whether Rrp44p coordinates a zinc ion, a GST-fusion of full-
length Rrp44p should be expressed and purified from E. coli. The purified protein sample should 
then be subjected to atomic absorption spectroscopy, a technique used to determine the 
concentration of a particular metal element in a sample (Sperling and Welz, 1999). Briefly, this 
technique transforms a liquid protein sample into an atomic gas and then analyzes the free atoms 
of the protein sample. As an internal control, this technique should detect the presence of Mn2+, 
which is coordinated by the PIN domain active site, and Mg2+, which is coordinated by the RNB 
domain active site. If these metals are not detected, the GST-fusion of Rrp44p should be purified 
using different purification conditions to ensure that the lack of metals is not due to the protein 
purification conditions.  
The coordination of a zinc ion may be needed, directly or indirectly, for Rrp44p protein 
stabilization, interaction with the exosome, and/or for Rrp44p nuclease activity. Indeed, 
preliminary evidence suggests that endonuclease activity of Rrp44p is stimulated by the addition 
of zinc (Filipa Reis and Dr. Cecilia Arraiano, personal communication). In addition, mutation of 
the three cysteine residues of the CR3 region results in growth defects and defects in exosome 
interaction and function. However, the requirement for the CR3 region in exosome interaction 
may be indirect. If the coordination of a zinc atom between the CR3 region and H184 is needed 
for proper folding, the CR3 region in the triple CR3 mutant may not be folded correctly, which 
could also cause the upstream linker region to misfold. Since this region contains residues that 
contact the exosome (Y40, L41, R42, and D44), this misfolding could disrupt exosome 
interaction. Therefore, further studies are needed to determine whether the CR3 region is directly 
involved in exosome interaction or if the lack of interaction seen in the triple CR3 mutant is a 
secondary consequence of protein misfolding. 
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Several experiments, including in vivo genetic analysis and in vitro biochemical nuclease 
assays, also suggest that the CR3 region is needed for the nuclease activities of Rrp44p. 
Therefore, the overall conclusion is that the defects seen in the triple CR3 mutant may be 
explained by the lack of coordination of a zinc ion.  
 
The CR3 region of Rrp44p may be needed for 3’ to 5’ mRNA degradation because this 
region may interact with a protein involved in 3’ to 5’ mRNA decay. 
 The observation that mutating the three cysteine residues of the CR3 region is 
synthetically lethal with the D171A mutant and a mutant that inactivates the 5’ to 3’ mRNA 
degradation pathway, suggests that the CR3 region is needed for exonuclease activity of Rrp44p. 
Although the CR3 region and the active site of the RNB domain are not in close proximity in the 
crystal structure, the CR3 region may be needed to interact with cytoplasmic exosome cofactors 
that are required for 3’ to 5’ mRNA degradation, including Ski7p and the Ski complex. It has 
been previously reported that Ski7p interacts with the exosome (Araki et al., 2001), however, an 
interaction between the exosome and the Ski complex has not yet been shown. To determine 
whether the CR3 region of Rrp44p interacts with these cofactors, Rrp44p and the cytoplasmic 
exosome cofactors should be C-terminally tagged. Specifically, Ski7p and members of the Ski 
complex, Ski2p, Ski3p, and Ski8p, should be C-terminally Myc-tagged, whereas wild-type 
Rrp44p and the triple CR3 mutant should be C-terminally TAP-tagged. Wild-type Rrp44p, the 
triple CR3 mutant, and a strain containing an empty vector should be purified. Proteins bound to 
Rrp44p should be eluted, subjected to SDS-PAGE, and Western blot analysis should be 
performed. Specifically, interactions between Rrp44p, Ski7p, and the Ski complex should be 
detected using antibodies specific to the Myc tag.  
 Targeted co-purification of proteins bound to Rrp44p followed by Western blot analysis 
is one way to detect interactions between Rrp44p and the cytoplasmic exosome cofactors, 
however, a limitation of this technique is that the individual proteins must be tagged. Therefore, 
a more global approach should be taken to determine what proteins bind to the CR3 region of 
Rrp44p. Specifically, C-terminally TAP-tagged wild-type Rrp44p and the triple CR3 mutant 
should be purified and subjected to SDS-PAGE. The SDS gel should then be stained with 
Coomassie Brilliant Blue. Any proteins that bind to wild-type Rrp44p, but not to the triple CR3 
mutant, should be extracted and analyzed by mass spectrometry.  
Another possible explanation for why the triple CR3 mutant is synthetically lethal with 
the D171A mutant is that the CR3, D171A mutant protein is not expressed. A potential decrease 
in expression, coupled with a loss of exosome interaction due to the triple CR3 mutation, may 
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explain the lack of complementation by the CR3, D171A mutant. To determine whether the lack 
of growth is an artifact of expression, the CR3, D171A mutant should be C-terminally TAP-
tagged and protein expression should be analyzed using SDS-PAGE and Western blot analysis. 
 
Nonstop mRNA degradation requires Rrp44p. 
A functional nonstop mRNA degradation pathway may not require the nuclease activities of 
Rrp44p. 
 The data presented here suggest that the nuclease activities of Rrp44p are not needed for 
the degradation of nonstop transcripts. These findings can be explained by one of three 
possibilities. First, the nucleases may be redundant in nonstop decay. One method used to 
determine whether the nuclease activities of Rrp44p are redundant in this mRNA surveillance 
pathway was to measure the stability of a representative nonstop reporter in a strain that 
abolishes both of the nuclease activities of Rrp44p. Specifically, the GAL::pgk1pG-nonstop 
reporter was transformed into an rrp44 deletion strain that was complemented by a plasmid 
encoding a temperature-sensitive allele of rrp44 (rrp44ts). This strain also contained a plasmid 
encoding the D171A or D551N point mutation of Rrp44p. These strains were initially grown at 
the permissive temperature (23°C) then shifted to the non-permissive temperature (37°C) for ten 
hours to inactivate the rrp44ts allele. However, Northern blot analysis revealed that 
GAL::pgk1pG-nonstop transcript was still unstable after the ten hour shift to the non-permissive 
temperature, indicating that this time course was not sufficient to inactivate the rrp44ts allele. 
Therefore, alternative means must be used to test whether nonstop transcripts are degraded when 
both the endo- and exonuclease activities of Rrp44p are abolished. 
 Another way to test the redundancy of the Rrp44p nucleases in nonstop decay is to test 
whether the double catalytically inactive D171A, D551N mutant can rescue the nonstop mRNA 
decay defect of the triple CR3 mutant using the his3-nonstop growth assay. Briefly, an rrp44 
deletion strain that is complemented by a plasmid encoding the triple CR3 mutation (rrp44" 
C47S, C52S, C55S) will be transformed with a plasmid encoding the double D171A, D551N 
point mutation. As a control, the rrp44" C47S, C52S, C55S strain will also be transformed with 
plasmids encoding wild-type RRP44, the D171A mutation alone, the D551N mutation alone, and 
an empty vector. The resulting strains will then be transformed with the his3-nonstop reporter, 
which contains a nonstop mutation in the HIS3 open reading frame. The basis for this assay is 
that the his3-nonstop transcript will be stable in a strain that is defective in nonstop mRNA 
degradation, and will, therefore, be viable on media lacking histidine. Conversely, in a strain 
with a functional nonstop decay pathway the his3-nonstop transcript will be rapidly degraded, 
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resulting in a lack of viability on media lacking histidine. Since, independently, the nuclease 
activities of Rrp44p are not required for nonstop decay, wild-type Rrp44p, the D171A mutant, 
and the D551N mutant should rescue the nonstop decay defects caused by the triple CR3 mutant, 
which will result in a lack of growth of these strains on media lacking histidine. In contrast, if the 
nuclease activities of Rrp44p are redundant in nonstop decay, the double catalytically inactive 
mutant should not be able to rescue the triple CR3 mutant, and should, therefore, be viable on 
media lacking histidine.  
A second explanation for why the endo- and exonuclease activities of Rrp44p are not 
needed to degrade nonstop transcripts is that nonstop decay is independent of the known 
catalytic activities of the cytoplasmic exosome. Under this hypothesis, a different cellular 
nuclease would be responsible for the degradation of nonstop transcripts. Interestingly, a recent 
genome-wide screen to identify factors involved in nonstop decay did not identify any additional 
nucleases (Wilson et al., 2007). 
Lastly, abolishing the nuclease activities of Rrp44p may not have an effect on nonstop 
decay because Rrp6p, a known nuclear exosome cofactor, may be required for the degradation of 
nonstop transcripts. Although Rrp6p is presumed to be present only in the nucleus, a small 
fraction of the protein may associate with the cytoplasmic exosome. In this case, a small amount 
of Rrp6p activity may be sufficient for the degradation of nonstop transcripts. In support of this, 
the human homolog of Rrp6p localizes to the nucleus and the cytoplasm in human cell lines 
(Lejeune et al., 2003). Additionally, Rrp6p has been shown to interact with Ski7p, a cytoplasmic 
exosome cofactor required for general 3’ to 5’ mRNA degradation and nonstop mRNA decay 
(Collins et al., 2007; Peng et al., 2003). To determine whether Rrp6p is involved in nonstop 
decay, the stability of a representative nonstop transcript, GAL::pgk1pG-nonstop, should be 
measured in an rrp6 deletion strain. As a control, the nonstop reporter should also be 
transformed into a wild-type strain and a ski7 deletion strain. The aforementioned strains should 
be grown in liquid media containing galactose to induce expression of the reporter and then 
switched to media containing dextrose to shut off reporter transcription. RNA should then be 
isolated from the strains and subject to agarose formaldehyde gel electrophoresis. Northern blot 
analysis should then be performed using probes specific to pgk1pG, and SCR1 as a loading 
control. If the GAL::pgk1pG-nonstop transcript has a similar half-life in the rrp6 deletion strain 
as it does in the ski7 deletion strain, Rrp6p may be involved in nonstop decay, which would 
suggest that it is not excluded from the cytoplasm.  
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The CR3 region of Rrp44p is needed for a functional nonstop mRNA decay pathway. 
Nonstop transcripts are not efficiently degraded in the triple CR3 mutant, which suggests 
that the CR3 region is needed for nonstop decay. This result can be interpreted in one of two 
ways. In the first interpretation, the nuclease activities of Rrp44p are redundant in nonstop 
decay. In the second interpretation, the nuclease activities of Rrp44p are not required for nonstop 
decay, meaning that a nuclease activity that is independent of the exosome is responsible for the 
degradation of nonstop transcripts. 
If the nuclease activities of Rrp44p are redundant in nonstop decay, the nonstop decay 
defects observed in the triple CR3 mutant may be because the triple CR3 mutant protein is 
expressed at lower levels than wild-type Rrp44p. Under this hypothesis, decreased expression of 
Rrp44p could result in decreased nuclease activity, which would result in the stabilization of 
nonstop transcripts. If the nuclease activities of Rrp44p are found to be redundant in nonstop 
decay, the stability of a representative nonstop transcript should be analyzed in a strain that 
overexpresses the triple CR3 mutant. Briefly, an rrp44 deletion strain that is complemented by a 
plasmid that overexpresses the triple CR3 mutant should be transformed with the GAL::pgk1pG-
nonstop transcript. As a control, the GAL::pgk1pG-nonstop reporter should also be transformed 
into a wild-type strain and in a ski7 deletion strain. RNA should be isolated from these strains 
and subjected to agarose formaldehyde gel electrophoresis. The stability of the GAL::pgk1pG-
nonstop transcript should be analyzed in these strains by performing Northern blot analysis. 
Specifically, blots should be hybridized with probes that are specific to pgk1pG, and SCR1 as a 
loading control. If the decreased expression of the triple CR3 mutant is responsible for a non-
functional nonstop decay pathway, the GAL::pgk1pG-nonstop transcript should be rapidly 
degraded in a strain that overexpresses the triple CR3 mutant. Alternatively, stabilization of the 
nonstop reporter in the strain that overexpresses the triple CR3 mutant would suggest that the 
CR3 region is truly needed for nonstop decay. If the nuclease activities of Rrp44p are redundant 
in nonstop decay, the latter result would not be surprising given that the CR3 region seems to be 
needed for the nuclease activities of Rrp44p. 
The CR3 mutant could have defects in nonstop decay even if the nuclease activities of 
Rrp44p are not redundant for the degradation of nonstop transcripts. If the nuclease activities are 
not redundant, another nuclease is responsible for degrading nonstop transcripts. It may be that 
the CR3 region of Rrp44p interacts with this nuclease, and that this interaction is required for 
nonstop decay. This hypothesis could be tested by determining whether any cellular nucleases 
associate with wild-type Rrp44p but not with the triple CR3 mutant.  
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Lastly, regardless of whether the nuclease activities of Rrp44p are redundant in nonstop 
decay, the nonstop decay defects observed in the triple CR3 mutant may be because the CR3 
region of Rrp44p is needed interact with the nonstop mRNA degradation machinery. 
Specifically, the CR3 region could be tested for its interaction with the cytoplasmic exosome 
cofactors, Ski7p and the Ski complex (see above).  
  
The far N-terminus of Rrp44p is needed for viability and is only one of several regions of 
Rrp44p that is required for interaction with the exosome.  
The N-terminus of Rrp44p consists of the far N-terminus, which includes residues 1 to 
46, a CR3 region, and a PIN domain. The structure and function of the far N-terminus is not yet 
known. This region, however, does contain a linker region of conserved residues, specifically, 
residues 34 to 46. The results presented here indicate that this linker region is important for 
viability and that at least the first 33 residues of the far N-terminus of Rrp44p are needed for 
exosome interaction. What is not yet known is which residues of the linker region are needed for 
viability and whether the rest of the far N-terminus of Rrp44p mediates interaction with the 
exosome. 
 
Determining which residues of the far N-terminus of Rrp44p are needed for viability 
 The data presented here indicate that the linker region, which consists of the highly 
conserved residues 34 to 46, is needed for viability. Interestingly, individually mutating six of 
the most conserved residues of this region has no effect on cell growth. This discrepancy may be 
because the residues of the linker region make redundant protein-protein interactions that are 
required for viability. For example, the linker region may be needed to interact with the exosome 
(Bonneau et al., 2009) and/or with an exosome cofactor. If this interaction is required for 
viability, mutation of one residue would not affect cell growth, however, deletion of the entire 
region would be lethal. In support of this, the data presented here and in other studies indicate 
that the N-terminus is needed for interaction with the exosome (Bonneau et al., 2009; Lehner and 
Sanderson, 2004; Schneider et al., 2009; Wang et al., 2007). To test whether these residues are 
redundant for viability, several combinations of linker mutants would have to be generated and 
tested for complementation of an rrp44# [RRP44, URA3] strain. The generation of these mutants 
would be laborious given that there are six highly conserved residues, with a large number of 
combinations that could be tested. 
This experiment would determine whether the linker residues are redundant for viability, 
but would not establish whether these residues are redundant for an essential protein-protein 
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interaction. To test this would be difficult, given that a vital protein-protein interaction would 
have to be identified and combinations of linker mutants would have to be tested for the lack of 
this protein-protein interaction. Although the results presented here, along with several other 
studies, seem to indicate that multiple regions of Rrp44p are needed for association with the 
exosome, no one study has identified whether these regions are truly redundant for exosome 
interaction. Additionally, it is not yet known whether the interaction between Rrp44p and the 
yeast exosome is required for viability. 
 
Determining which regions of the N-terminus of Rrp44p are needed for exosome interaction 
The data shown here indicate that the first 33 residues of Rrp44p are needed for 
exosome interaction, however, the data do not exclude the possibility that the entire far N-
terminus of Rrp44p is needed for association with the exosome. Specifically, the linker region, 
residues 34 to 46, may function with the first 33 residues to mediate the interaction between 
Rrp44p and the exosome.  
Therefore, to determine if the linker region of Rrp44p is also required for exosome 
interaction, an exosome subunit, Rrp43p, should be C-terminally Myc-tagged. In addition, wild-
type Rrp44p, the 34-1001 and 47-1001 truncations, and a truncation that lacks the conserved 
stretch of linker residues, residues 34 to 46, should be C-terminally TAP-tagged and then 
purified. Proteins bound to wild-type and truncated Rrp44p should be eluted and subjected to 
SDS-PAGE and Western blot analysis. Specifically, the interactions between Rrp44p and the 
exosome, namely Rrp43p, should be observed through the use of an antibody specific to the Myc 
tag. If only the first 33 residues of Rrp44p are required for exosome interaction, wild-type 
Rrp44p and a truncation lacking residues 34 to 46 would interact with the exosome. In contrast, 
if the entire far N-terminus, which includes residues 1 to 46, is required to interact with the 
exosome, an interaction between only wild-type Rrp44p and the exosome would be observed. If 
the residues of this region make redundant contacts with the exosome, and the interaction 
between Rrp44p and the exosome is essential, this result would explain why deletion of the first 
46 residues of Rrp44p does not support viability.  
Although the first 33 residues of the far N-terminus of Rrp44p are necessary for 
association with the exosome, this region does not appear to be sufficient for exosome 
interaction. Specifically, the data presented here and in other studies, indicate that the entire N-
terminus of Rrp44p, including the uncharacterized far N-terminus, CR3 region, and PIN domain, 
are required for exosome interaction (Schneider et al., 2009). In addition, a cryo-EM structure of 
the yeast exosome suggests that the RNB domain of Rrp44p also makes contacts with the 
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exosome (Wang et al., 2007). Therefore, the N-terminus is likely one of many regions of Rrp44p 
that are needed for exosome interaction.  
 
Determining the function of the three conserved residues of the far N-terminus of Rrp44p  
 Point mutations of three of the conserved residues of the far N-terminus (Y40A, L41A, 
and R42A) are synthetically lethal with a C-terminal truncation of Rrp44p that lacks the 
exonucleolytic RNB domain. Because at least one nuclease activity of Rrp44p is required for cell 
viability, this finding suggests that these residues may be needed for the endonuclease activity of 
Rrp44p. However, these three point mutants are not synthetically lethal with the D551N mutant, 
which suggests that these residues are not needed for PIN domain nuclease activity. To 
differentiate between these possibilities, the Y40A, L41A, and R42A point mutants, as well as 
wild-type Rrp44p, should be expressed and purified as GST-fusions from E. coli. The purified 
Rrp44p proteins should then be in incubated with a 32P 5’-end labeled A30 oligonucleotide. RNA 
aliquots should be isolated at certain times and subjected to denaturing urea-polyacrylamide gel 
electrophoresis for single nucleotide separation. A PhosphorImager screen should then be used 
to detect endonucleolytic cleavage of the A30 substrate.   
 The synthetic lethality observed when these three point mutations where generated in a 
C-terminal truncation of Rrp44p that lacks the RNB domain could also be because these three 
linker residues and the RNB domain make redundant contacts with the exosome and/or exosome 
cofactors. If the interaction between Rrp44p and the exosome/exosome cofactor are required for 
viability, mutating the linker residues alone, or in combination with D551N, would still allow for 
Rrp44p to make these vital protein-protein interactions, and would thus not affect viability. In 
contrast, mutating these conserved residues in a truncation that lacks the RNB domain may mean 
that Rrp44p is no longer able to participate these essential protein-protein interactions, resulting 
in a synthetic lethal phenotype. To determine whether these regions of Rrp44p are redundant for 
protein-protein interactions, the following proteins should be C-terminally TAP-tagged and 
purified: wild-type Rrp44p, the individual linker point mutants, the D551N mutant, and a mutant 
version of Rrp44p that combines a linker mutant with the D551N mutant. The purified proteins 
should be subject to SDS-PAGE, followed by staining of the SDS gel with Coomassie Brilliant 
Blue. Any proteins that bind to the individual linker mutants and the D551N mutant, but not to 
the combination mutant, should be extracted and analyzed by mass spectrometry.  
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Determining the essential function of Rrp44p  
Thirteen years after the discovery of the exosome (Mitchell et al., 1997), its essential 
function(s) is not yet known. In addition, it is not clear why the ten subunits of the exosome are 
all required for viability. The essential function of Rrp44p is likely nuclear because none of the 
known cytoplasmic functions of the exosome are required for viability and removing the putative 
NLSs of Rrp44p results in a lack of cell growth. The data presented here, however, do not 
exclude the possibility that the Rrp44p truncation that lacks the putative NLSs (13-235) can still 
localize to the nucleus. To address this, the cellular localization of this truncated protein will be 
determined by GFP-tagging residues 13-235. In addition to being nuclear, the essential function 
of Rrp44p requires its nuclease activities, as abolishing both the endo- and exonuclease activities 
of Rrp44p results in a lack of cell growth.  
Although it is possible that the essential function of the exosome is distinct from that of 
Rrp44p, the findings presented here suggest that the essential function of the exosome mirrors 
that of Rrp44p. Specifically, Rrp44p is the only catalytic subunit of the exosome, with two 
separate nuclease active sites. Since the exosome has only been shown to be involved in RNA 
metabolism, the essential function of the exosome most likely requires the nuclease activity of 
Rrp44p. Additionally, the likely nuclear essential function of the exosome would have to rely on 
the nuclear localization of Rrp44p since Rrp44p is the only subunit that contains a putative NLS. 
The data presented here suggest that the essential function of Rrp44p and the exosome is 
nuclear, however, the nuclear exosome is involved in numerous RNA processing reactions. 
Because the products of these processing reactions are required for cell survival, it is impossible 
to know which of the processing reactions is/are needed for viability. The essential function of 
Rrp44p and the exosome is likely not the processing of rRNA, snRNA, or snoRNAs because 
when the exonuclease activity of Rrp44p is abolished or any of the exosome subunits are 
depleted, these mature RNAs are still produced (Allmang et al., 1999a; Allmang et al., 1999b; de 
la Cruz et al., 1998; Dziembowski et al., 2007; LaCava et al., 2005; Lebreton et al., 2008; 
Mitchell et al., 1997; Mitchell et al., 1996; Schaeffer et al., 2009; Schneider et al., 2009; van 
Hoof et al., 2000a). This is likely because there are redundant pathways for nuclear RNA 
processing.  
 The nuclear exosome is also involved in nuclear RNA surveillance, whereby it degrades 
aberrantly processed forms of RNA, as well as CUTs, and the 5’ ETS of the 35S rRNA 
precursor. Therefore, it is possible that the essential function of Rrp44p, and the exosome, is the 
degradation of aberrant nuclear RNAs. In support of this, the degradation of these RNAs requires 
the TRAMP complex, a nuclear cofactor complex that is also essential for cell survival (Castano 
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et al., 1996; Inoue et al., 2000; Liang et al., 1996). To test whether the degradation of aberrant 
RNAs is required for viability is difficult given that these aberrant RNAs arise spontaneously 
and are present at low levels. Additionally, this would be difficult to test because there are so 
many aberrant RNAs that are degraded by the nuclear exosome. If the essential function of 
Rrp44p and the exosome is the degradation of aberrant RNAs, cell viability would likely require 
the efficient degradation of more than one aberrant RNA.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
166 
CONCLUDING REMARKS 
 This dissertation has contributed to the field of eukaryotic RNA metabolism by 
providing a detailed genetic and biochemical analysis of the catalytic subunit of the eukaryotic 
RNA degrading exosome, Rrp44p. Specifically, this work has described a novel nuclease 
activity of Rrp44p and has shown that the regions/domains of Rrp44p have specific functions in 
both the cytoplasmic and nuclear exosome. Further, this work has uncovered the roles of Rrp44p 
in eukaryotic RNA metabolism, as a post-transcriptional regulator of gene expression and as an 
RNA surveillance protein to maintain the fidelity of gene expression. 
 Finally, this dissertation work provides a foundation on which to develop further 
experiments to elucidate the RNA substrates of Rrp44p and to structurally, and functionally, 
define the CR3 region of Rrp44p. 
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Appendix: The essential function of Rrp44p cannot be carried out by 
other 3’ to 5’ exoribonucleases. 
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INTRODUCTION 
The crystal structure of the eukaryotic exosome shows homology to two RNA 
degradation complexes, bacterial PNPase and the archaeal exosome. Specifically, PNPase and 
the archaeal and eukaryotic exosomes contain a PH ring that consists of six PH domains, or 
subunits (Liu et al., 2006), that are homologous to RNase PH (Zuo and Deutscher, 2001). In 
bacteria, RNase PH is a phosphorolytic 3’ to 5’ exoribonuclease that uses inorganic phosphate to 
process, or trim, tRNA precursors to form mature tRNA species (Wen et al., 2005). In PNPase 
and the archaeal exosome, three of the PH domains have 3’ to 5’ exoribonuclease activity 
(Buttner et al., 2005; Lorentzen and Conti, 2005; Navarro et al., 2008; Symmons et al., 2000). 
Because of the similarity between these RNA degradation complexes, it was initially thought 
that the PH ring of the eukaryotic exosome was the site of RNA degradation. However, recent 
studies have shown that despite the sequence and structural similarity to PNPase and the archaeal 
exosome, the six PH subunits of the eukaryotic exosome are catalytically inactive due to 
mutations the RNase PH-like active sites. Therefore, unlike PNPase and the archaeal exosome, 
the PH ring of the yeast and human exosome does not have exonuclease activity (Dziembowski 
et al., 2007; Liu et al., 2006). 
Interestingly, however, a PH subunit in the Arabidopsis thaliana exosome, Rrp41p 
(AtRrp41p), displays phosphorolytic 3’ to 5’ exoribonuclease activity in vitro and can also 
rescue the rRNA processing and mRNA degradation defects of a yeast rrp41 mutant. AtRrp41p 
can also interact with several of the yeast exosome subunits in vivo and in vitro (Chekanova et 
al., 2000), which suggests that this catalytically active subunit can participate in the 
evolutionarily conserved interactions that are needed for the structural integrity of the exosome. 
Three of the ten exosome subunits bind to one side of the PH ring, forming a cap. These 
subunits contain multiple RNA binding domains and are, therefore, thought to bind the RNA 
substrates of the exosome. The last remaining subunit, Rrp44p, is the only catalytically active 
subunit of the yeast and Drosophila exosome (Dziembowski et al., 2007; Mamolen and 
Andrulis, 2009). This is also likely the case in humans, where the other nine exosome subunits 
are catalytically inactive (Liu et al., 2006). Rrp44p is homologous to bacterial RNase II and 
RNase R, two hydrolytic 3’ to 5’ exoribonucleases. Specifically, these enzymes use a water 
molecule to degrade mRNA from the 3’-end (Cannistraro and Kennell, 1994; Cheng and 
Deutscher, 2002).  
Rrp44p has a similar domain organization and is, thus structurally similar, to RNase II 
and RNase R. Specifically, E. coli RNase II has 44% amino acid similarity and 22% amino acid 
identity to yeast Rrp44p, whereas E. coli RNase R has 48% amino acid similarity and 25% 
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amino acid identity to Rrp44p. These proteins have two consecutive N-terminal cold shock 
domains (CSDs), a central catalytic domain (RNB), that is responsible for the 3’ to 5’ 
exoribonuclease activity of the proteins, and a C-terminal S1 domain (Figure A.2A). The CSDs 
and S1 domain are putative RNA binding domains that are positioned on one side of the RNB 
domain. In all three proteins, ssRNA is threaded through the putative RNA binding domains, 
such that the 3’-end of the RNA rests in the catalytic site of the RNB domain (Bonneau et al., 
2009; Frazao et al., 2006; Lorentzen et al., 2008; Zuo et al., 2006). Biochemically, Rrp44p is 
more similar to RNase R. Unlike RNase II, RNase R and Rrp44p are able to degrade structured 
RNAs and double stranded RNAs that contain a single stranded 3’ overhang (Dziembowski et 
al., 2007; Vincent and Deutscher, 2006).  
The eukaryotic exosome is involved in RNA processing and degradation in the nucleus 
and cytoplasm. Because Rrp44p is the catalytic subunit, Rrp44p is most likely responsible for 
these RNA processing and degradation reactions. Specifically in the nucleus, the pairing of 
Rrp44p with another hydrolytic 3’ to 5’ exoribonuclease, Rrp6p (Briggs et al., 1998), is required 
for efficient RNA processing of RNA precursors to form small, stable, mature RNAs (Allmang 
et al., 1999a; Allmang et al., 1999b; Mitchell et al., 1997; Mitchell et al., 1996), and for the rapid 
degradation of aberrantly processed RNAs (Bousquet-Antonelli et al., 2000; Davis and Ares, 
2006; Kadaba et al., 2004; Libri et al., 2002; Torchet et al., 2002). Although these proteins are 
structurally dissimilar, it has recently been reported that these enzymes are functionally 
redundant (Lebreton et al., 2008).  
In this Appendix, AtRrp41p, E. coli RNase II and RNase R, and S. cerevisiae Rrp6p, 
were tested individually for complementation of a yeast rrp44 deletion strain. Here, the data 
indicate that none of these 3’ to 5’ exonucleases can carry out the essential function of Rrp44p. 
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RESULTS 
A. thaliana Rrp41p cannot carry out the essential function of Rrp44p. 
 Although none of the PH subunits of the yeast exosome are catalytically active, 
AtRrp41p has 3’ to 5’ exonuclease activity in vitro. In addition, AtRrp41p can complement the 
RNA processing and degradation defects of a yeast rrp41 mutant (Chekanova et al., 2000). To 
determine whether AtRrp41p can carry out the essential function of Rrp44p, a plasmid 
containing A. thaliana RRP41 under the control of the constitutively active glyceraldehyde-3-
phosphate dehydrogenase (GPD) promoter was generated and transformed into an rrp44! 
[RRP44, URA3] strain. Transformants were spotted onto media containing 5-FOA and grown for 
several days. Growth of AtRrp41p was compared to two controls, wild-type RRP44 and empty 
vector. Similar to the empty vector control, AtRrp41p was not able to suppress the rrp44 
deletion (Figure A.1A). This lack of suppression was not due to a lack of expression, as 
AtRrp41p was able to complement a yeast rrp41 deletion strain (Figure A.1B). This suggests 
that although AtRrp41p is catalytically active, it is not able to carry out the essential function of 
Rrp44p.  
 
E. coli RNase II and RNase R cannot carry out the essential function of Rrp44p. 
 E. coli RNase II and RNase R are structurally and functionally similar to yeast Rrp44p 
(Frazao et al., 2006; Zuo et al., 2006). To determine whether these bacterial exonucleases can 
carry out the essential function of Rrp44p, plasmids containing E. coli RNase II and RNase R 
under the control of the constitutively active GPD promoter were generated and transformed into 
an rrp44! [RRP44, URA3] strain. Transformants were spotted onto media containing 5-FOA and 
grown for several days. Growth of the bacterial exonucleases was compared to two controls, 
wild-type RRP44 and empty vector. Despite their similarities to Rrp44p, overexpression of 
RNase II or RNase R did not suppress the rrp44 deletion (Figure A.2B). This suggests that 
neither of these bacterial exonucleases can carry out the essential function of yeast Rrp44p. 
 The data presented in Chapter 3 indicate that cells lacking the exonuclease activity of 
Rrp44p have a slow growth phenotype, indicating that this nuclease activity is not needed for 
viability but rather for optimal cell growth. Although RNase II and RNase R cannot carry out the 
essential function of Rrp44p, the exonuclease activities of these proteins may be interchangeable 
with the exonuclease activity of Rrp44p. Under this hypothesis, coupling RNase II and/or RNase 
R in trans with a truncation of Rrp44p that lacks exonuclease activity should restore optimal cell 
growth. To test this, plasmids that overexpress RNase II and RNase R were individually 
transformed into an rrp44! [RRP44, URA3] strain that also contains a plasmid encoding a C-
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Figure A.1: A. thaliana Rrp41p does not suppress a yeast rrp44 deletion. A, An rrp44 
deletion strain complemented by full-length RRP44 on a plasmid with a URA3 marker was 
transformed with a plasmid that overexpressed A. thaliana RRP41. Transformants were spotted 
onto media containing 5-FOA and control media (SC –HIS –URA + 2% dextrose), and grown 
for several days. Growth of A. thaliana RRP41 was compared to two controls, wild-type RRP44 
and empty vector. Growth on 5-FOA would suggest that A. thaliana Rrp41p can carry out the 
essential function of Rrp44p. B, An S. cerevisiae rrp41 deletion strain complemented by full-
length S. cerevisiae RRP41 on a plasmid with a URA3 marker was transformed with a plasmid 
that overexpressed A. thaliana RRP41. Transformants were spotted onto media containing 5-
FOA and control media (SC –HIS –URA + 2% dextrose), and grown for several days. Growth of 
A. thaliana RRP41 was compared to empty vector. Growth on 5-FOA would suggest that A. 
thaliana Rrp41p can carry out the essential function of yeast Rrp41p.  
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terminal truncation that lacks the exonucleolytic RNB domain of Rrp44p. Transformants were 
then spotted onto media containing 5-FOA and grown for several days. Growth of the strains 
containing the bacterial exonucleases and truncated Rrp44p were compared to three controls, 
wild-type RRP44, a strain containing only the C-terminal truncation of Rrp44p, and empty 
vector. Despite the lack of suppression of an rrp44 deletion strain, overexpressed RNase R was 
able to restore optimal growth in a strain that lacked Rrp44p exonuclease activity. In contrast, 
overexpressing RNase II in trans with the same C-terminal truncation of Rrp44p did not restore 
optimal growth (Figure A.2C). The lack of in trans suppression by RNase II is not due to a lack 
of protein expression, as RNase II is expressed in yeast (Figure A.2D). These results suggest that 
the exonuclease activity of E. coli RNase R, but not RNase II, may be able to substitute for yeast 
Rrp44p exonuclease activity. Additionally, these results are consistent with the 34-1001 
truncation and triple CR3 mutant of Rrp44p being able to complement an rrp44 deletion, but not 
being able to interact with the exosome. 
 
S. cerevisiae Rrp6p cannot carry out the essential function of Rrp44p. 
 Rrp6p and Rrp44p share some overlapping functions in the nucleus (Chapter 3; Lebreton 
et al., 2008). Since the essential function of Rrp44p is likely nuclear, Rrp6p may be redundant 
with the essential function of Rrp44p. To test this, a plasmid encoding S. cerevisiae Rrp6p under 
the control of the constitutively active GPD promoter was generated and transformed into an 
rrp44! [RRP44, URA3] strain. Transformants were spotted onto media containing 5-FOA and 
grown for several days. Growth of yeast Rrp6p was compared to two controls, wild-type RRP44 
and empty vector. Similar to the empty vector control, Rrp6p did not support viability (Figure 
A.3A). The lack of suppression by yeast Rrp6p was not due to a lack of expression, as Rrp6p 
was able to complement an rrp6 deletion strain (Figure A.3B). Therefore, although Rrp6p and 
Rrp44p may share some overlapping functions in the nucleus, none of these functions are the 
essential function of Rrp44p. 
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Figure A.2: E. coli RNase II or RNase R does not suppress a yeast rrp44 deletion.  
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Figure A.2: E. coli RNase II or RNase R does not suppress a yeast rrp44 deletion.  
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Figure A.2: E. coli RNase II or RNase R does not suppress a yeast rrp44 deletion. A, A 
schematic representation of the domain organization of S. cerevisiae Rrp44p and E. coli RNase 
II and RNase R. Also shown are the percent amino acid similarity and identity between the three 
homologs. B, An rrp44 deletion strain complemented by full-length RRP44 on a plasmid with a 
URA3 marker was transformed with plasmids that overexpressed E. coli RNase II and RNase R. 
Transformants were spotted onto media containing 5-FOA and control media (SC –HIS –URA + 
2% dextrose), and grown for several days. Growth of the yeast strains containing E. coli RNase 
II and RNase R was compared to two controls, wild-type RRP44 and empty vector. Growth on 5-
FOA would suggest that the E. coli RNases can carry out the essential function of Rrp44p. C, An 
rrp44 deletion strain complemented by full-length RRP44 on a plasmid with a URA3 marker was 
transformed with a C-terminal truncation of rrp44 that lacks the region that is homologous to 
RNase II and RNase R and a plasmid that overexpressed E. coli RNase II or RNase R. 
Transformants were spotted onto media containing 5-FOA and control media (SC –HIS –URA + 
2% dextrose), and grown for several days. Growth of the mutants was compared to two controls, 
wild-type RRP44 and empty vector. Growth on 5-FOA indicates that the N-terminus of Rrp44p, 
in trans with an E. coli RNase, can carry out the essential function of Rrp44p. C, Whole-cell 
lysate was obtained from a strain containing a plasmid that overexpressed E. coli RNase II and 
was analyzed by Western blot analysis with antibodies specific to the His tag to detect RNase II. 
Expression of E. coli RNase II was compared to empty vector.  
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Figure A.3: S. cereivisiae Rrp6p does not suppress an rrp44 deletion.  
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Figure A.3: S. cerevisiae Rrp6p does not suppress an rrp44 deletion. An rrp44 deletion strain 
complemented by full-length RRP44 on a plasmid with a URA3 marker was transformed with a 
plasmid that overexpressed S. cerevisiae RRP6. Transformants were spotted onto media 
containing 5-FOA and control media (SC –HIS –URA + 2% dextrose), and grown for several 
days. Growth of RRP6 was compared to two controls, wild-type RRP44 and empty vector. 
Growth on 5-FOA would suggest that S. cerevisiae Rrp6p can carry out the essential function of 
Rrp44p. B, An S. cerevisiae rrp6 deletion strain was transformed with a plasmid that 
overexpressed S. cerevisiae RRP6. Transformants were spotted onto selection media and grown 
for several days at the indicated temperatures. Growth of RRP6 was compared to empty vector. 
Growth at 37°C indicates that Rrp6p can rescue the temperature-sensitive phenotype of the rrp6 
deletion strain.  
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DISCUSSION 
The data presented in this Appendix indicate that AtRrp41p, E. coli RNase II and RNase 
R, and yeast Rrp6p, were not able to carry out the essential function(s) of yeast Rrp44p. Because 
each of these enzymes is distinct, they were tested for suppression of an rrp44 deletion strain for 
different reasons.  
AtRrp41p was tested for suppression of an rrp44 deletion strain because it has 3’ to 5’ 
exonuclease activity in vitro and can interact with the yeast exosome in vivo and in vitro. In 
addition, AtRrp41p is able to rescue the RNA processing defects of a yeast rrp41 mutant 
(Chekanova et al., 2000), which suggests that it localizes to the nucleus. This assumed 
localization is important as the essential function of Rrp44p is likely nuclear. Despite these 
observations, AtRrp41p was not able to suppress an rrp44 deletion. There are several possible 
explanations for this lack of suppression. First, it may be that AtRrp41p and yeast Rrp44p have 
different essential functions. For example, if AtRrp41p is required for RNA processing and yeast 
Rrp44p is required for the degradation of aberrant RNAs in the nucleus, overexpressing 
AtRrp41p in an rrp44 deletion strain would not restore viability. Another explanation is that, 
although AtRrp41p can associate with yeast Rrp4p and Rrp44p (Chekanova et al., 2000), 
AtRrp41p may have weak or non-existent interactions with the exosome in the rrp44 deletion 
strain.  
E. coli RNase II and RNase R were tested for suppression of an rrp44 deletion strain 
because these enzymes are biochemically similar to Rrp44p. More importantly for these 
suppression studies, Rrp44p, RNase II, and RNase R share a similar domain organization of the 
same three RNA binding domains and catalytic RNB domain (Bonneau et al., 2009; Frazao et 
al., 2006; Lorentzen et al., 2008; Zuo et al., 2006). If these domains of Rrp44p were required for 
the protein’s essential function, RNase II and RNase R should be able to suppress an rrp44 
deletion. The data presented in Chapter 3, however, indicate that the N-terminus of Rrp44p, 
specifically the CR3 region and PIN domain, are required for viability. Since RNase II and 
RNase R do not have these regions, it is not surprising that these proteins are unable to carry out 
the essential function of Rrp44p. Unexpectedly, however, overexpressing RNase R in trans with 
a C-terminal truncation of Rrp44p that lacks exonuclease activity restored optimal growth. This 
suggests that Rrp44p functions as an exonuclease independent of its association with the 
exosome. In support of this, the triple CR3 mutant of Rrp44p and a truncation lacking the first 33 
residues of Rrp44p can complement an rrp44 deletion, however, these mutant proteins do not 
interact with the exosome. Similarly, although human Rrp44p is essential, its interaction with the 
exosome is not required for viability (Allmang et al., 1999b; Raijmakers et al., 2004). Another 
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study also indicates that the interaction between yeast Rrp44p and the exosome is not required 
for viability, since human Rrp44p can complement a yeast rrp44 mutant (Shiomi et al., 1998). 
Therefore, a general theme that has emerged from these, and other, studies is that the interaction 
between Rrp44p and the exosome is not required for Rrp44p exonuclease activity or for cell 
survival. 
In the in trans RNase R overexpression studies, a C-terminal truncation that consisted of 
residues 1-440 was used. Because this truncation includes a portion of the RNase II/R homology 
region, specifically CSD1 and a portion of CSD2, this truncation does not accurately address 
whether overexpressing RNase R in trans with the N-terminus of Rrp44p (including the CR3 
region and PIN domain) can restore optimal cell growth. To better test this, an rrp44 deletion 
strain that is complemented by a plasmid encoding only the regions of Rrp44p that are not 
homologous to RNase II/R (residues 1-235) should be transformed with a plasmid that 
overexpresses E. coli RNase R.  
Lastly, yeast Rrp6p was tested for suppression of an rrp44 deletion strain because these 
proteins share some overlapping functions, as demonstrated in Chapter 3 and in previous studies 
(Lebreton et al., 2008). Specifically, combining the catalytically inactive exonuclease point 
mutant of Rrp44p, D551N, with an rrp6 deletion, results in a synthetic sick phenotype. 
Additionally, these proteins are known to be required for some of the same RNA processing and 
degradation reactions in the nucleus (Briggs et al., 1998). Despite this, yeast Rrp6p cannot carry 
out the essential function of Rrp44p. This may be because these proteins have different essential 
functions. In support of this, the functional interaction between Rrp44p and Rrp6p is important 
for only certain Rrp6p substrates (Callahan and Butler, 2008).  
Because the exonucleolytic RNB domain of Rrp44p interacts with Rrp6, future studies 
should focus on whether the exonuclease activity of Rrp6p can substitute for the exonuclease 
activity of Rrp44p. Briefly, Rrp6p should be overexpressed in yeast strains that contain the 
D551N mutant or a C-terminal truncation of Rrp44p that lacks exonuclease activity. If 
overexpressing Rrp6p is able to restore optimal growth in these strains, this would suggest that 
overexpression of Rrp6p abrogates the need for the 3’ to 5’ exonuclease activity of Rrp44p in the 
nucleus.  
Moreover, although AtRrp41p, E. coli RNase II and RNase R, and yeast Rrp6p are 
expressed in yeast and are catalytically active, these proteins cannot carry out the essential 
function of Rrp44p. This is likely because the exonuclease activity of the catalytic subunit is not 
needed for viability and may be because AtRrp41p and yeast Rrp6p have different essential 
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functions. Until the essential function(s) of Rrp44p is known, it will be difficult to find a single 
protein that is redundant for the essential function of the catalytic subunit of the exosome. 
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